Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027135	s-igg1	g/l (g/l)	3062	4159	0.00%
3027135	s-igg1	— (—)	1415	1878	100.00%	Distribution not available
3027135	s-immunoglobuliinig,alaluokka1	g/l (g/l)	24	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Undetermined asthma, excluding more controls

292

207

14.77

322.83

1.7

1.2

6.04

7.00

g/l

2.50

218

137

Undetermined asthma

292

214

14.29

316.76

1.7

1.2

6.04

7.01

g/l

2.58

218

141

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1325

2828

3.34

316.54

1.4

6.73

6.72

g/l

0.02

959

1922

Acute pancreatitis (for exclusion)

459

636

7.56

314.41

1.6

1.3

6.09

6.86

g/l

2.91

212

463

Abnormal findings on diagnostic imaging of lung

751

1395

5.39

307.65

1.4

1.3

6.99

6.87

g/l

0.27

548

966

Asthma, hospital admissions 3, pneumonia

682

1074

6.56

307.65

1.4

1.3

6.32

7.06

g/l

4.25

520

733

Acute pancreatitis

459

558

8.63

307.65

1.6

1.3

6.09

6.87

g/l

3.03

212

410

Chronic sinusitis

758

1472

5.29

307.65

1.5

1.3

6.20

7.13

g/l

7.80

576

979

Oral corticosteroids

1974

1966

6.23

307.65

1.5

1.2

6.59

6.89

g/l

1.74

1405

1315

Pneumonia, organism unspecified

1245

2552

3.59

307.65

1.4

6.75

g/l

0.00

902

1721

Pneumonias (Asthma/COPD co-morbidities)

1357

2831

3.37

307.65

1.4

6.73

6.70

g/l

0.09

982

1923

1279

1876

4.35

307.65

1.4

1.3

6.70

6.98

g/l

1.20

929

1234

Asthma (only as main-diagnosis), excluding more controls

1215

997

7.43

307.65

1.5

1.3

6.22

7.06

g/l

6.72

890

627

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1279

1876

4.35

307.65

1.4

1.3

6.70

6.98

g/l

1.20

929

1234

Chronic lower respiratory diseases

1612

2642

3.35

307.65

1.4

1.3

6.43

6.94

g/l

4.77

1180

1771

908

1551

6.00

307.65

1.5

1.3

6.14

6.83

g/l

6.15

690

1062

Asthma, excluding more controls

1260

997

6.88

307.65

1.5

1.3

6.28

7.06

g/l

5.90

923

627

First line medication for Crohn's disease

1818

1847

5.48

307.65

1.5

1.2

6.69

6.85

g/l

0.69

1292

1237

Asthma, including avohilmo

1535

2814

3.21

307.65

1.5

1.3

6.28

7.01

g/l

10.11

1126

1893

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

959

2004

4.54

307.65

1.5

1.3

7.07

6.80

g/l

0.97

677

1383

ILD medications: immunosuppressive drugs

1030

1606

6.31

307.65

1.6

1.2

6.88

6.82

g/l

0.14

739

1076

Asthma

1280

1040

6.74

307.65

1.5

1.3

6.27

7.09

g/l

6.45

942

651

Asthma (diagnoses ohter than nonallergic)

1334

2884

4.03

307.65

1.5

1.3

6.22

6.98

g/l

11.25

983

1972

Fever of other and unknown origin

894

1683

5.04

307.65

1.4

1.3

6.82

6.80

g/l

0.05

638

1165

Certain disorders involving the immune mechanism

567

679

8.89

307.65

1.9

1.3

5.63

6.82

g/l

8.24

424

472

Asthma, hospital admission 2, infections

1097

2028

5.47

307.65

1.5

1.3

6.17

7.00

g/l

10.00

830

1392

ILD medications: prednisolone, methylprednisolone, prednisone

1933

1826

6.12

307.65

1.5

1.2

6.62

6.86

g/l

1.36

1382

1208

Inflammatory bowel disease treatment related agents

1995

2068

5.60

307.65

1.5

1.2

6.69

6.84

g/l

0.68

1421

1390

ILD medications

1943

1873

5.82

307.65

1.5

1.2

6.70

6.85

g/l

0.60

1391

1242

Systemic connective tissue disorders

676

1190

5.88

307.65

1.7

1.3

7.02

6.58

g/l

1.44

490

820

Asthma, hospital admissions , main diagnosis only

1265

2931

3.94

307.65

1.5

1.3

6.21

6.97

g/l

10.84

934

2003

Asthma-related pneumonia or sepsis

682

1074

6.56

307.65

1.4

1.3

6.32

7.06

g/l

4.25

520

733

Asthma, unspecified (mode), excluding more controls

747

891

6.72

307.65

1.5

1.3

6.34

7.13

g/l

4.60

522

569

Asthma (mode)

1239

1044

6.65

307.65

1.5

1.3

6.25

7.09

g/l

6.69

914

654

Immunodeficiencies

350

140

30.69

307.65

2.0

1.3

5.07

7.13

g/l

5.17

284

Bronchiectasis

267

150

19.43

307.65

1.4

1.3

7.12

7.13

g/l

0.01

198

106

Immunodeficiency with predominantly antibody defects

275

53.90

307.65

2.1

1.3

4.94

7.49

g/l

3.47

230

Influenza and pneumonia

1431

2811

3.40

307.65

1.4

1.3

6.68

6.74

g/l

0.18

1041

1905

Asthma-related infections

1097

2028

5.47

307.65

1.5

1.3

6.17

7.00

g/l

10.00

830

1392

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1355

2781

3.55

307.65

1.5

1.3

6.62

6.80

g/l

0.72

973

1930

All pneumoniae

1361

2844

3.35

307.65

1.4

6.72

6.71

g/l

0.04

985

1928

Asthma, unspecified (mode)

750

926

6.55

307.65

1.5

1.3

6.34

7.16

g/l

4.92

525

589

Asthma (only as main-diagnosis)

1223

1040

7.26

307.65

1.5

1.3

6.23

7.09

g/l

6.87

896

651

Asthma-related pneumonia

680

1069

6.57

307.65

1.4

1.3

6.32

7.07

g/l

4.36

519

731

Asthma/COPD (KELA code 203)

1240

2626

3.38

301.38

1.5

1.3

6.19

6.95

g/l

10.10

919

1760

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

292

130

17.41

288.18

1.5

1.2

7.65

7.08

g/l

0.80

202

Other systemic involvement of connective tissue (FG)

473

749

6.48

282.41

1.8

1.2

7.28

6.63

g/l

1.66

345

511

Second line medication for Crohn's disease

855

2274

3.84

277.04

1.6

1.3

7.01

6.70

g/l

1.06

612

1585

L04AX Other immunosuppressants

834

2219

3.84

270.13

1.6

1.3

6.97

6.74

g/l

0.73

601

1539

Autoimmune diseases related-to ILD

1087

2981

3.26

266.06

1.4

7.12

6.57

g/l

3.46

747

2076

Other pulmonary diagnosis

890

1050

4.30

262.15

1.3

6.60

7.08

g/l

2.07

626

658

Excluding asthma or asthma-COPD overlap

888

1050

4.29

260.88

1.3

6.63

7.08

g/l

1.84

623

658

ILD differential diagnosis

883

1044

4.29

259.40

1.3

6.63

7.09

g/l

1.86

620

654

Other systemic involvement of connective tissue

489

878

5.75

259.16

1.8

1.3

7.24

6.52

g/l

2.20

356

608

COPD differential diagnosis

883

1045

4.28

259.13

1.3

6.63

7.09

g/l

1.88

621

654

COPD/asthma related infections

1216

1878

3.28

251.58

1.4

1.3

6.53

6.98

g/l

2.80

886

1235

COPD/asthma/ILD related infections

1216

1878

3.28

251.58

1.4

1.3

6.53

6.98

g/l

2.80

886

1235

Abnormalities of breathing

1114

2033

3.30

247.30

1.4

1.3

6.44

6.91

g/l

3.01

791

1365

Cough

588

1232

4.68

244.71

1.4

1.3

6.47

6.94

g/l

1.81

446

837

Asthma and opportunity respiratory infection

186

21.71

243.50

1.4

1.3

6.66

7.29

g/l

0.53

133

Other and unspecified immunodeficiencies with predominantly antibody defects

142

56.13

240.63

2.2

1.4

4.46

6.71

g/l

4.52

118

Allergic asthma (mode), excluding more controls

355

482

7.39

240.34

1.5

1.3

6.07

7.06

g/l

4.30

288

304

Acute sinusitis

752

1882

3.80

235.68

1.5

1.3

6.26

6.88

g/l

4.43

572

1265

Allergic asthma (mode)

355

493

7.23

235.57

1.5

1.3

6.07

7.14

g/l

4.69

288

311

Other respiratory diseases principally affecting the interstitium

333

453

7.66

231.66

1.4

1.3

7.45

6.70

g/l

1.61

230

311

Autoimmune diseases excluding thyroid diseases

1259

2412

2.93

226.14

1.4

1.3

7.07

6.47

g/l

4.35

892

1664

1282

2343

2.92

225.24

1.4

1.3

6.48

7.06

g/l

4.82

943

1557

Disorders of gallbladder, biliary tract and pancreas

1169

2575

2.96

224.33

1.5

1.3

6.82

6.77

g/l

0.13

697

1903

Other interstitial pulmonary diseases

298

373

8.36

222.90

1.4

1.3

7.69

6.69

g/l

2.14

204

254

Any gastric operation

932

1305

3.62

222.43

1.4

1.2

6.74

6.68

g/l

0.16

614

1020

GASTRO-related operations

932

1305

3.62

222.43

1.4

1.2

6.74

6.68

g/l

0.16

614

1020

Interstitial lung disease

298

377

8.27

220.92

1.4

1.3

7.69

6.68

g/l

2.18

204

257

Interstitial lung disease endpoints

298

377

8.27

220.92

1.4

1.3

7.69

6.68

g/l

2.18

204

257

ILD, hospital admissions

296

372

8.33

220.69

1.4

1.3

7.66

6.68

g/l

2.04

202

256

Non-allergic asthma (mode), excluding more controls

287

344

8.48

218.84

1.5

1.2

6.27

7.18

g/l

2.41

215

225

ILD, hospital admission 2, with pulmonary infections

207

161

13.55

217.32

1.4

7.58

6.81

g/l

0.79

143

111

ILD medications: azathioprine

290

365

8.25

215.54

1.8

1.2

7.01

6.80

g/l

0.30

205

251

General symptoms and signs

1269

2222

2.89

215.33

1.4

1.3

6.73

6.72

g/l

0.03

909

1513

Autoimmune diseases excluding thyroid diseases, strict definition

1208

2337

2.91

215.13

1.4

1.3

7.07

6.49

g/l

4.02

862

1624

Non-allergic asthma (mode)

287

358

8.15

211.79

1.5

1.2

6.27

7.27

g/l

2.67

215

232

Reimbursement for rheumatic diseases

773

2318

3.39

207.92

1.5

1.4

7.13

6.71

g/l

1.69

564

1610

Azathioprine

290

382

7.88

207.37

1.8

1.2

7.01

6.64

g/l

0.64

205

262

ILD, hospital admissions 1, main diag only

268

324

8.68

206.40

1.4

1.3

7.73

6.68

g/l

2.05

185

225

Bacterial pneumonia (organism specified)

579

1291

4.16

204.82

1.4

6.65

6.86

g/l

0.47

414

878

Bacterial pneumoniae

531

1082

4.43

201.68

1.4

6.64

6.85

g/l

0.47

384

726

ILD, hospital admissions 3, with pneumonia sepsis

183

146

13.25

189.31

1.2

1.3

7.79

6.87

g/l

0.87

126

Chronic rhinitis, nasopharyngitis and pharyngitis

465

1049

4.54

188.59

1.4

6.34

7.06

g/l

3.81

374

705

Symptoms and signs involving the circulatory and respiratory systems

1143

2048

2.83

186.61

1.4

1.3

6.61

6.92

g/l

1.57

810

1371

Bacterial pneumonia, not elsewhere classified

497

1027

4.37

185.39

1.3

6.64

6.83

g/l

0.38

359

687

Obesity related asthma

470

1095

4.39

182.99

1.4

1.3

6.14

7.03

g/l

5.36

327

730

Bronchitis

1188

3028

2.60

180.83

1.4

1.3

6.46

6.88

g/l

2.77

864

2062

Other acute lower respiratory infections

684

2032

3.26

171.90

1.5

1.4

6.39

6.83

g/l

1.98

501

1404

Nonhereditary hypogammaglobulinemia

101

52.80

170.45

2.3

1.3

4.29

6.91

g/l

3.79

Chronic pancreatitis

241

323

7.79

170.10

1.9

1.2

6.49

6.97

g/l

0.96

124

240

Acute upper respiratory infections

1128

2751

2.60

168.94

1.5

1.3

6.32

6.98

g/l

6.42

835

1857

Dyspnoea

979

2853

2.66

162.17

1.4

6.51

6.82

g/l

1.52

689

2001

Autoimmune diseases

1196

2423

2.54

161.99

1.4

1.3

7.09

6.47

g/l

4.41

840

1673

Used for control exclusion in common control thyroid runs

1129

2216

2.61

159.93

1.4

1.3

7.16

6.49

g/l

4.57

772

1552

Bacterial infection, other or unspecified

590

1578

3.43

157.96

1.4

6.91

6.81

g/l

0.18

424

1085

Examination and observation for other reasons

691

1276

3.33

157.59

1.5

1.3

6.35

6.99

g/l

3.36

584

751

Asthma and allergy, excluding more controls

212

266

8.08

155.23

1.5

1.3

6.09

7.13

g/l

3.12

176

179

Asthma and allergy

212

270

7.96

153.29

1.5

1.2

6.09

7.17

g/l

3.22

176

Acute bronchitis

519

1451

3.57

150.90

1.5

1.3

6.38

6.82

g/l

1.48

381

1003

Other bacterial diseases

1007

2761

2.55

149.54

1.4

6.93

6.68

g/l

0.85

708

1913

Diseases of the respiratory system

620

861

3.64

149.43

1.4

1.3

6.52

7.19

g/l

2.76

435

544

Kela reimbursement Agammaglobulinemia (D80-84)

62.03

148.43

2.2

1.4

4.44

7.64

g/l

2.92

Pain in joint

649

1329

3.27

148.15

1.4

6.49

6.97

g/l

1.88

473

888

Enlarged lymph nodes

264

456

5.97

145.90

1.5

1.2

7.25

6.60

g/l

1.23

193

320

Other diseases of pleura

502

1266

3.57

142.56

1.5

1.4

6.78

6.94

g/l

0.36

343

870

Cholangitis (primary sclerosing, PSC)

144

125

12.20

141.36

1.8

1.2

7.85

6.88

g/l

1.33

Any reimbursement code in KELA

650

976

3.37

140.65

1.4

1.3

6.61

6.77

g/l

0.43

457

669

Suggestive for eosinophilic asthma

188

237

8.31

139.96

1.9

1.3

6.13

6.93

g/l

1.86

147

161

Other diseases of biliary tract

162

171

9.91

138.60

2.1

1.3

7.15

6.83

g/l

0.37

127

Acute upper respiratory infections of multiple and unspecified sites

807

2259

2.71

137.79

1.4

1.3

6.34

6.94

g/l

4.37

589

1526

Septicaemia

458

1226

3.65

137.51

1.4

1.3

7.19

6.74

g/l

0.95

318

856

Other necrotizing vasculopathies

159

170

9.88

135.05

1.4

6.15

7.00

g/l

1.25

116

124

Tramadol

827

1995

2.69

134.22

1.4

6.57

6.93

g/l

1.56

592

1375

Anaemias

341

463

4.99

134.13

1.4

1.3

7.08

6.60

g/l

0.99

239

339

Other specified/unspecified systemic involvement of connective tissue

154

160

10.25

133.80

2.4

1.4

7.56

6.73

g/l

0.84

122

110

Other diseases of upper respiratory tract

1101

2411

2.40

133.70

1.4

1.3

6.37

7.04

g/l

6.35

804

1603

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

161

181

9.33

131.45

1.7

1.4

8.03

6.97

g/l

1.19

107

124

Finngen Rheumatological endpoints

1022

2413

2.44

131.41

1.5

1.3

6.94

6.68

g/l

1.05

728

1639

FESS (DNB20)

250

455

5.72

131.19

1.7

1.4

6.42

6.72

g/l

0.54

181

312

Early onset COPD, excluding more controls

217

342

6.46

131.07

1.6

1.3

6.15

7.40

g/l

3.39

153

221

Gastrointestinal diseases

629

971

3.28

130.67

1.5

1.3

6.65

6.66

g/l

0.03

436

711

Ethmoidectomy

255

478

5.55

129.56

1.7

1.4

6.42

6.77

g/l

0.67

185

331

Diseases of oesophagus, stomach and duodenum

1093

2881

2.33

129.34

1.4

6.58

6.82

g/l

1.09

781

1988

Explicit Sepsis

480

1378

3.39

128.77

1.4

1.3

7.17

6.73

g/l

0.97

335

968

Other necrotizing vasculopathies (FG)

137

128

11.31

128.09

1.5

1.3

6.28

7.10

g/l

0.87

Diseases of liver

428

1206

3.62

127.80

1.3

1.4

7.99

6.63

g/l

5.49

279

846

Pain in throat and chest

819

1917

2.64

125.89

1.4

1.3

6.48

6.93

g/l

2.88

597

1283

Other septicaemia

399

1075

3.70

123.03

1.4

1.3

6.90

6.77

g/l

0.23

283

756

Abnormal findings on examination of blood, without diagnosis

515

1551

3.16

122.08

1.6

1.4

7.23

6.86

g/l

0.96

362

1064

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

550

1823

2.99

120.59

1.4

1.3

6.33

7.10

g/l

5.49

378

1205

Headache

654

1993

2.77

120.33

1.5

1.3

6.43

6.74

g/l

1.35

481

1374

Bacterial Sepsis

465

1262

3.33

118.75

1.4

6.89

6.79

g/l

0.14

323

871

Codeine

947

2209

2.38

114.35

1.4

6.50

6.90

g/l

2.23

655

1524

Certain infectious and parasitic diseases

988

2127

2.34

112.78

1.4

1.3

6.91

6.66

g/l

0.87

685

1448

Opioids

989

2259

2.32

111.60

1.4

6.67

6.90

g/l

0.81

681

1556

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

354

397

4.51

110.96

1.3

6.52

6.77

g/l

0.50

248

254

Medical observation and evaluation for suspected diseases and conditions

688

1279

2.78

110.48

1.5

1.3

6.87

7.00

g/l

0.26

524

754

Other diseases of pancreas

136

156

9.11

109.28

1.7

1.3

6.69

6.91

g/l

0.19

112

Polyarthropathies

712

1848

2.59

108.80

1.4

6.98

6.80

g/l

0.46

522

1268

Other and unspecified dermatitis

555

2009

2.80

108.24

1.5

1.4

6.89

6.84

g/l

0.08

401

1407

Vasomotor and allergic rhinitis

432

1340

3.22

107.67

1.4

1.3

6.45

7.03

g/l

2.83

343

891

Other immunodeficiencies

27.39

106.56

2.3

1.3

5.44

6.81

g/l

1.70

Dermatitis

635

2481

2.59

106.34

1.5

1.4

6.85

6.81

g/l

0.09

458

1746

Other soft tissue disorders, not elsewhere classified

913

2495

2.28

104.01

1.4

1.3

6.42

6.97

g/l

4.20

666

1697

Parasetamol

792

1639

2.49

102.93

1.4

1.3

6.60

7.03

g/l

1.97

557

1078

Infections, IBD-co-morbidities

198

235

6.25

101.64

1.6

1.2

6.68

6.82

g/l

0.16

136

159

Other specific joint derangements/joint disorders

758

2113

2.43

101.39

1.3

1.4

6.51

6.77

g/l

0.93

549

1445

Mixed connective tissue disease

143

195

7.72

99.76

1.8

1.5

7.71

6.75

g/l

1.03

112

132

Implicit bacterial Sepsis

384

1071

3.33

99.42

1.4

6.45

6.86

g/l

1.01

270

747

Symptoms and signs involving the digestive system and abdomen

965

2178

2.24

99.27

1.4

1.3

6.55

6.89

g/l

1.61

651

1531

L04AA Selective immunosuppressants

313

860

3.73

97.42

1.5

1.3

6.40

6.58

g/l

0.33

230

601

Sicca syndrome [Sjögren]

159

252

6.57

96.27

1.6

1.4

8.52

6.93

g/l

1.92

104

180

Abdominal and pelvic pain

950

2177

2.21

95.16

1.4

1.3

6.52

6.89

g/l

1.91

642

1530

Gastro-oesophageal reflux disease

662

2441

2.43

94.43

1.4

6.34

6.85

g/l

3.14

458

1691

Primary_lymphoid and hematopoietic malignant neoplasms

290

772

3.83

94.31

1.4

7.20

6.85

g/l

0.34

210

543

Malaise and fatigue

449

1279

2.96

93.13

1.3

6.58

6.85

g/l

0.61

323

892

Primary_lymphoid and hematopoietic malignant neoplasms

290

782

3.79

92.66

1.4

7.20

6.74

g/l

0.49

210

546

Other diseases of intestines

1036

2925

2.07

92.38

1.4

1.3

6.57

6.78

g/l

0.92

737

2022

Adrenocortical insufficiency

10.96

89.88

1.7

1.4

6.38

7.41

g/l

0.75

Codeine or tramadol medication

1070

2944

2.03

88.76

1.4

6.47

6.86

g/l

2.44

737

2031

Low back pain

700

2341

2.32

88.04

1.5

1.3

6.38

6.97

g/l

3.53

496

1587

Implicit Sepsis

672

2236

2.36

87.55

1.4

6.62

6.74

g/l

0.29

459

1554

Other disorders of adrenal gland

111

133

8.86

86.51

1.6

1.4

6.28

7.00

g/l

0.60

Dermatitis and eczema

1023

3361

2.01

86.45

1.4

1.3

6.72

6.73

g/l

0.03

729

2314

Nasal polyp

235

577

4.16

85.65

1.7

1.3

6.38

7.27

g/l

2.59

193

385

Noninfective enteritis and colitis

509

1988

2.59

85.31

1.3

1.4

6.96

6.74

g/l

0.50

345

1400

Other diseases of blood and blood-forming organs, wide

285

815

3.57

83.56

1.4

7.33

6.72

g/l

0.88

190

575

Exclusions for E4_PCOS_BROAD

256

683

3.84

83.22

1.5

1.4

6.16

6.74

g/l

1.35

127

505

Other special examinations and investigations of persons without complaint or reported diagnosis

627

1279

2.50

82.40

1.4

1.3

6.71

7.00

g/l

0.81

447

754

Haemorrhage from respiratory passages

305

841

3.41

82.25

1.4

1.3

6.71

7.06

g/l

0.70

209

563

Heart failure, not strict

676

2044

2.30

81.04

1.5

1.4

6.74

6.85

g/l

0.22

465

1410

Drug-induced adrenocortical insufficiency

17.20

80.65

1.9

1.4

6.17

6.33

g/l

0.08

Dorsalgia

919

2440

2.05

78.58

1.4

1.3

6.35

6.95

g/l

4.61

645

1651

Other disorders of white blood cells

110

146

7.90

78.56

1.4

6.73

6.84

g/l

0.06

103

Vocal cord dysfunction

165

297

5.26

78.46

1.7

1.2

6.52

6.76

g/l

0.28

109

201

Diagnoses used for exclusion with ILD

289

874

3.36

77.52

1.4

1.3

6.92

6.80

g/l

0.19

194

620

Budesonide

154

292

5.38

77.04

1.4

1.2

7.70

6.71

g/l

1.56

104

196

Diseases of the skin and subcutaneous tissue

942

2338

2.03

76.88

1.4

1.3

6.83

6.69

g/l

0.41

654

1577

All influenza

264

759

3.53

76.59

1.5

1.3

6.70

6.66

g/l

0.04

196

525

Disorders of other endocrine glands

462

1787

2.58

76.41

1.5

1.3

6.43

6.70

g/l

0.74

269

1279

Idiopathic pulmonary fibrosis

107

142

7.80

76.19

1.4

1.2

8.01

6.96

g/l

1.13

102

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

126

200

6.53

76.16

1.5

1.4

9.47

6.97

g/l

2.12

142

Neurological diseases

848

2041

2.11

75.85

1.3

1.4

6.49

7.03

g/l

3.03

578

1438

Disorders of lacrimal system

424

1611

2.67

75.50

1.5

1.4

6.65

6.74

g/l

0.18

295

1121

Nausea and vomiting

273

794

3.43

75.44

1.4

1.3

6.49

6.81

g/l

0.68

200

578

Diseases of salivary glands

242

665

3.71

75.32

1.6

1.3

6.76

6.78

g/l

0.03

161

444

Cholelithiasis, broad definition with cholecystitis

726

2318

2.16

75.17

1.4

1.3

6.88

6.82

g/l

0.13

460

1716

Viral Sepsis

225

589

3.90

75.12

1.4

1.3

6.42

6.53

g/l

0.12

163

424

Implicit viral Sepsis

224

586

3.90

74.85

1.4

6.42

6.50

g/l

0.09

162

421

Oedema, not elsewhere classified

282

855

3.32

74.45

1.6

1.3

6.67

6.84

g/l

0.33

206

593

Cardiovascular diseases

647

1534

2.32

74.10

1.4

1.3

6.76

6.62

g/l

0.36

442

1098

Neurological diseases, wide definition

321

466

3.49

73.46

1.4

1.2

6.38

6.72

g/l

0.76

221

320

General examination and investigation of persons without complaint and reported diagnosis

580

1279

2.43

73.31

1.4

1.3

6.45

7.00

g/l

2.43

481

754

Unspecified acute lower respiratory infection

199

486

4.19

73.21

1.5

1.4

6.70

6.81

g/l

0.12

149

334

Respiratory disorders in diseases classified elsewhere

18.28

73.11

1.9

1.3

5.91

6.64

g/l

0.62

Other diseases of the respiratory system

220

581

3.86

72.51

1.4

1.3

6.29

6.97

g/l

1.17

153

410

Other respiratory disorders and diseases

220

581

3.86

72.51

1.4

1.3

6.29

6.97

g/l

1.17

153

410

Other disorders involving the immune mechanism, not elsewhere classified

10.69

72.44

2.5

1.3

6.07

6.98

g/l

1.25

Sulfasalazine

252

729

3.50

72.35

1.4

1.2

6.86

6.77

g/l

0.11

176

487

Wegener granulomatosis

18.05

72.05

1.7

1.4

6.29

6.34

g/l

0.02

Osteoporosis

248

676

3.56

71.77

1.5

1.3

6.38

6.89

g/l

1.13

175

460

Eosinophilic disease (BM)

23.28

71.69

1.6

1.2

6.90

9.85

g/l

0.64

Other heart diseases

508

1365

2.48

71.19

1.4

1.3

7.06

6.71

g/l

0.93

356

964

Other disorders of lacrimal gland

359

1301

2.80

70.22

1.6

1.3

6.52

6.73

g/l

0.48

250

901

Pain in limb

699

2397

2.13

70.17

1.4

1.3

6.44

6.99

g/l

3.57

512

1639

Oxycodone

319

1048

2.98

69.64

1.5

1.4

6.28

7.10

g/l

3.18

218

730

Other inflammatory liver diseases

113

178

6.60

68.88

1.3

1.4

9.05

6.37

g/l

3.78

122

Irritable bowel syndrome

306

1029

3.02

68.67

1.5

1.4

6.15

6.71

g/l

2.34

215

702

Other arthritis (FG)

312

1061

2.98

68.58

1.4

1.2

6.66

6.71

g/l

0.07

224

720

Cardiovascular diseases (excluding rheumatic etc)

665

1768

2.19

68.02

1.4

1.3

6.67

6.68

g/l

0.03

444

1255

Pain (limb, back, neck, head abdominally)

636

1417

2.26

67.61

1.4

6.65

6.96

g/l

1.06

453

949

Lower back pain or/and sciatica

906

3315

1.91

67.07

1.4

6.33

6.87

g/l

4.20

645

2275

COPD

346

1017

2.83

66.57

1.4

1.3

6.70

7.16

g/l

1.12

247

671

Pneumonia due to other infectious organisms, not elsewhere classified

11.21

65.97

1.5

1.3

7.08

6.94

g/l

0.05

Cholelithiasis

680

2289

2.10

65.71

1.4

1.3

6.88

6.83

g/l

0.10

431

1696

Aplastic and other anaemias

383

1403

2.62

65.19

1.4

6.89

g/l

0.00

242

984

Other chronic obstructive pulmonary disease

331

970

2.87

65.13

1.4

1.3

6.63

7.20

g/l

1.56

237

641

Episodal and paroxysmal disorders

1003

2768

1.87

64.87

1.4

6.48

6.88

g/l

2.22

671

1952

Other heart diseases, wide

859

2770

1.94

64.81

1.4

7.11

6.56

g/l

2.73

592

1946

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

10.66

64.36

2.6

1.3

6.09

7.04

g/l

1.16

Pain, not elsewhere classified

259

821

3.20

64.31

1.7

1.3

6.10

6.81

g/l

2.90

208

567

Simple and mucopurulent chronic bronchitis

9.87

64.26

1.3

6.01

7.64

g/l

1.58

Hypothyroidism, levothyroxine purchases

275

469

3.41

64.15

1.4

1.3

7.21

6.57

g/l

1.33

182

334

Hypothyroidism and >3 levothyroxin purchases

275

469

3.41

64.15

1.4

1.3

7.21

6.57

g/l

1.33

182

334

5-aminosalicylic acid

204

559

3.70

63.69

1.4

1.2

7.98

6.58

g/l

3.58

126

369

Hypothyroidism (congenital or acquired)

276

474

3.38

63.60

1.4

1.3

7.21

6.58

g/l

1.32

183

337

15.22

63.57

1.5

1.3

7.18

7.04

g/l

0.07

Other dorsopathies, not elsewhere classified

893

2468

1.92

63.22

1.4

1.3

6.46

6.95

g/l

2.86

625

1673

Disorders of eyelid, lacrimal system and orbit

730

2902

1.99

62.40

1.5

1.4

6.62

6.82

g/l

0.72

518

2029

Other headache syndromes

409

1676

2.47

62.25

1.4

6.29

6.89

g/l

1.93

290

1184

Cholangitis (primary sclerosing, PSC), with reimbursement 202

12.32

62.18

2.0

1.3

9.22

6.17

g/l

3.51

COPD (mode)

201

419

3.84

62.18

1.3

6.75

7.18

g/l

0.63

142

263

Disorders of thyroid, IBD co-morbidities

166

269

4.55

61.72

1.4

1.2

6.41

6.94

g/l

1.11

115

177

Spondylopathies

672

1973

2.08

61.65

1.4

6.36

7.02

g/l

4.41

462

1326

Other and unspecified anaemias

350

1292

2.65

61.40

1.4

6.97

6.94

g/l

0.03

222

905

Temporomandibular joint disorders

174

439

4.03

61.18

1.5

1.4

6.10

6.93

g/l

2.36

118

311

Osteopathies and chondropathies

496

2105

2.26

61.04

1.5

1.4

6.45

6.83

g/l

1.10

348

1465

Condition for Implicit Sepsis (Organ dysfunction codes)

717

2631

1.99

60.89

1.4

6.62

6.74

g/l

0.30

484

1848

Pleural effusion

154

356

4.41

60.89

1.5

1.3

7.28

6.71

g/l

0.88

103

250

Other specified/unspecified arthritis

276

938

2.98

60.83

1.4

6.81

6.83

g/l

0.02

196

636

Rheumatoid arthritis

310

1009

2.83

60.70

1.5

1.4

6.96

6.90

g/l

0.07

232

687

Sleep disorders (combined)

866

3042

1.88

60.43

1.3

1.4

6.49

6.82

g/l

1.96

564

2145

Other anaemias

351

1305

2.62

60.34

1.4

6.96

6.94

g/l

0.02

223

912

Allergic rhinitis

356

1375

2.60

60.17

1.4

1.3

6.26

6.81

g/l

2.91

289

941

Other joint disorders

795

2171

1.96

60.08

1.4

6.56

6.76

g/l

0.68

568

1483

Fibrosis and cirrhosis of liver

109

191

5.90

59.68

1.2

1.5

9.87

6.59

g/l

4.47

130

Intestinal infectious diseases

823

3436

1.88

59.34

1.4

1.3

6.79

6.71

g/l

0.22

575

2388

Viral pneumonia

147

336

4.47

59.03

1.3

6.52

6.59

g/l

0.06

103

240

Diseases of the eye and adnexa

774

1971

1.98

58.91

1.4

1.3

6.44

6.88

g/l

2.48

550

1334

ILD-related respiratory insufficiency

10.91

58.40

1.2

9.05

7.84

g/l

0.38

Childhood asthma (age<16), excluding more controls

141

233

4.87

58.39

1.3

1.2

6.42

6.98

g/l

0.90

102

144

Migraine

467

1753

2.29

58.15

1.4

1.3

6.11

6.79

g/l

4.53

336

1256

Childhood asthma (age<16)

141

234

4.85

58.14

1.3

1.2

6.42

7.02

g/l

1.00

102

144

Endocrine, nutritional and metabolic diseases

770

2002

1.97

58.06

1.4

1.3

6.66

6.76

g/l

0.24

509

1432

Symptoms and signs involving the skin and subcutaneous tissue

607

2993

2.03

57.87

1.5

1.3

6.79

6.77

g/l

0.04

466

2080

Dental caries

278

965

2.89

57.86

1.5

1.3

6.91

6.75

g/l

0.22

210

658

Soft tissue disorders

910

2568

1.85

57.58

1.5

1.3

6.46

6.96

g/l

3.51

638

1749

Hernia of abdominal wall, postoperative

147

342

4.36

57.56

1.5

1.2

6.33

6.60

g/l

0.39

102

273

Arthropathies

818

2186

1.92

57.06

1.4

6.70

6.76

g/l

0.16

589

1497

Dorsopathies

900

2503

1.85

56.18

1.4

1.3

6.59

6.95

g/l

1.58

625

1703

Other noninfective gastroenteritis and colitis

265

923

2.91

55.88

1.5

1.3

6.34

6.67

g/l

0.66

187

660

Eosinophilia

13.81

55.33

1.6

1.2

6.90

7.25

g/l

0.15

Hypertensive diseases (excluding secondary)

511

1338

2.24

55.31

1.4

1.3

6.47

6.73

g/l

0.81

340

942

Pneumocystosis

15.79

55.17

1.6

1.4

6.43

7.05

g/l

0.19

Respiratory insufficiency

8.42

55.16

1.3

5.96

6.93

g/l

0.79

COPD, hospital admission 2, with asthma infections

271

805

2.91

55.06

1.4

6.33

7.08

g/l

2.54

197

551

Methotrexate

140

325

4.38

55.05

1.6

1.2

6.86

6.54

g/l

0.35

101

225

Diseases of the musculoskeletal system and connective tissue

490

1075

2.30

54.31

1.4

1.3

6.59

6.71

g/l

0.29

349

735

Sarcoidosis

168

452

3.80

54.17

1.4

1.3

6.99

6.93

g/l

0.06

109

322

Other diseases of pericardium

8.16

53.94

1.4

1.2

7.17

6.84

g/l

0.17

Complications of surgical and medical care, not elsewhere classified

822

3243

1.83

53.92

1.4

6.68

6.78

g/l

0.31

597

2234

Infection due to other mycobacteria

17.39

53.51

1.3

6.94

6.56

g/l

0.25

Provisional assignment of new diseases of uncertain etiology

430

1928

2.25

53.32

1.5

1.3

6.25

6.82

g/l

2.43

321

1338

L04AD Calcineurin inhibitors

161

427

3.88

53.14

1.4

6.91

6.67

g/l

0.26

113

307

Codes for special purposes

430

1932

2.25

53.05

1.5

1.3

6.25

6.82

g/l

2.40

321

1342

Diarrhoea and gastroenteritis of presumed infectious origin

622

2900

1.96

52.87

1.4

1.3

6.64

6.71

g/l

0.15

436

2018

Functional dyspepsia

254

893

2.88

52.72

1.4

6.58

6.69

g/l

0.17

187

609

Chronic laryngitis and laryngotracheitis

150

380

4.02

52.59

1.4

1.3

6.14

7.17

g/l

3.09

107

251

Dentinal caries

244

840

2.93

52.13

1.5

1.3

6.91

6.81

g/l

0.12

184

569

Inflammatory bowel disease

330

1333

2.51

52.01

1.3

7.34

6.64

g/l

1.94

218

928

COPD, hospital admissions 3, with asthma pneumonia sepsis

227

629

3.11

51.79

1.4

6.43

7.26

g/l

2.33

169

434

Symptoms and signs concerning food and fluid intake

120

259

4.73

51.72

1.5

1.3

7.30

6.73

g/l

0.59

191

Other intervertebral disc disorders

688

2193

1.93

51.64

1.4

6.56

6.99

g/l

1.99

487

1478

Covid-19 confirmed case

284

1071

2.69

51.57

1.6

1.3

6.17

6.76

g/l

1.49

191

726

Colitis, primary sclerosing

11.97

51.23

1.4

1.2

9.49

6.16

g/l

3.52

Persons encountering health services for examination and investigation

541

1279

2.13

50.25

1.4

1.3

6.77

7.00

g/l

0.56

400

754

Renal failure

341

1293

2.43

49.72

1.4

7.18

6.83

g/l

0.64

217

899

Mycoses

267

997

2.72

49.51

1.5

1.3

6.81

6.78

g/l

0.04

183

699

Fungal Sepsis

8.49

49.47

1.4

6.61

6.80

g/l

0.08

Diseases of the digestive system

383

1685

2.29

49.43

1.5

1.4

6.86

6.84

g/l

0.04

261

1156

Depression medications

288

507

2.88

49.42

1.4

1.3

6.42

6.63

g/l

0.37

201

359

Other functional intestinal disorders

379

1579

2.31

49.38

1.5

1.4

6.33

6.81

g/l

1.44

271

1108

Antihypertensive medication - note that there are other indications

592

1614

2.02

48.94

1.4

1.3

6.51

6.76

g/l

0.84

399

1150

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

111

7.02

48.60

1.5

1.4

7.81

7.00

g/l

0.51

Protozoal diseases

8.89

48.53

1.5

1.4

6.58

7.61

g/l

0.41

Voice disturbances

261

974

2.72

48.46

1.4

1.3

6.11

6.78

g/l

2.34

185

679

Anxiety disorders, excluding more controls

725

2618

1.85

48.41

1.5

1.4

6.49

6.85

g/l

1.53

532

1797

Biological medicines for asthma

12.29

48.30

1.4

1.3

6.09

7.50

g/l

1.28

Other diseases of liver

198

638

3.16

48.14

1.3

1.4

7.28

6.58

g/l

1.28

128

451

Implicit fungal Sepsis

8.87

48.03

1.4

6.10

6.89

g/l

0.52

Complications of medical and surgical care

597

2976

1.92

47.84

1.4

6.70

6.81

g/l

0.25

432

2066

Primary biliary cholangitis (PBC)

12.75

47.43

1.2

8.48

6.76

g/l

1.26

Hypopituitarism

117

267

4.53

47.36

1.5

1.3

5.78

6.92

g/l

1.72

204

Purpura and other haemorrhagic conditions

159

453

3.58

47.15

1.5

1.4

6.77

6.69

g/l

0.08

121

325

Rheumatoid arthritis, including avohilmo

346

1494

2.34

47.04

1.5

1.4

7.04

6.71

g/l

0.65

255

1020

Fibromyalgia

115

260

4.53

46.98

1.6

1.4

6.29

6.78

g/l

0.63

180

Explicit bacterial Sepsis

116

264

4.49

46.92

1.4

9.12

6.65

g/l

2.09

194

Persons encountering health services in other circumstances, wide

999

3082

1.69

46.78

1.4

1.3

6.98

6.67

g/l

1.40

720

2114

Sleep apnoea

752

2852

1.80

46.38

1.3

1.4

6.64

6.83

g/l

0.70

489

2008

Coagulation defects, purpura and other haemorrhagic conditions

207

701

3.00

46.16

1.5

1.4

6.69

6.71

g/l

0.03

156

493

Persons encountering health services for specific procedures and health care

909

3315

1.71

45.96

1.3

1.4

6.63

6.76

g/l

0.41

642

2298

Osteoporosis with pathological fracture (FG)

121

6.45

45.81

1.6

1.2

6.12

7.53

g/l

1.29

Chronic hepatitis, not elsewhere classified

7.88

45.74

1.5

1.4

10.04

6.60

g/l

2.68

Urticaria and erythema

357

1583

2.28

45.62

1.5

1.4

6.67

g/l

0.00

269

1107

Viral infections characterized by skin and mucous membrane lesions

381

1734

2.22

45.59

1.5

1.4

6.28

6.72

g/l

1.40

279

1205

Ulcerative colitis

256

976

2.66

45.59

1.3

7.89

6.67

g/l

3.66

170

684

Abnormalities of heart beat

266

1023

2.60

45.47

1.3

1.4

6.47

6.94

g/l

1.48

184

680

Rheumatism, unspecified

154

440

3.56

45.43

1.8

1.4

6.13

6.95

g/l

1.78

111

306

Other general symptoms and signs

131

6.16

45.13

1.7

1.3

6.63

6.71

g/l

0.06

Cardiac arrhythmias

557

1882

1.97

45.02

1.3

1.4

7.17

6.71

g/l

1.46

376

1327

Sleep apnoea, including avohilmo

790

2932

1.76

44.74

1.4

6.59

6.82

g/l

0.98

510

2058

Other antidepressants

862

2604

1.74

44.48

1.4

6.53

6.91

g/l

2.01

585

1799

Seropositive rheumatoid arthritis

220

784

2.83

44.37

1.5

1.3

7.00

6.75

g/l

0.36

166

531

Anxiety disorders

772

3134

1.76

44.30

1.5

1.3

6.51

6.75

g/l

0.90

563

2145

Ulcerative colitis, NAS

169

521

3.31

44.28

1.3

1.4

8.12

6.70

g/l

2.94

116

373

Chronic kidney disease

234

862

2.73

44.09

1.4

1.3

6.90

6.89

g/l

0.00

152

608

Other chronic obstructive pulmonary disease, including avohilmo

401

1549

2.17

44.06

1.4

6.56

7.01

g/l

1.49

292

1059

Cholecystectomy

563

2630

1.91

43.79

1.4

6.88

6.81

g/l

0.12

350

1872

Early onset COPD

217

777

2.83

43.69

1.6

1.4

6.15

6.91

g/l

2.32

153

527

Symptoms and signs involving speech and voice

294

1226

2.43

43.33

1.4

6.19

6.79

g/l

2.06

210

847

Other pleural conditions

204

4.85

43.25

1.5

1.3

7.08

6.95

g/l

0.11

149

Neurotic, stress-related and somatoform disorders

762

3118

1.75

43.04

1.5

1.3

6.50

6.74

g/l

0.86

557

2139

Myalgia

219

798

2.78

42.63

1.5

1.3

6.20

6.92

g/l

2.34

158

543

Hypermobility syndrome

166

5.35

42.51

1.6

1.4

6.38

6.27

g/l

0.08

117

Polymyalgia rheumatica

115

281

4.16

42.41

1.5

1.3

6.88

g/l

0.00

198

Neoplasms

691

2043

1.82

42.25

1.4

6.74

6.70

g/l

0.08

464

1428

Pulmonary heart disease, diseases of pulmonary circulation

261

1043

2.53

42.14

1.4

7.01

6.92

g/l

0.11

198

718

Sciatica+with lumbago

408

1865

2.09

41.92

1.4

1.3

6.10

7.02

g/l

7.07

296

1268

Complications of procedures, not elsewhere classified

641

3088

1.80

41.86

1.4

6.80

6.79

g/l

0.01

473

2129

Streptococcal septicaemia

211

4.70

41.60

1.4

1.3

9.00

6.66

g/l

1.68

161

Lumbar disc prolapse

506

2073

1.95

41.56

1.4

6.50

7.02

g/l

2.21

353

1395

Persons encountering health services for other counselling and medical advice, not elsewhere classified

895

3079

1.67

40.65

1.4

1.3

6.83

6.66

g/l

0.58

673

2111

Constipation

688

2803

1.77

40.57

1.4

6.58

6.81

g/l

0.75

471

1988

Disorders of conjunctiva

684

3282

1.76

40.48

1.5

1.3

6.48

6.75

g/l

1.15

512

2268

Depression or dysthymia

597

1791

1.88

40.38

1.4

6.56

6.96

g/l

1.57

410

1236

Renal tubulo-interstitial diseases

680

2972

1.76

40.35

1.4

7.14

6.69

g/l

1.45

462

2079

Dysphagia

196

694

2.86

40.27

1.4

1.3

6.50

7.10

g/l

1.56

132

487

COPD, hospital admissions

331

1255

2.25

39.95

1.4

6.62

6.98

g/l

0.86

237

845

Multiple myeloma and malignant plasma cell neoplasms

6.69

39.77

1.4

1.3

11.09

7.43

g/l

1.40

Symptoms and signs involving the nervous and musculoskeletal systems

469

2430

1.94

39.57

1.6

1.4

6.31

6.87

g/l

3.13

340

1704

Dentofacial anomalies [including malocclusion]

263

1075

2.45

39.49

1.4

1.3

6.18

6.58

g/l

1.26

178

750

Other disorders of fluid, electrolyte and acid-base balance

244

937

2.54

39.45

1.4

1.3

7.17

6.87

g/l

0.33

168

637

Benign neoplasm of colon, rectum, anus and anal canal

434

1534

2.04

39.22

1.4

6.73

6.83

g/l

0.23

320

1070

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

139

410

3.45

39.13

1.5

1.4

5.97

6.78

g/l

1.28

286

Chronic diseases of tonsils and adenoids

603

2096

1.83

38.95

1.3

6.26

6.96

g/l

4.34

452

1389

COPD, early/later onset

331

1266

2.23

38.87

1.4

6.63

6.97

g/l

0.80

237

854

Inflammatory diseases of the central nervous system

106

261

4.16

38.84

1.5

1.4

6.70

6.86

g/l

0.13

180

Pneumonia derived septicemia

7.56

38.80

1.4

10.00

6.60

g/l

1.57

Nutritional anaemias

378

1777

2.09

38.70

1.4

7.08

6.80

g/l

0.54

280

1235

Other disorders of skin and subcutaneous tissue

526

2602

1.86

38.58

1.4

7.01

6.81

g/l

0.45

380

1810

Pneumonia due to Streptococcus pneumoniae

6.67

38.48

1.5

1.2

8.39

6.81

g/l

0.70

Other symptoms and signs involving the nervous and musculoskeletal systems

361

1722

2.12

38.48

1.6

1.3

6.31

6.82

g/l

2.05

261

1199

Drug-induced cataract

8.66

38.43

1.5

1.3

5.62

6.99

g/l

0.92

Benign neoplasm of colon, rectum, anus and anal canal

449

2083

1.96

38.16

1.4

6.73

6.91

g/l

0.49

333

1426

Spondyloarthritis

171

579

2.99

38.16

1.4

1.3

6.47

6.63

g/l

0.21

117

409

Hypertensive diseases

670

2149

1.77

38.09

1.4

6.57

6.82

g/l

0.95

453

1499

Multiple myeloma, excluding all cancers (controls excluding all cancers)

107

6.28

38.04

1.4

10.99

7.22

g/l

1.53

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

771

3128

1.68

37.90

1.4

6.85

6.71

g/l

0.34

527

2218

Giant cell arteritis

7.34

37.90

1.2

1.5

6.11

7.29

g/l

0.92

Metabolic disorders

753

2763

1.70

37.80

1.5

1.4

6.76

6.81

g/l

0.10

527

1916

Pulmonary embolism

237

954

2.51

37.76

1.4

6.69

6.92

g/l

0.39

177

651

Bleeding

632

2614

1.77

37.51

1.4

6.89

6.80

g/l

0.21

445

1808

Hypertension

667

2147

1.77

37.45

1.4

6.55

6.82

g/l

1.04

451

1497

Dialysis, with operation codes

139

422

3.36

37.43

1.4

6.78

6.65

g/l

0.09

303

Pulmonary heart disease

237

960

2.49

37.27

1.4

6.69

6.96

g/l

0.46

177

657

Nerve, nerve root and plexus disorders

827

3161

1.65

37.22

1.4

6.37

6.87

g/l

3.73

578

2179

Unspecified jaundice

6.62

37.15

2.0

1.2

7.43

7.25

g/l

0.09

Diseases of arteries, arterioles and capillaries (FINNGEN)

203

511

2.80

36.98

1.4

7.11

6.94

g/l

0.19

148

343

Nephropathy related operations

136

411

3.38

36.91

1.4

6.94

6.74

g/l

0.14

295

Colitis, primary sclerosing, strict definition

11.06

36.88

1.4

1.2

9.14

6.14

g/l

2.72

Multiple myeloma and malignant plasma cell neoplasms

107

6.18

36.88

1.4

11.09

7.22

g/l

1.54

Later onset COPD, excluding more controls

108

206

4.12

36.72

1.1

1.3

7.46

7.36

g/l

0.07

133

Spondylopathies (FG)

146

462

3.21

36.69

1.5

1.3

6.33

6.72

g/l

0.64

103

308

Hypertension, essential

635

2046

1.78

36.65

1.4

6.50

6.84

g/l

1.47

429

1421

Intestinal malabsorption

118

5.87

36.61

1.3

7.01

7.03

g/l

0.01

Benign neoplasm: Colon

375

1393

2.08

36.41

1.4

6.66

6.88

g/l

0.57

275

979

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

392

1206

2.08

36.37

1.5

1.3

6.85

6.79

g/l

0.10

256

851

Benign neoplasms

664

2154

1.75

36.31

1.4

6.62

6.78

g/l

0.52

453

1496

Diverticular disease of intestine

511

1817

1.88

36.21

1.6

1.4

6.51

6.88

g/l

1.41

380

1241

Benign neoplasm: Colon

381

1855

2.03

36.20

1.5

1.4

6.64

6.98

g/l

1.07

281

1273

Other and unspecified iron deficiency

267

1156

2.33

36.19

1.5

1.3

7.01

6.70

g/l

0.56

196

810

Migraine with aura

220

876

2.54

35.92

1.4

5.89

6.75

g/l

4.34

162

628

Abnormal findings on diagnostic imaging of other body structures

125

365

3.49

35.78

1.6

1.4

7.25

6.72

g/l

0.69

259

Abnormal results of function studies

100

252

4.06

35.53

1.5

1.3

7.43

6.69

g/l

0.59

180

Iron deficiency anaemia

327

1534

2.13

35.48

1.5

1.4

7.11

6.79

g/l

0.57

241

1062

Acute renal failure

169

598

2.86

34.89

1.4

1.3

7.40

6.96

g/l

0.51

423

Diseases of the ear and mastoid process

952

3049

1.59

34.89

1.4

6.51

6.82

g/l

1.80

660

2135

Hypothyroidism, strict autoimmune

508

1819

1.86

34.85

1.3

6.89

6.53

g/l

1.17

347

1281

Atrial fibrillation and flutter

266

732

2.39

34.79

1.3

1.4

7.78

6.90

g/l

1.65

187

505

Other diseases of hard tissues of teeth

517

2115

1.83

34.77

1.5

1.3

6.92

6.73

g/l

0.42

360

1439

Other specified/unspecified necrotizing vasculopathies

12.49

34.64

1.4

6.79

6.02

g/l

0.44

Diseases of pulp and periapical tissues

295

1357

2.19

34.60

1.5

1.3

6.70

6.77

g/l

0.09

225

920

Heart failure and antihypertensive medication

215

543

2.64

34.51

1.4

1.3

7.72

7.05

g/l

0.91

144

380

Glomerular diseases

175

636

2.79

34.41

1.6

1.3

6.65

6.71

g/l

0.05

116

450

Syncope and collapse

295

1193

2.21

34.40

1.4

1.3

6.50

6.85

g/l

0.87

197

826

Conjunctivitis

612

3112

1.72

34.33

1.5

1.3

6.48

6.72

g/l

0.94

465

2142

Persons encountering health services in other circumstances

325

1557

2.10

34.25

1.4

1.3

6.78

6.58

g/l

0.33

201

1059

IBD patients in KELA-register

229

951

2.44

34.23

1.2

1.3

7.83

6.64

g/l

3.30

142

666

Unspecified chronic bronchitis

8.14

34.21

1.3

1.4

7.20

7.82

g/l

0.27

Crohn disease

149

498

3.04

34.19

1.2

1.4

6.92

6.63

g/l

0.32

355

Other gastritis (incl. Duodenitis)

184

689

2.70

34.08

1.5

1.4

6.90

6.94

g/l

0.03

138

466

Mood disorders, excluding more controls

745

2747

1.66

33.91

1.4

6.46

6.87

g/l

2.11

527

1882

Polyarthrosis

164

553

2.88

33.91

1.6

1.5

7.23

6.94

g/l

0.30

109

382

Noninfectious colitis NAS

140

454

3.13

33.82

1.5

1.4

6.07

6.87

g/l

2.00

106

327

SLE (Finngen)

6.85

33.74

1.6

1.5

7.04

6.56

g/l

0.36

Benign neoplasm of other and ill-defined parts of digestive system

162

572

2.87

33.64

1.5

1.4

6.13

6.84

g/l

1.92

117

395

Other and unspecified disorders of white blood cells

100

6.10

33.56

1.3

6.50

7.17

g/l

0.25

Chronic periapical parodontitis

187

713

2.66

33.46

1.6

1.3

6.79

6.85

g/l

0.05

135

473

Infections of the skin and subcutaneous tissue

473

2586

1.83

33.45

1.4

6.84

6.72

g/l

0.30

357

1781

Recurrent or chronic depression

354

1248

2.06

33.39

1.3

6.35

6.91

g/l

2.30

252

871

Biological medication for rheuma

178

664

2.72

33.34

1.3

1.4

6.71

6.67

g/l

0.05

120

454

Depression

770

3276

1.63

33.29

1.4

6.43

6.80

g/l

1.92

543

2252

Diaphragmatic hernia

280

1282

2.20

33.26

1.4

1.3

6.46

6.86

g/l

1.20

211

884

Pericarditis

7.02

33.24

1.2

6.74

6.99

g/l

0.12

Benign neoplasms

788

2707

1.63

33.17

1.4

1.3

6.68

6.89

g/l

0.70

541

1866

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

459

2494

1.85

33.16

1.4

6.87

6.82

g/l

0.09

335

1723

Other disorders of teeth and supporting structures

186

718

2.62

32.47

1.7

1.3

6.66

6.91

g/l

0.35

140

469

IBD (strict) with PSC

12.00

32.46

1.3

10.65

6.40

g/l

3.20

Diseases of middle ear and mastoid

487

2210

1.82

32.38

1.4

1.3

6.34

6.73

g/l

1.58

338

1514

Heart failure,strict

350

1242

2.05

32.32

1.4

7.41

6.91

g/l

0.96

233

841

Collagenous colitis

261

3.84

32.27

1.4

6.87

g/l

0.00

186

Mood disorders

814

3368

1.59

32.25

1.4

6.49

6.80

g/l

1.53

572

2323

Urticaria

279

1295

2.18

32.09

1.5

1.4

6.46

6.66

g/l

0.41

213

905

Benign neoplasm of other and ill-defined parts of digestive system

162

587

2.80

32.08

1.5

1.4

6.13

6.81

g/l

1.77

117

406

Ulcerative colitis (strict) with PSC

13.74

32.00

1.3

10.32

6.47

g/l

2.46

Mood [affective] disorders

811

3366

1.59

31.92

1.4

6.49

6.80

g/l

1.50

570

2321

Candidiasis

138

460

3.05

31.84

1.5

1.4

7.14

6.86

g/l

0.25

322

Pulmonary eosinophilia, not elsewhere classified

13.29

31.83

1.8

1.3

6.54

6.73

g/l

0.09

Inflammatory bowel disease, strict (require KELA)

229

983

2.36

31.82

1.2

1.3

7.83

6.62

g/l

3.42

142

688

Migraine without aura

191

755

2.56

31.77

1.4

6.30

6.80

g/l

1.34

139

547

Acute suppurative otitis media

265

1124

2.22

31.75

1.4

1.3

6.28

6.65

g/l

0.89

190

780

Spondylosis

379

1677

1.95

31.69

1.5

1.4

6.35

7.11

g/l

3.58

246

1137

Migraine with aura and triptan purchases

163

597

2.77

31.64

1.4

5.97

6.75

g/l

2.59

123

418

Other reaction to severe stress, and adjustment disorders

326

1615

2.04

31.52

1.5

1.3

6.50

6.62

g/l

0.20

234

1112

Disorders of sclera, cornea, iris and ciliary body

434

2368

1.85

31.41

1.4

6.74

6.75

g/l

0.02

301

1650

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

287

1361

2.13

31.25

1.6

1.3

6.34

6.65

g/l

0.74

158

958

All influenza (not pneumonia)

138

466

3.00

31.07

1.3

6.58

6.59

g/l

0.01

323

Care involving use of rehabilitation procedures

503

2727

1.76

30.97

1.4

6.45

6.80

g/l

1.22

356

1912

Pneumococcal septicemia

6.25

30.82

1.5

1.3

10.32

6.68

g/l

1.60

Other diseases of lip and oral mucosa

147

517

2.88

30.78

1.4

1.3

6.90

6.73

g/l

0.16

110

353

Abnormal serum enzyme levels

226

966

2.33

30.67

1.6

1.3

6.91

7.01

g/l

0.14

169

663

Polypectomy (DHB20)

204

4.17

30.59

2.0

1.3

6.35

6.87

g/l

0.71

140

Nonsuppurative otitis media

223

822

2.37

30.52

1.5

1.3

5.92

6.70

g/l

4.15

160

580

Temporomandibular joint disorders, including avohilmo

359

1859

1.94

30.45

1.4

6.27

6.67

g/l

1.62

248

1303

DVT of lower extremities and pulmonary embolism

297

1438

2.07

30.28

1.4

1.3

6.66

6.88

g/l

0.43

214

999

Other bacterial intestinal infections

155

566

2.77

30.24

1.4

1.3

6.70

6.75

g/l

0.04

110

395

Herpesviral [herpes simplex] infections

125

407

3.13

30.08

1.4

6.54

6.78

g/l

0.24

289

Venous thromboembolism

383

1981

1.89

29.75

1.5

1.4

6.50

6.92

g/l

1.36

272

1362

Erysipelas

364

1738

1.92

29.54

1.5

1.4

6.90

6.80

g/l

0.17

265

1195

Cholecystitis

109

330

3.34

29.49

1.8

1.2

6.99

6.78

g/l

0.26

232

Congenital malformations of the respiratory system

7.33

29.21

1.5

1.4

6.19

6.07

g/l

0.08

Thrombocytopenia, unspecified

194

4.17

29.15

1.6

1.4

6.76

7.01

g/l

0.19

136

COPD related to multimorbidity

258

1002

2.18

29.15

1.4

6.60

7.08

g/l

0.98

181

677

Seropositive rheumatoid arthritis, wide

220

965

2.30

29.10

1.5

1.4

7.00

6.68

g/l

0.51

166

664

Factors influencing health status and contact with health services

235

493

2.40

29.03

1.3

6.64

7.26

g/l

1.37

167

314

COPD, hospital admissions 1, only main diagnosis

238

908

2.25

28.97

1.3

1.4

6.46

7.06

g/l

1.34

167

621

Suppurative and unspecified otitis media

330

1490

1.98

28.93

1.4

1.3

6.34

6.66

g/l

0.88

235

1034

Anxiety (asthma-related co-morbidities)

497

2256

1.75

28.88

1.4

6.52

6.82

g/l

0.92

377

1563

Other disorders of urethra and urinary system

516

2244

1.73

28.85

1.4

1.3

6.66

6.82

g/l

0.44

358

1571

Polyarteritis nodosa and related conditions

10.30

28.83

1.7

1.3

6.15

5.81

g/l

0.25

Systemic lupus erythematosus

5.83

28.80

1.6

1.3

7.04

6.66

g/l

0.22

Deposits [accretions] on teeth

235

3.78

28.79

1.7

1.3

7.07

6.49

g/l

0.31

178

Weight loss

278

3.56

28.69

1.4

1.3

7.40

6.77

g/l

0.52

200

Other specified/unspecified inflammatory spondylopathies

139

4.80

28.60

1.6

1.4

6.21

6.95

g/l

0.74

Abnormal weight loss

246

3.73

28.58

1.4

1.3

7.70

6.87

g/l

0.69

174

Gout

174

625

2.56

28.56

1.4

7.07

7.30

g/l

0.22

113

428

Bacterial intestinal infections, IBD co-morbidities

154

578

2.70

28.52

1.4

1.3

6.74

6.73

g/l

0.01

110

403

Postviral fatigue syndrome

13.35

28.51

2.0

1.2

6.05

6.37

g/l

0.19

Enterocolitis due to Clostridium difficile

256

3.65

28.40

1.5

1.4

6.54

6.94

g/l

0.34

182

Other diseases of urinary system

776

2784

1.57

28.37

1.4

6.78

6.82

g/l

0.09

547

1946

Any mental disorder

870

2835

1.54

28.34

1.4

6.59

6.86

g/l

1.04

624

1946

Other/unspecified dorsalgia

281

1365

2.06

28.28

1.2

1.4

6.22

7.03

g/l

3.37

194

932

Pollen allergy

201

850

2.37

28.25

1.4

1.3

6.49

6.52

g/l

0.04

170

599

Cystitis

641

2398

1.64

28.24

1.4

1.3

6.66

6.83

g/l

0.50

471

1687

Non-follicular lymphoma, hilmo, excluding all cancers

262

3.62

28.24

1.5

1.4

6.00

6.93

g/l

1.00

188

Psychiatric diseases

861

2802

1.54

28.23

1.4

6.58

6.85

g/l

1.08

615

1925

Zoster [herpes zoster]

145

531

2.77

28.18

1.5

1.3

6.04

6.88

g/l

1.82

114

361

Unknown and unspecified causes of morbidity

174

4.27

27.97

1.3

5.90

6.84

g/l

1.46

129

Non-follicular lymphoma

264

3.59

27.92

1.5

1.4

6.00

6.80

g/l

0.79

185

Alcohol-induced chronic pancreatitis

205

4.00

27.90

1.2

6.12

6.76

g/l

0.92

142

Transplanted organ and tissue status

110

348

3.22

27.84

1.5

1.4

6.97

6.62

g/l

0.21

260

Visual disturbances and blindness

385

2108

1.84

27.64

1.6

1.4

6.34

6.78

g/l

1.82

289

1453

Mucosal proctocolitis

132

467

2.87

27.43

1.4

1.3

8.64

6.61

g/l

4.89

329

Atopic dermatitis, strict definition with reimbursement

271

1280

2.07

27.38

1.4

1.3

6.86

6.65

g/l

0.35

205

892

Encephalitis

6.25

27.37

1.3

6.63

7.49

g/l

0.43

Disturbances of skin sensation

240

1122

2.16

27.21

1.3

6.35

6.72

g/l

0.81

177

758

Other encephalitis

6.50

27.17

1.3

6.67

7.74

g/l

0.53

Hypothyroidism, drug reimbursement

123

286

3.10

27.06

1.7

1.3

7.04

6.58

g/l

0.81

210

Other and unspecified tonsillitis

273

1126

2.07

27.02

1.4

6.49

6.82

g/l

0.88

194

740

Other Crohn's disease

238

3.69

26.87

1.2

1.3

7.08

6.65

g/l

0.36

167

Other symptoms and signs involving the digestive system and abdomen

129

456

2.86

26.80

1.4

1.3

6.14

7.01

g/l

1.46

333

Other/unspecified seropositive rheumatoid arthritis

213

957

2.25

26.66

1.5

1.4

7.01

6.69

g/l

0.50

162

659

All anxiety disorders

501

2384

1.70

26.62

1.4

1.3

6.53

6.75

g/l

0.64

381

1649

Heart failure, strict

367

1419

1.87

26.38

1.4

7.39

6.84

g/l

1.17

244

969

Alcohol-induced acute pancreatitis

106

5.27

26.33

1.3

6.01

6.76

g/l

0.87

Thyroiditis, ILD-related definition

111

365

3.09

26.30

1.5

1.3

7.01

6.62

g/l

0.47

257

Spinal stenosis

330

1352

1.92

26.21

1.4

6.28

7.24

g/l

5.10

242

909

Temporal arteritis

6.65

26.12

1.2

1.3

6.11

7.28

g/l

0.76

Other nutritional deficiencies

495

2894

1.68

25.96

1.4

6.26

6.83

g/l

3.48

351

2041

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

210

949

2.23

25.94

1.5

1.4

6.98

6.67

g/l

0.47

159

652

Symptoms and signs involving cognition, perception, emotional state and behaviour

716

3241

1.55

25.93

1.3

1.4

6.55

6.82

g/l

1.17

500

2254

Deviated nasal septum

236

1116

2.13

25.90

1.2

1.3

6.52

7.23

g/l

2.37

152

727

COPD-related respiratory insufficiency

259

3.48

25.71

1.4

1.3

6.05

6.90

g/l

1.23

183

Other ulcerative colitis

186

4.02

25.69

1.3

8.12

6.69

g/l

1.28

129

Atrial fibrillation and flutter with reimbursement

194

522

2.40

25.67

1.4

7.72

7.14

g/l

0.66

137

357

Hypokalaemia

103

329

3.18

25.64

1.3

7.20

6.70

g/l

0.51

224

Visual disturbances

361

1986

1.83

25.59

1.6

1.4

6.37

6.81

g/l

1.61

270

1362

Benzodiazepine use

743

3456

1.54

25.57

1.3

1.4

6.66

6.77

g/l

0.31

503

2404

Tumor necrosis factor alpha inhibitors

152

601

2.57

25.46

1.3

1.4

6.86

6.65

g/l

0.30

416

Viral pneumonia (unknown virus, not influenza)

192

3.94

25.37

1.2

1.3

6.54

6.85

g/l

0.21

134

Cirrhosis of liver, NAS

121

4.84

25.34

1.2

1.3

10.80

6.50

g/l

3.31

Non-invasive ventilation

163

622

2.48

25.34

1.3

5.96

7.05

g/l

2.20

425

Polyneuropathies and other disorders of the peripheral nervous system

170

709

2.42

25.33

1.4

1.3

6.44

6.83

g/l

0.65

125

494

Missing teeth due to accident, extraction or parodontitis

112

380

2.99

25.16

1.5

1.4

6.89

6.77

g/l

0.10

258

Continuous positive airway pressure

149

498

2.61

25.10

1.4

7.13

6.97

g/l

0.13

127

343

Lymphoid leukaemia

138

4.52

25.08

1.4

1.2

6.40

7.21

g/l

0.47

Glomerulonephritis

103

334

3.14

25.05

1.7

1.4

6.78

6.63

g/l

0.09

237

Giant cell arteritis with polymyalgia rheumatica

6.36

25.01

1.2

1.3

6.11

7.45

g/l

0.94

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

427

2439

1.73

25.01

1.6

1.3

6.40

6.72

g/l

1.31

330

1693

Other complications of surgical and medical care, not elsewhere classified

304

3.24

24.96

1.4

6.72

6.81

g/l

0.05

216

Lymphoid leukaemia

139

4.49

24.85

1.4

1.3

6.40

6.84

g/l

0.22

102

Non-rheumatic valve diseases

318

1215

1.92

24.85

1.4

7.58

6.67

g/l

2.36

218

841

Other and unspecified polyneuropathies, also in other diseases

150

596

2.55

24.83

1.4

1.3

6.48

6.81

g/l

0.47

110

416

Ulcerative colitis (strict definition, require KELA)

165

687

2.43

24.72

1.2

1.4

8.18

6.58

g/l

4.53

101

484

Cervicobrachial syndrome

178

766

2.35

24.70

1.6

1.3

6.11

6.92

g/l

2.03

141

518

Pain in thoracic spine

131

488

2.72

24.70

1.4

1.3

5.71

6.80

g/l

3.82

103

334

Valvular heart disease excluding rheumatic fever

321

1235

1.91

24.65

1.4

7.54

6.66

g/l

2.25

220

856

All-cause Heart Failure

356

1397

1.85

24.58

1.4

7.44

6.86

g/l

1.24

239

952

Shoulder lesions

540

2009

1.65

24.57

1.4

1.3

6.21

7.06

g/l

6.67

396

1356

Papulosquamous disorders

301

1586

1.91

24.49

1.4

6.51

6.85

g/l

1.08

219

1082

Other symptoms and signs involving the circulatory and respiratory systems

145

4.35

24.39

1.4

1.3

6.62

6.63

g/l

0.00

100

Suppurative and necrotic conditions of lower respiratory tract

133

4.54

24.37

1.4

1.3

6.67

6.91

g/l

0.19

Agranulocytosis

106

356

3.03

24.27

1.3

1.4

7.04

6.78

g/l

0.21

249

Follow-up examination after treatment for conditions other than malignant neoplasms

296

992

1.96

24.14

1.4

1.3

6.65

7.01

g/l

0.76

222

596

Concussion

356

1706

1.82

24.10

1.5

1.4

6.61

7.02

g/l

0.93

246

1199

Disorders of lens

477

1782

1.70

24.09

1.4

6.64

6.88

g/l

0.60

328

1269

Insulin, combination of fast acting with intermediate-acting or long-acting

434

2355

1.71

24.02

1.5

1.3

6.78

6.83

g/l

0.07

279

1653

Intracranial trauma

411

1764

1.75

23.93

1.5

1.4

6.67

7.02

g/l

0.85

284

1238

Diseases of oral cavity, salivary glands and jaws

670

2198

1.57

23.82

1.4

1.3

6.61

6.73

g/l

0.32

483

1499

Non-selective monoamine reuptake inhibitors

284

1436

1.93

23.74

1.4

6.11

6.94

g/l

4.31

199

999

Secondary hypertension

195

3.76

23.60

1.3

1.2

6.26

6.87

g/l

0.41

134

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

159

666

2.42

23.54

1.2

1.4

8.22

6.59

g/l

4.52

467

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

122

450

2.75

23.50

1.3

1.4

9.69

6.80

g/l

3.69

316

Cervical disc disorders

258

1311

1.98

23.37

1.4

6.03

7.14

g/l

5.82

175

888

Congenital malformations, deformations and chromosomal abnormalities

468

2717

1.66

23.36

1.5

1.4

6.51

6.69

g/l

0.53

320

1893

Adalimumab

102

343

3.03

23.35

1.3

1.4

6.58

6.51

g/l

0.06

244

Presence of other functional implants

374

1487

1.79

23.34

1.4

6.55

6.87

g/l

0.72

208

1053

Paralytic ileus and intestinal obstruction

173

755

2.31

23.23

1.3

6.74

7.06

g/l

0.36

112

517

Hypoparathyroidism

5.38

23.08

2.5

1.3

6.46

7.39

g/l

0.63

Disorders of parathyroid gland

148

598

2.47

22.96

1.8

1.3

6.51

6.88

g/l

0.55

105

409

Stomatitis and related lesions

259

3.34

22.93

1.4

7.09

6.58

g/l

0.32

170

Other overlap syndromes

8.87

22.92

1.6

1.4

8.82

5.81

g/l

1.31

Disorders of orbit

120

4.62

22.75

1.7

1.4

6.18

6.87

g/l

0.66

Other (seronegative) rheumatoid arthritis, wide

154

646

2.41

22.72

1.5

1.4

6.93

6.68

g/l

0.27

116

445

Allergic conjunctivitis

442

2621

1.67

22.69

1.6

1.3

6.38

6.70

g/l

1.41

343

1818

Asthma mixed form (mode), excluding more controls

5.52

22.43

1.7

1.3

6.12

7.32

g/l

1.17

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

404

2387

1.70

22.35

1.4

6.86

6.83

g/l

0.06

292

1657

Disorders of the thyroid gland

690

2986

1.52

22.13

1.5

1.3

6.65

6.76

g/l

0.29

452

2120

Use of hypnotics and sedatives

787

3083

1.48

22.06

1.3

1.4

6.54

6.83

g/l

1.09

565

2125

Lung diseases due to external agents

100

344

2.94

21.92

1.3

7.02

6.85

g/l

0.16

248

Systemic sclerosis (FG)

6.71

21.87

1.2

1.3

8.68

6.95

g/l

0.53

Extracorporeal dialysis

176

3.84

21.85

1.5

1.3

5.41

6.95

g/l

1.96

125

Recurring oral aphthae, including avohilmo

123

475

2.62

21.69

1.3

1.4

6.44

6.74

g/l

0.39

324

Migraine without aura and triptan purchases

152

648

2.37

21.67

1.3

1.4

6.24

6.73

g/l

1.15

112

454

GI-bleeding

211

1026

2.07

21.65

1.4

1.3

7.06

6.90

g/l

0.16

146

713

Correction of physiology of bite - demanding therapy visit

244

3.35

21.61

1.4

6.24

6.72

g/l

0.63

169

Other anxiety disorders

357

1817

1.75

21.59

1.3

6.48

6.67

g/l

0.42

278

1244

Iridocyclitis

188

877

2.16

21.57

1.5

1.3

6.41

6.70

g/l

0.46

136

612

Hypo-osmolality and hyponatraemia

125

486

2.59

21.54

1.4

1.3

6.87

6.78

g/l

0.06

338

Disorders of skin appendages

368

2143

1.73

21.51

1.3

1.4

6.35

6.75

g/l

1.53

267

1480

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

169

758

2.25

21.40

1.2

1.4

8.10

6.60

g/l

4.14

104

524

Atopic dermatitis

423

2172

1.67

21.36

1.3

6.75

6.66

g/l

0.17

316

1522

123

479

2.60

21.32

1.6

1.3

7.38

6.57

g/l

0.62

328

Gout, FINNGEN

174

791

2.22

21.26

1.4

7.07

7.21

g/l

0.13

113

540

Migraine, single triptan purchase ok & required. ICD-code if available is included

603

2658

1.54

21.09

1.4

6.51

6.74

g/l

0.83

418

1847

Triptan medication for migraine, single purchase ok

603

2658

1.54

21.09

1.4

6.51

6.74

g/l

0.83

418

1847

Insulin medication

434

2257

1.65

21.06

1.5

1.3

6.78

6.86

g/l

0.12

279

1562

Nonalcoholic fatty liver disease

333

2.93

20.84

1.3

1.4

6.88

6.75

g/l

0.15

229

Hypothyreosis and Thyroxine purchase for inclusion criteria

660

2897

1.51

20.81

1.4

1.3

6.93

6.72

g/l

0.57

435

2054

Coxibs

214

536

2.14

20.78

1.3

6.41

7.31

g/l

2.47

149

365

Other pulmonary heart/vessel disease

4.94

20.67

1.3

8.74

7.22

g/l

0.59

Hypothyroidism, other/unspecified

638

2787

1.52

20.61

1.4

1.3

6.81

6.75

g/l

0.14

418

1982

Asthma mixed form (mode)

5.07

20.45

1.7

1.3

6.12

7.42

g/l

1.42

Vasculitis limited to skin, not elsewhere classified

6.23

20.42

1.4

1.2

5.68

7.76

g/l

1.48

Other skin changes

130

531

2.48

20.39

1.8

1.3

6.53

6.77

g/l

0.30

101

373

Personal history of allergy to drugs, medicaments and biological substances

8.90

20.35

1.6

1.1

5.97

6.39

g/l

0.29

Secondary right heart disease

5.18

20.31

1.2

1.3

8.88

7.21

g/l

0.60

Other diseases of intestine

332

2.90

20.30

1.4

1.3

6.87

g/l

0.00

226

Care involving dialysis

244

3.25

20.24

1.5

1.3

5.81

6.56

g/l

0.83

171

Selective serotonin reuptake inhibitors

737

2631

1.48

20.22

1.3

1.4

6.40

6.90

g/l

2.77

509

1823

Disorders of oesophagus in diseases classified elsewhere

8.21

20.14

1.4

1.1

6.95

8.41

g/l

0.51

Other metabolic disorders

117

458

2.59

20.10

1.7

1.3

6.57

6.70

g/l

0.14

316

Diseases of spleen

7.56

20.08

1.8

1.3

7.83

7.02

g/l

0.37

Obesity and other hyperalimentation

455

2823

1.60

20.01

1.4

6.28

6.81

g/l

2.82

322

1990

Somatoform disorder

143

616

2.35

19.95

1.4

1.3

6.03

6.66

g/l

1.85

420

Disorders of synovium and tendon

369

1970

1.70

19.95

1.5

1.3

6.28

7.02

g/l

4.48

257

1344

Recurring oral aphthae

142

4.04

19.93

1.5

1.3

6.06

6.70

g/l

0.66

100

Pain and other conditions associated with female genital organs and menstrual cycle

170

753

2.18

19.88

1.4

6.62

6.79

g/l

0.21

117

520

Rotator cuff syndrome

405

1816

1.66

19.77

1.4

1.3

6.26

7.10

g/l

5.11

301

1225

Otitis media, unspecified

111

390

2.65

19.73

1.4

1.3

5.74

6.73

g/l

3.40

291

Glomerular disorders in diseases classified elsewhere

360

2.79

19.69

1.4

6.19

6.76

g/l

0.70

253

Myocarditis

113

4.41

19.68

1.4

1.2

7.16

6.42

g/l

0.53

Dermatitis due to substances taken internally

139

4.03

19.62

1.5

5.95

7.02

g/l

0.95

Acute laryngitis and tracheitis

106

393

2.68

19.59

1.3

6.01

6.94

g/l

2.25

258

Gastroduodenal ulcer

159

720

2.22

19.52

1.3

6.82

7.12

g/l

0.42

106

483

Triptan medication for migraine, min. 3 purchases

434

2118

1.63

19.52

1.4

1.3

6.14

6.78

g/l

4.38

318

1475

Other and unspecified vasculitis limited to skin

6.32

19.51

1.4

1.2

5.70

7.24

g/l

1.45

Obesity

451

2813

1.60

19.47

1.4

6.29

6.81

g/l

2.70

318

1983

Sequelae with surgical and medical care as external cause

153

686

2.25

19.43

1.5

1.3

7.09

6.76

g/l

0.33

113

473

Other specified/unspecified soft tissue disorders

102

4.59

19.42

1.5

1.3

6.35

7.14

g/l

0.58

Other diseases of the digestive system

207

1043

2.00

19.32

1.3

6.98

6.92

g/l

0.05

146

723

Total colectomy operation

111

4.43

19.28

1.6

1.3

7.79

7.14

g/l

0.34

Total colectomy

111

4.43

19.28

1.6

1.3

7.79

7.14

g/l

0.34

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

187

3.53

19.23

1.6

1.4

6.89

6.97

g/l

0.05

131

Other viral diseases, not elsewhere classified

169

790

2.16

19.23

1.5

1.4

6.98

6.57

g/l

0.56

128

565

Other or unspecified ileus, impaction or obstruction

124

510

2.45

19.14

1.3

7.00

6.79

g/l

0.15

351

Idiopathic thrombocytopenic purpura

5.15

19.14

1.3

7.85

7.29

g/l

0.22

Systemic sclerosis

5.84

19.11

1.2

8.68

6.85

g/l

0.61

Cutaneous abscess, furuncle and carbuncle

203

1021

2.01

19.09

1.3

6.97

6.65

g/l

0.63

149

703

Acute and subacute iridocyclitis

159

730

2.20

19.07

1.5

1.3

6.26

6.69

g/l

0.69

110

514

Sequelae of external causes of morbidity and mortality

186

907

2.07

19.06

1.5

1.3

6.98

6.73

g/l

0.27

136

625

Dizziness and giddiness

510

2678

1.55

19.01

1.4

6.52

6.83

g/l

1.17

355

1866

Lung cancer and mesothelioma

247

3.00

18.97

1.2

1.3

6.61

7.26

g/l

0.69

161

Cerebrovascular diseases (FINNGEN)

220

798

1.98

18.95

1.3

6.96

6.90

g/l

0.07

158

550

Nonorganic sleeping disorders, excluding more controls

149

670

2.25

18.80

1.3

5.97

6.86

g/l

3.08

100

446

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

4.84

18.78

1.5

1.3

7.77

7.36

g/l

0.17

Other viral diseases

249

1345

1.86

18.76

1.6

1.3

7.10

6.57

g/l

1.01

181

951

Direct fill therapy

130

554

2.38

18.64

1.4

6.51

6.65

g/l

0.13

402

Other inflammation of eyelid

109

430

2.57

18.47

1.5

1.3

6.38

6.93

g/l

0.70

297

Chronic gastritis

172

825

2.10

18.40

1.3

1.4

6.70

7.07

g/l

0.60

137

559

Cervicalgia

145

651

2.25

18.36

1.8

1.3

6.32

6.90

g/l

1.34

106

438

Arthrosis

474

1644

1.59

18.30

1.3

1.4

6.80

6.83

g/l

0.07

334

1121

Acetic acid derivatives and related substances

208

530

2.06

18.27

1.5

1.3

6.54

7.34

g/l

1.66

145

362

Diseases of arteries, arterioles and capillaries

409

1887

1.62

18.24

1.4

7.00

6.86

g/l

0.26

289

1289

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

271

3.00

18.16

1.5

1.4

5.68

6.82

g/l

1.98

189

Adverse effects, not elsewhere classified

167

799

2.11

18.06

1.6

1.3

6.44

6.61

g/l

0.23

120

561

Emphysema

121

4.10

18.02

1.2

1.3

6.97

7.48

g/l

0.27

Anterior Iridocyclitis

165

788

2.11

17.92

1.5

1.3

6.28

6.72

g/l

0.74

115

547

Paroxysmal tachycardia

163

647

2.15

17.89

1.4

1.3

6.68

6.84

g/l

0.21

112

444

Other abnormal immunological findings in serum

6.35

17.78

1.7

1.2

6.69

6.29

g/l

0.27

Other arthrosis

333

1403

1.71

17.78

1.3

1.4

6.65

6.89

g/l

0.53

243

962

Drug-induced osteoporosis

8.65

17.68

2.1

1.4

5.06

6.25

g/l

0.94

Other and unspecified urticaria

166

799

2.10

17.68

1.4

1.3

6.64

6.63

g/l

0.01

122

558

Volume depletion

208

3.26

17.60

1.4

1.3

6.27

6.73

g/l

0.41

143

Acute tubulo-interstitial nephritis

406

2260

1.60

17.55

1.4

6.88

6.74

g/l

0.24

294

1585

Seronegative rheumatoid arthritis

320

2.78

17.53

1.4

1.3

7.25

6.79

g/l

0.28

211

Endocarditis

5.18

17.47

1.4

1.2

8.96

6.41

g/l

1.12

SLE, ICD10

112

4.22

17.35

1.6

1.4

6.90

6.79

g/l

0.06

SLE, strict definition

112

4.22

17.35

1.6

1.4

6.90

6.79

g/l

0.06

Hernia

660

3097

1.45

17.29

1.4

6.71

6.74

g/l

0.05

465

2125

Exposure to unspecified factor

688

3737

1.43

17.28

1.4

6.81

6.72

g/l

0.21

441

2637

Intestinal stricture

204

1069

1.92

17.07

1.3

1.4

6.62

6.91

g/l

0.37

136

738

Chronic ulcer of skin, not elsewhere classified

154

3.63

16.99

1.9

1.3

6.74

7.19

g/l

0.33

110

Psoriatic and enteropathic arthropathies

377

2.60

16.98

1.3

6.70

6.72

g/l

0.02

253

Crohn's disease of small intestine

234

3.09

16.95

1.3

1.4

6.44

6.71

g/l

0.20

167

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

4.43

16.92

1.7

1.4

6.04

6.90

g/l

0.53

Benign neoplasm: Colon, unspecified

155

736

2.11

16.87

1.4

1.5

6.55

6.89

g/l

0.57

110

511

Internal derangement of knee

254

1429

1.78

16.77

1.5

1.4

6.41

6.84

g/l

1.01

174

976

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.38

16.70

1.7

1.3

6.04

6.99

g/l

0.60

Seropositive rheumatoid arthritis, strict definition

120

519

2.34

16.68

1.4

1.3

6.93

6.75

g/l

0.17

354

Non-ischemic cardiomyopathy

182

751

2.00

16.59

1.4

1.3

7.11

6.83

g/l

0.39

120

514

Insulin, fast-acting

258

1467

1.77

16.57

1.5

1.3

6.63

6.77

g/l

0.20

168

1029

Gingivitis and periodontal diseases

618

2176

1.47

16.54

1.4

1.3

6.69

6.75

g/l

0.16

445

1478

Other arrhythmias

427

2096

1.57

16.50

1.4

6.89

6.62

g/l

0.85

280

1467

Bronchitis, not specified as acute or chronic

222

3.10

16.46

1.5

1.3

6.61

7.02

g/l

0.48

149

Chronic iridocyclitis

149

3.63

16.33

1.5

1.3

6.08

6.88

g/l

0.85

107

Diabetes mellitus

741

3146

1.41

16.30

1.4

6.54

6.79

g/l

0.85

497

2216

Keratitis

251

1424

1.77

16.30

1.4

6.93

6.78

g/l

0.27

168

979

Other disorders of ear

632

2924

1.44

16.22

1.5

1.4

6.44

6.83

g/l

2.05

440

2049

Diabetes, varying definitions

737

3133

1.41

16.22

1.4

6.52

6.80

g/l

0.94

491

2210

Ulcerative enterocolitis

4.54

16.20

1.4

1.3

7.73

6.64

g/l

0.75

Deforming dorsopathies

193

1011

1.92

16.20

1.4

6.30

6.98

g/l

2.15

148

685

Persons with potential health hazards related to communicable diseases

306

1822

1.68

16.16

1.4

1.3

6.31

6.68

g/l

1.11

185

1307

Dermatographic urticaria

220

3.10

16.12

1.8

1.4

6.12

6.66

g/l

0.75

151

Other diseases of stomach and duodenum

146

3.62

16.02

1.3

6.91

7.43

g/l

0.40

Convulsions, not elsewhere classified

155

745

2.07

15.99

1.4

1.3

6.77

6.65

g/l

0.15

113

512

Gonarthrosis [arthrosis of knee](FG)

447

1698

1.55

15.98

1.3

6.73

6.82

g/l

0.20

322

1158

Other and unspecified effects of external causes

216

1180

1.84

15.94

1.5

1.3

6.57

6.61

g/l

0.06

153

821

Benign neoplasm: Colon, unspecified

155

757

2.06

15.91

1.4

1.3

6.55

7.02

g/l

0.84

110

529

6-mercaptopurine

5.27

15.85

2.3

1.2

9.47

6.63

g/l

0.74

Ascites

152

3.54

15.82

1.3

1.2

7.59

7.06

g/l

0.25

110

Viral infections of the central nervous system

239

2.98

15.74

1.4

5.60

6.71

g/l

2.41

162

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

660

3024

1.43

15.72

1.4

6.95

6.77

g/l

0.44

443

2120

Hepatic failure, not elsewhere classified

4.72

15.70

1.4

1.3

7.62

6.49

g/l

0.74

Unspecified kidney failure

218

3.06

15.68

1.4

1.2

7.14

6.85

g/l

0.15

153

Gastric ulcer

106

446

2.39

15.67

1.3

1.4

6.94

6.96

g/l

0.01

304

Vascular disorders of the intestines

116

3.93

15.64

1.2

1.3

7.83

7.21

g/l

0.30

Psoriasis

207

1123

1.86

15.62

1.2

1.4

6.65

6.82

g/l

0.32

147

775

Personality disorders, excluding more controls

190

1003

1.91

15.60

1.3

6.26

6.81

g/l

1.94

130

672

Other disorders of skin and subcutaneous tissue, not elsewhere classified

106

448

2.39

15.55

1.7

1.3

6.35

6.85

g/l

0.77

316

Postprocedural disorders of nervous system

246

2.93

15.55

1.5

1.4

6.23

6.58

g/l

0.32

178

Benign neoplasm: Transverse colon

279

2.80

15.52

1.6

1.4

6.47

7.10

g/l

0.81

196

Systemic sclerosis, icd10

4.82

15.52

1.2

1.3

8.68

7.14

g/l

0.49

Oxicams

169

468

2.07

15.49

1.3

6.22

7.31

g/l

3.27

124

320

Algoneurodystrophy

100

4.20

15.44

1.4

1.3

6.02

6.92

g/l

0.74

Benign neoplasm: Transverse colon

280

2.79

15.42

1.6

1.4

6.47

6.98

g/l

0.62

201

Genitourinary diseases

462

1507

1.54

15.42

1.4

6.65

6.80

g/l

0.40

323

1034

Heart failure and bmi 25plus

195

702

1.93

15.41

1.3

1.4

7.66

6.74

g/l

1.33

122

437

Excessive, frequent and irregular menstruation

292

948

1.72

15.39

1.3

1.4

6.11

6.75

g/l

2.50

202

651

Other disorders of eye and adnexa

116

513

2.29

15.36

1.3

1.4

5.93

6.86

g/l

3.51

357

Other/unspecified rheumatoid arthritis

355

2.56

15.33

1.5

1.3

6.25

6.99

g/l

1.34

242

Other infectious diseases

216

3.05

15.32

1.5

1.3

7.44

6.95

g/l

0.32

152

Symptoms and signs involving the urinary system

503

2626

1.49

15.32

1.5

1.4

6.95

6.75

g/l

0.50

358

1806

Radiculopathy

109

470

2.34

15.27

1.4

1.3

6.10

6.95

g/l

2.13

327

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

4.72

15.24

2.0

1.2

6.22

7.03

g/l

0.27

Disorders of ocular muscles, binocular movement, accommodation and refraction

339

2103

1.61

15.22

1.5

1.4

6.43

6.75

g/l

1.18

245

1475

Obesity due to excess calories

329

2046

1.62

15.17

1.3

1.4

6.41

6.81

g/l

1.30

229

1420

Congenital malformations and deformations of the musculoskeletal system

373

2.52

15.17

1.6

1.3

6.20

6.37

g/l

0.22

282

Pruritus

334

2.61

15.14

1.6

1.3

7.16

7.02

g/l

0.11

234

Acute pharyngitis

112

487

2.30

15.13

1.3

6.06

6.98

g/l

2.14

324

Misadventures to patients during surgical and medical care

107

460

2.35

15.13

1.4

1.3

6.58

6.84

g/l

0.28

327

Crohn's disease NAS

218

3.03

15.10

1.2

1.3

7.00

6.79

g/l

0.15

152

Cerebral cysts

157

3.43

15.10

1.7

1.3

6.34

6.72

g/l

0.25

112

Invasive ventilation

208

3.08

15.03

1.3

5.38

6.90

g/l

2.21

148

Chorioretinal inflammation

4.91

15.03

1.4

6.52

7.19

g/l

0.37

Combined immunodeficiencies

8.37

15.02

1.4

1.2

4.96

6.74

g/l

1.92

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.74

14.92

1.3

1.2

5.55

6.11

g/l

0.60

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

285

2.74

14.92

1.3

1.4

7.60

6.83

g/l

0.44

201

Ocular pain

274

2.78

14.92

1.4

1.5

6.12

6.65

g/l

0.86

190

Insulin, intermediate and long-acting

353

2196

1.58

14.92

1.4

6.71

6.85

g/l

0.27

231

1537

Other enthesopathies

205

1127

1.83

14.84

1.6

1.3

5.89

7.05

g/l

5.57

148

759

Senile cataract

393

1559

1.57

14.83

1.4

6.64

6.92

g/l

0.62

266

1107

Insulin, fast-acting or short human

259

1523

1.71

14.82

1.5

1.3

6.62

6.81

g/l

0.27

169

1061

Conjunctivitis (acute, non atopic)

206

1133

1.82

14.74

1.4

1.3

6.81

6.63

g/l

0.25

154

792

Fissure and fistula of anal and rectal regions

165

849

1.96

14.66

1.2

1.3

6.89

6.79

g/l

0.12

108

568

Other cataract

269

1229

1.70

14.61

1.5

1.3

6.81

6.88

g/l

0.11

188

877

Hepatomegaly and splenomegaly, not elsewhere classified

8.10

14.57

1.4

1.2

7.19

5.90

g/l

0.68

Rare circulating lymphoid malignancy

4.54

14.55

2.0

1.2

6.22

6.90

g/l

0.24

Other CVD (FINNGEN)

199

2.87

14.51

1.3

6.43

7.49

g/l

1.03

134

Pyogenic arthritis

161

3.34

14.50

1.3

8.09

7.10

g/l

0.72

112

TMD related pain

110

3.91

14.39

1.4

5.92

6.42

g/l

0.63

Nephrotic syndrome

4.13

14.34

1.9

1.3

4.85

6.85

g/l

2.17

Other diseases of jaws

214

2.99

14.32

1.6

1.4

6.44

6.71

g/l

0.24

136

Heartburn

269

2.74

14.26

1.4

1.3

6.11

6.93

g/l

1.42

192

Chronic nephritic syndrome

111

3.86

14.19

2.0

1.3

7.82

6.95

g/l

0.29

Pyothorax

102

4.00

14.19

1.4

1.3

6.69

7.16

g/l

0.31

Cluster headache, strict

4.24

14.18

1.3

1.2

6.51

6.54

g/l

0.02

Type 2 diabetes

675

2878

1.40

14.15

1.5

1.4

6.55

6.83

g/l

0.91

457

2018

Cluster headache, wide

4.12

14.04

1.3

6.39

6.51

g/l

0.11

Demyelinating diseases of the central nervous system

324

2.57

13.99

1.4

6.30

6.56

g/l

0.27

226

Ulcerative ileocolitis

131

3.58

13.96

1.2

1.3

9.33

6.44

g/l

2.04

Pneumothorax

155

3.33

13.96

1.3

1.2

7.68

6.84

g/l

0.65

114

Acute lymphadenitis

208

2.98

13.81

1.9

1.3

6.63

6.40

g/l

0.17

149

Exposure to other specified factors

513

3350

1.44

13.78

1.5

1.4

6.77

6.73

g/l

0.08

367

2316

Atopic dermatitis, strict definition

241

1392

1.71

13.74

1.4

6.95

6.59

g/l

0.63

184

978

Polyarthritis, unspecified

4.22

13.72

1.8

1.4

6.44

7.23

g/l

0.40

Reactive arthropathies, FINNGEN

209

2.96

13.67

1.4

1.3

6.48

6.61

g/l

0.12

142

Exclusions for E4_PCOS_CONSORTIUM

526

2284

1.45

13.65

1.4

6.30

6.73

g/l

1.83

317

1653

Postprocedural endocrine and metabolic disorders, not elsewhere classified

425

2.33

13.64

1.8

1.3

6.54

6.72

g/l

0.19

294

Disorders of mineral metabolism

231

2.85

13.64

1.4

6.88

6.62

g/l

0.17

158

Abscess of lung

6.08

13.64

1.4

1.3

6.68

7.07

g/l

0.17

Soft tissue disorders related to use, overuse and pressure

171

913

1.88

13.64

1.4

1.3

6.52

7.07

g/l

1.24

130

611

Adenocarcinoma and ductal carcinoma of pancreas

5.02

13.62

1.1

1.3

6.37

7.76

g/l

0.68

Haemorrhoids and perianal venous thrombosis

174

934

1.87

13.60

1.2

1.4

7.51

6.98

g/l

0.76

114

634

Cardiac murmurs and other cardiac sounds

250

2.76

13.60

1.1

1.4

6.64

6.56

g/l

0.06

186

Diseases of pulp and periapical tissues, including avohilmo

774

2960

1.36

13.60

1.4

6.88

6.71

g/l

0.52

530

2063

Benign neoplasm: Stomach

282

2.66

13.59

1.8

1.4

6.04

6.88

g/l

1.40

195

Dental operations

429

1453

1.52

13.57

1.4

1.3

6.93

6.69

g/l

0.51

293

1017

Dental pulpitis 4

775

2966

1.36

13.55

1.4

6.87

6.71

g/l

0.51

534

2066

Benign neoplasm: Caecum

277

2.67

13.52

1.6

1.4

6.68

7.15

g/l

0.49

196

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

5.78

13.48

1.5

1.3

6.97

6.33

g/l

0.18

Secondary and unspecified malignant neoplasm of lymph nodes

233

2.83

13.43

1.4

6.50

6.83

g/l

0.20

163

Meniscus derangement

347

1519

1.57

13.40

1.3

1.4

6.55

6.83

g/l

0.73

219

1035

Dental pulpitis 1

774

2968

1.36

13.39

1.4

6.88

6.71

g/l

0.53

532

2069

Behavioural syndromes associated with physiological disturbances and physical factors

241

1432

1.69

13.34

1.3

1.4

6.35

6.69

g/l

0.66

165

1015

Diseases of tongue

170

3.16

13.32

1.5

5.86

6.89

g/l

1.35

115

Rash and other nonspecific skin eruption

320

2.53

13.32

1.4

6.66

6.87

g/l

0.21

230

Disorders of optic nerve and visual pathways

326

2.52

13.32

1.5

1.4

6.02

6.60

g/l

0.74

229

Type 2 diabetes, wide definition

475

2116

1.47

13.31

1.5

1.3

6.61

6.92

g/l

0.78

345

1539

Dental caries 1 and operation codes

592

2146

1.42

13.25

1.4

1.3

6.70

6.71

g/l

0.01

405

1512

Localized swelling, mass and lump of skin and subcutaneous tissue

210

1205

1.75

13.23

1.7

1.3

7.27

6.79

g/l

0.82

170

816

Chronic lymphocytic leukaemia

5.03

13.16

1.3

7.13

7.19

g/l

0.01

Abnormal findings on diagnostic imaging of central nervous system

127

3.53

13.10

1.6

1.3

6.40

6.84

g/l

0.38

Ulcerative colitis (strict definition, all Crohn cases excluded)

118

562

2.12

13.07

1.2

1.4

8.30

6.59

g/l

3.80

398

Other disorders of bone

151

786

1.94

13.05

1.4

1.3

6.00

6.70

g/l

1.75

109

548

Ankylosing spondylitis

288

2.60

13.04

1.3

1.4

6.66

6.89

g/l

0.28

200

Tonsillectomy and adenotomy

439

2073

1.48

13.02

1.4

1.3

6.34

6.65

g/l

1.01

330

1424

Benign neoplasm: Caecum

283

2.61

12.97

1.6

1.4

6.68

6.95

g/l

0.26

199

Chronic lymphocytic leukaemia, helper endpoint

4.94

12.91

1.3

1.2

7.13

7.48

g/l

0.08

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

4.94

12.91

1.3

1.2

7.13

7.48

g/l

0.08

Gout, idiopatic and unspecified

140

713

1.98

12.89

1.4

1.3

6.94

7.09

g/l

0.12

496

Diseases of the myoneural junction and muscle

362

2.40

12.83

1.5

1.4

5.95

6.75

g/l

1.57

258

Benign neoplasm: Stomach

291

2.57

12.78

1.8

1.4

6.04

7.00

g/l

1.67

198

Other and unspecified drugs and medicaments

251

2.70

12.75

1.4

5.67

6.85

g/l

1.84

172

Other noninfective disorders of lymphatic vessels and lymph nodes

4.26

12.75

1.4

1.3

6.48

6.55

g/l

0.03

Hypersensitivity pneumonitis due to organic dust

6.14

12.68

1.1

1.4

8.43

7.11

g/l

0.64

Sleep disorders

165

893

1.86

12.67

1.3

1.4

6.10

6.70

g/l

1.91

112

623

Other demyelinating diseases of the central nervous system

130

3.46

12.67

1.5

1.4

6.42

6.77

g/l

0.24

Pleural plaque

191

2.96

12.66

1.3

1.2

7.32

6.66

g/l

0.65

138

Lichen simplex chronicus and prurigo

160

3.17

12.63

1.1

1.5

7.25

6.84

g/l

0.26

110

Sacroiliitis, not elsewhere classified

135

3.39

12.62

1.4

6.63

6.61

g/l

0.01

Bullous disorders

135

3.38

12.62

1.4

1.3

7.53

7.23

g/l

0.20

Subjective visual disturbances

170

930

1.84

12.62

1.4

1.3

6.45

6.69

g/l

0.43

126

631

Inflammatory diseases of female pelvic organs

414

2110

1.48

12.61

1.4

6.41

6.68

g/l

0.84

299

1485

Ischemic heart diseases

490

2131

1.44

12.59

1.4

6.87

6.84

g/l

0.06

341

1463

Scleritis and episcleritis

192

2.96

12.59

1.4

1.5

6.81

6.72

g/l

0.06

136

Diffuse large B-cell lymphoma

102

3.79

12.58

1.4

1.3

4.81

7.27

g/l

2.87

Persons encountering health services for specific procedures, not carried out

236

2.75

12.56

1.4

1.3

6.17

6.84

g/l

1.00

159

Panic disorder

120

585

2.07

12.51

1.4

1.3

6.81

6.73

g/l

0.10

400

Nonorganic sleeping disorders

149

784

1.92

12.50

1.3

1.4

5.97

6.70

g/l

2.39

100

547

TMD related operations

136

694

1.98

12.50

1.4

6.35

6.69

g/l

0.63

481

Disorders of muscles

318

2.48

12.49

1.3

6.40

6.79

g/l

0.38

222

Non-Hodgkin lymphoma, all

4.28

12.48

1.4

1.2

5.35

7.30

g/l

1.54

Other diseases of oesophagus

231

2.75

12.48

1.2

1.3

6.78

7.06

g/l

0.26

160

Brachial plexus disorders

349

2.41

12.44

1.5

1.4

5.81

6.50

g/l

1.34

239

Gonarthrosis

389

1479

1.51

12.41

1.3

1.4

6.77

6.90

g/l

0.27

278

1017

Other meningitis

5.52

12.38

1.6

1.2

5.57

6.57

g/l

0.88

Crohn's disease of large intestine

173

3.06

12.33

1.3

7.14

6.80

g/l

0.17

124

Aortic aneurysm

128

632

2.00

12.23

1.4

1.3

7.29

7.05

g/l

0.18

443

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

240

932

1.68

12.11

1.2

1.4

6.42

6.44

g/l

0.05

174

662

Coeliac disease

429

2.24

12.07

1.7

1.4

6.76

6.83

g/l

0.06

298

Other bursopathies

391

2.30

12.06

1.6

1.2

6.47

6.81

g/l

0.41

265

Failure and rejection of transplanted organs and tissues

5.87

12.06

1.3

6.14

7.16

g/l

0.39

Cardiomyopathy

109

521

2.11

11.98

1.4

1.3

7.47

6.93

g/l

0.58

363

Obesity, other/unspecified

238

1453

1.65

11.96

1.5

1.3

6.44

6.75

g/l

0.72

185

1009

Postmenopausal osteoporosis with pathological fracture

120

3.47

11.95

1.3

5.74

6.91

g/l

1.24

Psoriasis vulgaris

134

692

1.95

11.91

1.2

1.3

6.56

6.84

g/l

0.49

479

Special screening examination for other diseases and disorders

209

2.80

11.88

1.3

6.35

6.58

g/l

0.17

130

Oter anti-inflammatory and antirheumatic agents, non-steroids

147

417

1.97

11.86

1.2

1.3

6.65

7.34

g/l

0.92

109

288

Chronic tubulo-interstitial nephritis

3.93

11.84

1.3

1.5

8.21

6.72

g/l

0.88

Carpal tunnel syndrome

385

2360

1.48

11.84

1.4

6.49

6.88

g/l

1.52

278

1636

Hypothyroidism, strict autoimmune, 3 medication purchases required

553

2718

1.39

11.75

1.3

7.11

6.72

g/l

1.16

383

1930

375

2331

1.48

11.75

1.3

1.4

6.42

6.84

g/l

1.45

226

1605

Ovarian cyst

259

916

1.64

11.74

1.3

1.4

6.28

6.76

g/l

1.27

179

624

Alcohol use disorder, Swedish definition

355

2208

1.50

11.72

1.2

1.4

6.38

6.88

g/l

1.83

214

1522

Erythema nodosum

4.09

11.71

1.6

1.4

7.61

7.10

g/l

0.17

Psoriatic arthropathies

329

2.40

11.63

1.3

6.58

6.85

g/l

0.26

224

Ulcerative rectosigmoiditis

281

2.52

11.63

1.3

7.82

6.78

g/l

1.03

195

Colectomy operation

108

521

2.09

11.62

1.4

1.3

7.63

6.79

g/l

0.98

359

Hyperlipidaemia, other/unspecified

216

1224

1.68

11.61

1.5

1.4

6.87

7.02

g/l

0.17

159

832

Ischaemic heart disease, wide definition

476

2091

1.43

11.60

1.4

6.88

6.85

g/l

0.05

324

1443

Other disorders of conjunctiva

424

2.21

11.56

1.5

1.3

6.47

6.91

g/l

0.64

293

Other neurological diseases

438

2456

1.44

11.53

1.4

6.38

6.88

g/l

1.98

305

1699

External causes of morbidity and mortality

505

1783

1.42

11.52

1.4

1.3

6.61

6.91

g/l

1.07

355

1232

Erythema multiforme

4.76

11.48

1.3

8.49

6.85

g/l

0.70

Crohn disease (strict definition, require KELA, min 2 HDR)

225

2.71

11.46

1.2

1.3

6.69

6.81

g/l

0.07

159

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

645

2914

1.36

11.45

1.4

6.57

6.80

g/l

0.67

434

2053

Subacute thyroiditis

3.75

11.44

1.5

1.4

6.12

6.97

g/l

0.75

Fenamates

104

325

2.17

11.42

1.5

1.3

6.63

7.52

g/l

1.56

228

Hernia of abdominal wall

280

1798

1.56

11.42

1.5

1.4

6.69

6.87

g/l

0.34

201

1249

L04AC Interleukin inhibitors

165

3.02

11.41

1.3

1.4

6.27

6.94

g/l

0.73

116

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

5.51

11.41

1.5

1.2

8.18

7.37

g/l

0.22

Other peripheral vascular diseases

231

2.67

11.41

1.3

1.4

5.86

6.56

g/l

1.14

161

Chronic periodontitis

101

479

2.13

11.37

1.4

1.3

6.81

7.03

g/l

0.12

326

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.29

11.32

1.1

1.2

6.37

7.41

g/l

0.53

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

110

3.52

11.30

1.4

1.2

4.81

6.99

g/l

2.66

Diffuse large B-cell lymphoma, helper endpoint

110

3.52

11.30

1.4

1.2

4.81

6.99

g/l

2.66

Substance abuse, excluding more controls

351

2066

1.49

11.29

1.3

1.4

6.28

6.93

g/l

3.20

236

1395

Systemic lupus erythematosus, unspecified

3.73

11.29

1.4

7.40

6.46

g/l

0.61

Abnormal findings on examination of urine, without diagnosis

115

3.45

11.27

1.4

1.3

6.13

7.05

g/l

0.86

Crohn disease (strict definition, require KELA)

227

2.68

11.27

1.2

1.3

6.69

6.78

g/l

0.05

161

Enthesopathies of lower limb, excluding foot

142

762

1.88

11.25

1.5

1.3

6.68

6.97

g/l

0.46

103

509

Gout, unspecified

116

582

2.01

11.22

1.3

7.00

7.08

g/l

0.05

410

Meningitis

156

3.06

11.22

1.6

1.3

5.68

6.78

g/l

1.67

111

Faecal incontinence

199

2.79

11.22

1.4

1.2

6.37

7.10

g/l

0.63

132

Other external causes of accidental injury

624

2295

1.37

11.19

1.4

1.3

6.59

6.81

g/l

0.78

433

1602

Viral and other specified intestinal infections

154

829

1.83

11.16

1.6

1.3

6.59

6.56

g/l

0.04

105

581

Other obstetric conditions, not elsewhere classified

241

959

1.64

11.16

1.2

1.4

6.36

6.43

g/l

0.15

176

681

Acute generalized exanthematous pustulosis

131

3.26

11.13

1.5

1.3

5.93

7.00

g/l

0.88

Injuries to the abdomen, lower back, lumbar spine and pelvis

237

1464

1.62

11.07

1.2

1.4

6.39

6.81

g/l

1.21

171

1005

394

2441

1.45

11.04

1.3

1.4

6.44

6.84

g/l

1.37

239

1683

Hodgkin lymphoma

4.09

10.99

1.6

1.2

6.21

6.36

g/l

0.08

Other or ill-defined heart diseases

132

3.22

10.96

1.4

1.2

7.68

6.87

g/l

0.58

Paracetamol of NSAID medication

128

321

2.02

10.86

1.4

1.3

6.49

7.55

g/l

2.35

234

Hyperparathyroidism

105

508

2.06

10.85

1.4

1.3

6.53

6.91

g/l

0.45

352

Haemolytic anaemias

3.69

10.84

1.7

1.3

7.91

6.78

g/l

0.35

Substance use, excluding alcohol

147

808

1.83

10.83

1.4

1.3

6.39

6.75

g/l

0.59

100

556

Coxarthrosis [arthrosis of hip](FG)

279

1296

1.56

10.81

1.3

6.61

6.92

g/l

0.80

214

879

Viral pneumonia (known virus, not influenza)

4.52

10.79

1.4

1.2

5.97

7.17

g/l

0.85

Tongue abnormality

165

2.95

10.79

1.5

5.71

6.98

g/l

1.51

114

Retention of urine

189

938

1.71

10.78

1.4

7.07

7.06

g/l

0.01

133

639

Phlebitis and thrombophlebitis (not including DVT)

146

802

1.83

10.77

1.3

1.4

5.79

6.64

g/l

2.60

568

Extreme obesity with alveolar hypoventilation

104

3.52

10.75

1.4

1.3

7.79

7.02

g/l

0.26

Disorders of vestibular function (Vertigo)

280

1811

1.54

10.74

1.4

6.53

6.83

g/l

0.75

183

1264

Cluster headache, strict, including avohilmo

155

3.02

10.72

1.3

6.15

6.83

g/l

0.87

107

Trochanteric bursitis

386

2.22

10.70

1.5

1.4

5.94

6.97

g/l

2.06

267

Disorders of plasma-protein metabolism, not elsewhere classified

7.92

10.68

1.3

6.51

6.45

g/l

—

Spondylolisthesis/Spondylolysis

113

573

1.99

10.63

1.6

1.3

5.85

6.89

g/l

3.08

391

Hodgkin lymphoma, hilmo

3.98

10.62

1.6

1.3

6.21

6.72

g/l

0.27

Other abnormalities of plasma proteins

5.94

10.61

1.9

1.2

7.56

6.17

g/l

0.32

Reactive arthropathies

282

2.44

10.57

1.4

7.01

7.03

g/l

0.01

188

Other CVD

103

507

2.04

10.52

1.4

1.3

6.51

6.71

g/l

0.17

352

Generalized skin eruption due to drugs and medicaments

111

3.39

10.44

1.5

1.3

5.89

6.96

g/l

0.72

Cluster headache, wide,, including avohilmo

163

2.93

10.42

1.3

6.07

6.87

g/l

1.10

111

Dental caries, including avohilmo

520

1920

1.39

10.41

1.4

1.3

6.51

6.76

g/l

0.76

351

1347

Thyroiditis

237

2.56

10.36

1.5

6.38

6.90

g/l

0.56

167

Benign neoplasm: Pancreas

4.36

10.36

1.5

1.3

6.39

7.47

g/l

—

Secondary uncertain malignant neoplasm

353

2.26

10.36

1.5

1.4

6.34

7.02

g/l

0.60

248

Disorders of calcium metabolism

169

2.88

10.34

1.3

1.4

7.08

6.97

g/l

0.05

116

Isolated proteinuria

3.72

10.31

1.4

1.3

6.33

6.58

g/l

0.18

Dental caries 1

520

1924

1.39

10.27

1.4

1.3

6.51

6.76

g/l

0.76

351

1351

Hyperhidrosis

4.60

10.27

1.4

1.2

6.09

7.33

g/l

0.69

Rosacea

413

2.15

10.25

1.3

1.4

6.56

6.93

g/l

0.41

285

Menorrhagia

243

837

1.61

10.22

1.4

6.37

6.76

g/l

0.84

170

574

Chronic hepatitis NAS

5.45

10.20

1.2

7.91

6.61

g/l

—

Optic neuritis

149

3.01

10.19

1.6

1.4

5.91

6.83

g/l

0.97

105

Cytomegalovirus infection, IBD co-morbidity

4.30

10.16

1.4

1.2

6.92

6.86

g/l

0.01

Neuromuscular dysfunction of bladder

257

2.48

10.16

1.3

6.17

7.04

g/l

0.93

179

Benign neoplasm: Pancreas

4.29

10.15

1.5

1.6

6.39

7.07

g/l

—

Cerebral palsy and other paralytic syndromes

395

2.17

10.14

1.3

1.4

6.10

6.61

g/l

0.55

278

Carrier of infectious disease

4.04

10.10

1.6

1.3

6.63

6.84

g/l

0.11

Other bullous disorders

4.03

10.09

1.2

1.4

7.64

6.73

g/l

0.59

Dental operations, only avohilmo

452

1642

1.41

10.08

1.4

6.94

6.73

g/l

0.45

303

1147

Dental caries 3 and operation codes

605

2311

1.35

10.04

1.4

6.67

6.74

g/l

0.16

413

1634

Vitamin deficiency

124

3.19

10.03

1.2

1.4

6.47

7.01

g/l

0.29

Vitamin deficiency, wide

124

3.19

10.03

1.2

1.4

6.47

7.01

g/l

0.29

Synovial cyst of popliteal space [Baker]

183

2.76

10.03

1.3

6.25

7.05

g/l

0.75

127

Insomnia

121

642

1.90

10.01

1.4

5.98

6.76

g/l

2.27

453

Exophthalmic conditions

6.30

10.01

1.6

1.3

6.10

5.97

g/l

0.05

Irregular menses

323

1776

1.48

9.98

1.5

1.4

6.17

6.72

g/l

2.57

231

1269

Other and unspecified rosacea

278

2.40

9.95

1.2

1.4

6.47

6.90

g/l

0.39

196

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

242

2.51

9.94

1.2

1.3

6.69

6.87

g/l

0.10

170

Dystonia

173

2.82

9.93

1.4

1.5

6.95

6.55

g/l

0.13

118

Cardiomyopathy, other and unspecified

201

2.66

9.93

1.4

1.2

7.76

6.45

g/l

1.06

148

Acquired haemolytic anaemia

4.34

9.89

1.7

1.4

7.70

7.08

g/l

0.12

Accidents

613

2295

1.34

9.88

1.4

1.3

6.64

6.81

g/l

0.55

429

1602

Coronary atherosclerosis

395

1785

1.43

9.86

1.4

6.95

6.84

g/l

0.18

274

1216

Hypotension

394

2.15

9.78

1.3

6.68

6.73

g/l

0.03

277

Other medical care

233

1453

1.57

9.78

1.3

1.4

6.39

6.83

g/l

0.90

160

1003

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

180

1080

1.67

9.77

1.2

1.3

6.12

6.82

g/l

2.56

124

734

Type 2 diabetes, definitions combined

608

2727

1.33

9.77

1.4

6.48

6.86

g/l

1.39

412

1912

Episcleritis

164

2.85

9.72

1.5

1.4

6.63

6.91

g/l

0.20

117

Tuberculosis, IBD comorbidity

153

2.90

9.70

2.1

1.4

7.63

7.16

g/l

0.30

110

Achalasia of cardia

5.40

9.68

1.3

1.4

6.14

6.80

g/l

—

Otalgia

270

2.40

9.63

1.7

1.3

5.99

6.76

g/l

1.19

197

Hyperkinetic disorders, excluding more controls

386

2.14

9.60

1.3

6.52

6.65

g/l

0.13

262

Umbilical hernia

169

1003

1.69

9.59

1.5

1.4

6.91

6.80

g/l

0.14

118

693

Cytomegaloviral disease

4.10

9.57

1.4

1.3

6.92

7.05

g/l

0.03

Viral meningitis

113

3.24

9.49

1.4

1.3

5.72

6.18

g/l

0.48

Disorders of refraction and accommodation

190

1162

1.64

9.47

1.4

1.3

6.37

6.58

g/l

0.53

142

818

Abnormality of white blood cells, not elsewhere classified

6.83

9.45

1.3

1.2

5.38

5.72

g/l

—

Covid-19 suspected case

155

903

1.73

9.43

1.4

1.3

6.53

6.67

g/l

0.23

134

618

Other congenital malformations

342

2.22

9.41

1.3

1.4

6.64

6.25

g/l

0.55

251

Diseases of inner ear

318

2141

1.46

9.40

1.3

1.4

6.60

6.83

g/l

0.55

204

1493

Amyloidosis

5.25

9.40

1.5

1.4

9.13

7.14

g/l

0.43

Mouth breathing

271

1806

1.51

9.39

1.4

6.49

6.78

g/l

0.68

184

1262

Injury, poisoning and certain other consequences of external causes

402

1418

1.42

9.35

1.5

1.3

6.73

6.91

g/l

0.40

289

950

Procreative management

239

1303

1.55

9.35

1.5

1.4

6.71

6.56

g/l

0.26

162

893

Special screening examination for infectious and parasitic diseases

149

634

1.76

9.34

1.4

1.3

6.30

6.82

g/l

0.88

113

366

Disorders of lipoprotein metabolism and other lipidaemias

486

2240

1.37

9.30

1.4

6.71

6.84

g/l

0.25

346

1536

conjunctival haemorrhage

191

2.65

9.27

1.6

1.3

6.49

7.11

g/l

0.60

134

Other/unspecified reactive arthropathies

221

2.52

9.21

1.4

1.3

6.53

6.62

g/l

0.07

155

Small fibre neuropathy

3.77

9.21

1.6

1.3

6.01

7.23

g/l

1.14

Benign paroxysmal vertigo

168

1007

1.68

9.21

1.3

1.4

6.46

6.74

g/l

0.51

106

699

Acute bronchiolitis

224

2.44

9.18

1.4

1.3

6.71

6.23

g/l

0.31

180

Falls/tendency to fall

790

3095

1.28

9.18

1.4

6.79

6.72

g/l

0.18

551

2143

Fentanyl

215

2.53

9.17

1.4

1.2

6.37

7.27

g/l

0.69

155

Endometriosis

233

882

1.58

9.17

1.3

1.4

6.38

6.76

g/l

0.87

170

602

Type 2 diabetes, strict (exclude DM1)

609

2760

1.32

9.17

1.4

6.49

6.86

g/l

1.32

413

1926

Disorders of vitreous body and globe

287

1897

1.48

9.16

1.4

6.84

6.81

g/l

0.04

209

1318

Cellulitis

139

792

1.77

9.16

1.4

1.3

6.69

6.62

g/l

0.07

111

547

Dental pulpitis 4, only avohilmo

755

3074

1.29

9.07

1.4

6.84

6.70

g/l

0.42

510

2149

Benign neoplasm: Small intestine

106

3.26

9.07

1.2

1.5

6.70

7.35

g/l

0.41

Erosion of teeth

4.19

9.06

1.3

5.61

7.06

g/l

1.35

Etanercept

217

2.52

9.05

1.5

1.3

7.58

6.54

g/l

1.28

155

Chronic suppurative otitis media, including avohilmo

266

2.36

9.01

1.8

1.4

6.20

6.65

g/l

0.65

190

Other and unspecified visual disturbances

291

2.29

9.00

1.8

1.3

6.56

6.74

g/l

0.13

201

Allergic purpura

3.60

8.99

1.3

5.54

6.26

g/l

0.80

Other hearing loss

143

811

1.74

8.98

1.5

1.3

5.89

7.14

g/l

4.50

558

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

138

2.93

8.98

1.5

1.2

8.01

7.18

g/l

0.35

102

Diabetes, insulin treatment (Kela reimbursement)

656

3090

1.30

8.95

1.4

6.57

6.80

g/l

0.63

442

2167

Benign neoplasm: Small intestine

107

3.23

8.94

1.2

1.4

6.70

6.88

g/l

0.10

Diabetes insipidus

5.96

8.89

1.9

1.2

6.72

6.43

g/l

—

Nummular dermatitis

219

2.49

8.87

1.4

6.67

6.96

g/l

0.24

155

Diabetes medication

686

3234

1.29

8.86

1.4

6.62

6.78

g/l

0.41

466

2272

Diplopia

431

2.04

8.84

1.9

1.3

5.82

6.97

g/l

2.53

304

Conductive and sensorineural hearing loss

468

2389

1.36

8.84

1.5

1.3

6.56

6.84

g/l

0.92

318

1667

Nonspecific lymphadenitis

208

2.53

8.81

1.4

1.3

6.89

6.47

g/l

0.32

151

Disorders of vitreous body

278

1850

1.48

8.76

1.4

6.89

6.81

g/l

0.11

200

1286

Unspecified/other endometriosis

347

2.15

8.70

1.5

1.4

5.73

6.85

g/l

1.95

237

Ankylosing spondylitis, ICD10

328

2.19

8.68

1.3

6.66

6.76

g/l

0.11

229

Haemorrhage, not elsewhere classified

3.99

8.62

1.2

1.3

7.09

7.92

g/l

0.33

Injuries to the knee and lower leg

786

3558

1.27

8.61

1.5

1.4

6.61

6.78

g/l

0.66

567

2450

Other diseases of anus and rectum

159

956

1.67

8.60

1.2

1.4

6.75

6.90

g/l

0.19

124

663

Lupus erythematosus

4.12

8.56

1.2

8.68

7.32

g/l

0.36

Sensorineural hearing loss

436

2237

1.37

8.56

1.5

1.4

6.51

6.89

g/l

1.47

291

1554

Benign neoplasm of major salivary glands

285

2.27

8.55

1.6

1.4

7.18

6.92

g/l

0.19

199

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

153

829

1.69

8.53

1.3

6.47

6.56

g/l

0.13

113

591

Benign neoplasm: salivary glands, exclude unknown (D119)

254

2.35

8.53

1.6

1.4

7.22

6.93

g/l

0.19

177

Allergic urticaria

273

2.29

8.51

1.3

1.5

6.68

6.50

g/l

0.15

192

Dental caries 3

545

2097

1.33

8.50

1.4

6.57

6.79

g/l

0.62

366

1481

Oesophagitis

121

3.01

8.47

1.3

1.2

5.78

7.19

g/l

1.47

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

3.72

8.47

1.3

1.4

6.43

7.38

g/l

0.57

Benign neoplasm: Duodenum

3.95

8.46

1.2

1.5

7.06

7.11

g/l

0.01

Benign neoplasm: Ascending colon

371

2.09

8.45

1.4

1.3

6.73

7.15

g/l

0.44

257

Unspecified misadventure during surgical and medical care

149

2.79

8.41

1.3

1.4

6.36

7.03

g/l

0.71

104

Ulcer of lower limb, not elsewhere classified

365

2.10

8.40

1.3

7.00

6.87

g/l

0.10

256

Childhood allergy (age < 16)

115

519

1.84

8.40

1.3

6.27

6.35

g/l

0.11

368

Adenocarcinoma of pancreas

4.52

8.39

1.1

1.2

6.18

7.47

g/l

0.68

Viral encephalitis, not elsewhere classified/unspecified

4.06

8.39

1.3

5.13

7.09

g/l

2.49

Tuberculosis, wide

166

2.67

8.38

2.1

1.4

7.63

7.20

g/l

0.28

119

Type 2 diabetes, definitions combined, including avohilmo

608

2768

1.30

8.37

1.4

6.48

6.85

g/l

1.30

408

1934

Coxarthrosis

259

1176

1.50

8.34

1.3

1.4

6.68

6.97

g/l

0.69

198

813

Gout, strict definition

496

1.93

8.33

1.4

1.3

6.66

7.10

g/l

0.58

352

Vasomotor rhinitis (mode)

214

2.46

8.31

1.7

1.4

6.26

6.76

g/l

0.67

148

Other abnormal findings of blood chemistry

112

3.08

8.30

1.6

1.3

6.76

6.82

g/l

0.03

Other obstructive and reflux uropathy

112

3.07

8.29

1.2

1.3

8.36

6.08

g/l

2.78

Injuries to the ankle and foot

461

3141

1.34

8.27

1.4

6.59

6.71

g/l

0.33

340

2165

Ulcer of oesophagus

156

2.72

8.25

1.3

1.2

6.58

7.26

g/l

0.53

106

Acute nasopharyngitis (common cold)

399

2.03

8.24

1.3

7.09

7.06

g/l

0.02

256

Dental pulpitis 1, only avohilmo

751

3096

1.27

8.24

1.4

6.83

6.71

g/l

0.36

505

2167

CR(E)ST syndrome

4.65

8.18

1.4

1.3

8.24

7.47

g/l

0.11

Malignant neoplasm of pancreas

129

2.90

8.18

1.2

1.3

6.58

7.37

g/l

0.55

Other noninflammatory disorders of vulva and perineum

310

2.18

8.17

1.4

1.3

8.02

6.83

g/l

1.10

211

Benign neoplasm: Duodenum

3.83

8.11

1.2

1.3

7.06

7.58

g/l

0.20

Lesion of ulnar nerve

515

1.90

8.11

1.5

1.3

6.31

6.87

g/l

1.11

360

Supplementary factors related to causes of morbidity and mortality classified elsewhere

195

1253

1.56

8.11

1.6

1.3

6.38

6.71

g/l

0.77

144

857

Colonic or urogenital fistula

170

1058

1.62

8.10

1.2

1.3

6.88

6.78

g/l

0.12

112

729

Duodenal ulcer

229

2.37

8.07

1.2

1.3

7.06

7.01

g/l

0.02

159

Benign neoplasm: Ascending colon

379

2.05

8.01

1.4

6.73

6.92

g/l

0.18

264

Iron deficiency anaemia secondary to blood loss (chronic)

468

1.94

8.00

1.5

1.3

7.14

6.89

g/l

0.15

323

Juvenile arthritis (FINNGEN)

159

2.68

7.98

1.3

7.55

6.41

g/l

1.24

115

Endometriosis of pelvic peritoneum

114

631

1.79

7.98

1.4

6.26

6.83

g/l

0.80

433

Filling of root of tooth

3.32

7.97

1.9

1.3

7.70

7.04

g/l

0.20

Acute epiglottitis

5.28

7.97

1.6

1.4

6.49

8.15

g/l

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.33

7.96

1.1

1.2

6.18

7.97

g/l

0.82

Other diseases of arteries and capillaries

237

2.34

7.95

1.7

1.4

6.59

6.65

g/l

0.04

169

Heart failure and coronary heart disease

150

669

1.68

7.95

1.4

8.11

7.12

g/l

1.21

105

456

Other and unspecified disorders of vitreous body

230

1530

1.50

7.95

1.4

6.78

6.80

g/l

0.02

170

1059

Vitamin D deficiency

4.03

7.94

1.1

1.4

6.07

6.81

g/l

0.31

Complications of internal orthopaedic prosthetic devices, implants and grafts

118

670

1.77

7.93

1.3

1.4

6.61

6.93

g/l

0.46

461

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

225

2.38

7.93

1.5

1.4

6.66

6.80

g/l

0.07

160

Other specified/unspecified bacterial intestinal infections

177

2.57

7.92

1.2

1.5

7.01

6.85

g/l

0.07

124

Stenosis and insufficiency of lacrimal passages

269

2.25

7.92

1.3

7.03

7.12

g/l

0.05

188

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

3.99

7.91

1.2

7.13

7.74

g/l

0.29

Fibroblastic disorders

126

730

1.73

7.89

1.4

1.3

6.91

7.18

g/l

0.26

502

Hordeolum and other deep inflammation of eyelid

160

2.66

7.89

1.5

1.2

6.47

6.86

g/l

0.32

110

Fall on same level

781

3486

1.25

7.87

1.3

1.4

6.79

6.72

g/l

0.16

552

2419

Superficial injury of lower leg

155

951

1.64

7.84

1.3

6.35

6.65

g/l

0.50

121

653

Olecranon bursitis

178

2.56

7.84

1.4

1.2

7.44

7.00

g/l

0.24

123

Diseases of external ear

204

1336

1.53

7.80

1.3

1.4

6.93

6.82

g/l

0.20

149

926

Benign neoplasm: Descending colon

167

2.60

7.77

1.3

1.4

7.40

6.94

g/l

0.31

123

STROKE

346

1724

1.40

7.75

1.3

1.4

6.98

6.83

g/l

0.24

247

1178

TMD muscular pain linked with fibromyalgia

5.21

7.74

1.9

1.4

5.31

6.14

g/l

—

Arthropathic psoriasis

398

2.00

7.73

1.3

1.4

6.60

6.84

g/l

0.23

279

Other specified and unspecified disorders of eyelid

5.14

7.71

1.9

1.3

5.47

7.13

g/l

—

Type of accident

178

1134

1.58

7.71

1.6

1.3

6.34

6.67

g/l

0.78

132

780

Vascular diseases of the intestine

3.57

7.70

1.1

1.3

8.80

7.02

g/l

0.63

Excessive attrition of teeth

270

999

1.47

7.68

1.5

1.4

6.76

6.73

g/l

0.03

188

676

Polycystic ovarian syndrome, consortium definition

457

2065

1.34

7.67

1.4

6.36

6.70

g/l

1.27

322

1461

Glaucoma

296

1831

1.42

7.67

1.3

1.4

6.54

6.89

g/l

0.94

197

1281

Hyperkalaemia

112

2.98

7.66

1.7

1.3

6.71

7.36

g/l

0.41

Thoracic aortic aneurysm

406

1.99

7.66

1.5

1.3

6.69

6.92

g/l

0.24

287

Post-traumatic stress disorder

286

2.19

7.65

1.3

6.07

6.68

g/l

1.14

194

Viral warts

346

2.07

7.61

1.5

1.4

6.16

6.55

g/l

0.38

236

Personality disorders

190

1234

1.55

7.57

1.3

6.26

6.71

g/l

1.45

130

844

Symptoms and signs involving emotional state

3.21

7.57

1.1

1.3

6.95

6.28

g/l

0.42

Chronic suppurative otitis media

200

2.42

7.50

1.8

1.3

6.14

6.95

g/l

1.18

139

Hallux valgus (acquired)

189

879

1.56

7.50

1.5

1.4

6.91

6.74

g/l

0.22

141

609

Other/unspecified cytomegaloviral diseases

3.99

7.48

1.4

1.2

6.82

6.87

g/l

0.01

Dental caries 1, only avohilmo

517

2015

1.32

7.47

1.4

1.3

6.62

6.79

g/l

0.43

349

1417

Cardiomyopathies, Primary/intrinsic

349

2.05

7.43

1.4

1.3

7.23

6.86

g/l

0.34

244

Disorders of choroid and retina

463

2554

1.32

7.43

1.4

6.66

6.86

g/l

0.56

315

1774

Other retinal disorders

342

1993

1.38

7.40

1.4

6.79

6.93

g/l

0.30

228

1380

Postprocedural disorders of digestive system, not elsewhere classified

3.39

7.40

2.2

1.2

6.94

7.13

g/l

0.09

Appendectomy

419

3033

1.33

7.39

1.3

1.4

6.27

6.79

g/l

2.56

281

2116

Adhesive capsulitis of shoulder

101

560

1.81

7.39

1.3

6.07

6.94

g/l

2.07

383

Other coagulation defects

239

2.28

7.38

1.5

1.4

6.49

6.71

g/l

0.19

164

MS-disease / Multiple Sclerosis

271

2.20

7.38

1.4

6.02

6.56

g/l

0.77

192

Fracture of lumbar spine and pelvis

110

625

1.77

7.38

1.2

1.3

6.35

6.82

g/l

0.71

429

Other disorders of kidney and ureter

398

1.97

7.37

1.4

6.94

6.85

g/l

0.07

280

Benign neoplasm of major salivary glands

304

2.12

7.35

1.6

1.4

7.18

6.78

g/l

0.33

213

Hypertensive heart and/or renal disease

127

577

1.71

7.35

1.4

6.57

7.35

g/l

1.13

383

Pneumonitis due to solids and liquids

172

2.52

7.33

1.3

1.2

6.64

7.03

g/l

0.27

124

Other and unspecified follicular disorders

110

2.95

7.30

1.5

1.3

6.81

6.67

g/l

0.07

Spondylopathies in diseases classified elsewhere

5.54

7.30

1.2

7.47

9.41

g/l

—

Adult respiratory distress syndrome

5.53

7.29

1.1

1.2

4.85

7.08

g/l

—

Other follicular disorders

260

2.22

7.26

1.4

6.39

6.70

g/l

0.31

180

Benign neoplasm: Descending colon

173

2.51

7.26

1.3

1.4

7.40

7.08

g/l

0.20

118

Cervicocranial syndrome

306

2.11

7.22

1.5

1.3

5.78

6.77

g/l

2.61

215

Disorders of adult personality and behaviour

199

1320

1.51

7.22

1.3

1.4

6.37

6.67

g/l

0.78

140

911

Other embolism and thrombosis

415

1.94

7.22

1.8

1.3

6.50

6.71

g/l

0.19

291

Abnormal involuntary movements

436

1.92

7.22

1.4

1.3

5.88

6.81

g/l

2.33

304

Unspecified haematuria

224

1298

1.48

7.21

1.6

1.4

7.27

6.88

g/l

0.67

166

886

Phobic anxiety disorders

515

1.84

7.16

1.5

1.3

6.46

6.60

g/l

0.21

352

Cramp and spasm

145

2.66

7.15

1.4

5.74

7.16

g/l

1.98

103

Other juvenile arthritis

145

2.66

7.15

1.3

1.4

7.76

6.53

g/l

1.22

102

Other keratitis

383

1.97

7.09

1.4

6.55

6.69

g/l

0.12

267

Peritonsillar abscess

118

693

1.71

7.09

1.3

6.15

7.16

g/l

2.99

449

Ulcerative proctitis

206

2.36

7.06

1.4

1.3

7.04

6.73

g/l

0.24

146

Metatarsalgia

276

2.15

7.06

1.6

1.3

5.45

6.81

g/l

2.42

193

Other/unspecified synovitis and tenosynovitis

363

2.00

7.06

1.5

1.3

5.71

6.77

g/l

2.69

256

Excessive vomiting in pregnancy

317

2.07

7.00

1.4

1.5

6.12

6.72

g/l

0.86

219

Noninflammatory disorders of female genital tract

278

975

1.44

6.98

1.4

6.57

6.76

g/l

0.31

196

673

Conduction disorders

148

764

1.62

6.98

1.3

7.14

6.79

g/l

0.44

536

Cardiomyopathy (excluding other)

358

2.00

6.96

1.4

1.3

7.23

6.83

g/l

0.37

249

Other localized connective tissue disorders

4.04

6.93

1.6

1.2

9.90

7.24

g/l

—

Later onset COPD

115

525

1.73

6.90

1.1

1.4

7.52

7.20

g/l

0.30

366

Other endocrine disorders

212

2.30

6.89

1.3

7.13

6.41

g/l

0.70

170

Other contact dermatitis

253

2.19

6.87

1.5

1.4

6.40

6.80

g/l

0.42

179

Infective dermatitis

381

1.96

6.85

1.4

1.3

6.82

6.79

g/l

0.03

271

Other and unspecified nerve root and plexus disorders, also in other diseases

118

701

1.69

6.83

1.3

6.95

6.76

g/l

0.16

489

Non-allergic asthma

280

2.12

6.82

1.9

1.5

6.27

6.72

g/l

0.45

197

Restless leg syndrome

396

1.93

6.80

1.7

1.4

5.69

6.87

g/l

3.50

274

Decubitus ulcer and pressure area

109

2.87

6.80

1.5

1.2

8.53

7.46

g/l

0.48

Lichen planus

403

1.92

6.80

1.9

1.3

6.39

6.87

g/l

0.70

279

Kidney transplant status

179

2.43

6.79

1.7

1.3

5.47

6.65

g/l

0.97

130

Superficial injury of abdomen, lower back and pelvis

539

1.79

6.79

1.2

1.4

6.39

6.67

g/l

0.45

380

Other symptoms and signs involving cognitive functions and awareness

232

1505

1.45

6.78

1.3

1.4

6.53

6.91

g/l

0.79

166

1029

Disorders of continuity of bone

321

2.04

6.77

1.5

1.3

6.58

6.76

g/l

0.13

219

Seborrhoeic keratosis

119

711

1.68

6.74

1.6

1.3

6.12

6.86

g/l

1.60

492

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

5.13

6.74

1.3

1.2

6.61

6.56

g/l

—

Disorders resulting from impaired renal tubular function

2.98

6.72

1.2

1.3

6.82

7.01

g/l

0.07

Presence of cardiac and vascular implants and grafts

219

1129

1.47

6.71

1.4

7.52

6.99

g/l

0.86

163

786

Eustachian salpingitis and obstruction

323

2.03

6.67

1.6

1.3

6.13

6.85

g/l

1.19

224

Calcific aortic valvular stenosis, diagnosis (helper)

130

779

1.64

6.67

1.4

8.32

7.08

g/l

1.58

545

Operations 2 for CAVS

130

779

1.64

6.67

1.4

8.32

7.08

g/l

1.58

545

Preparation and fitting of bite rail to mouth

101

579

1.76

6.67

1.5

1.4

6.38

6.65

g/l

0.42

404

Psoriatic arthropathies, ICD10

399

1.92

6.66

1.3

1.4

6.55

6.81

g/l

0.27

276

Inflammation of lacrimal passages (acute and unspecified)

4.09

6.66

1.7

1.2

6.04

6.18

g/l

0.08

Other diseases of blood and blood-forming organs

187

2.38

6.63

1.3

1.4

8.71

6.77

g/l

0.68

130

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

197

1314

1.49

6.62

1.4

6.15

6.66

g/l

2.19

152

927

Fracture of rib(s), sternum and thoracic spine

158

1017

1.56

6.62

1.3

7.24

6.88

g/l

0.50

117

694

Osteonecrosis

157

2.51

6.61

1.5

1.4

7.94

6.79

g/l

0.27

107

Hypertensive Heart Disease

110

525

1.72

6.58

1.5

1.3

6.35

7.40

g/l

1.64

350

Calcific aortic valvular stenosis, including rheumatic fever

130

782

1.63

6.56

1.4

8.32

7.09

g/l

1.57

548

Glucagon-like peptide-1 (GLP-1) analogues

299

1785

1.38

6.55

1.3

1.4

7.09

6.92

g/l

0.23

206

1222

Vulvovaginal ulceration/inflammation in other diseases

207

2.30

6.55

1.5

1.4

6.41

6.55

g/l

0.10

147

Other enthesopathy of foot (+metatarsalgia)

305

2.05

6.53

1.5

1.3

5.41

6.76

g/l

2.52

210

Nail disorders

272

2.11

6.52

1.2

1.4

6.12

6.77

g/l

0.84

190

Cardiodefibrillation

180

1194

1.51

6.52

1.3

1.4

7.51

7.04

g/l

0.55

110

827

Calcific aortic valvular stenosis

130

784

1.63

6.52

1.4

8.32

7.08

g/l

1.59

550

Calcific aortic valvular stenosis, operated

130

784

1.63

6.52

1.4

8.32

7.08

g/l

1.59

550

Unspecified fall

281

2013

1.39

6.51

1.5

1.4

6.27

6.84

g/l

2.34

189

1400

Artrosis, including avohilmo

539

2316

1.28

6.51

1.3

1.4

6.77

6.79

g/l

0.04

381

1581

Injuries to the wrist and hand

632

3680

1.25

6.43

1.3

1.4

6.61

6.76

g/l

0.41

452

2545

Adjustment and management of implanted device

504

1.79

6.43

1.1

1.3

7.71

6.99

g/l

0.66

354

Injuries to the thorax

244

1724

1.42

6.43

1.3

1.4

7.05

6.91

g/l

0.20

180

1177

Other and unspecified psoriasis

190

2.34

6.41

1.2

1.5

7.76

6.96

g/l

0.57

133

Pure hypercholesterolaemia

398

2022

1.32

6.41

1.4

6.87

6.84

g/l

0.04

280

1379

Dental caries 3, only avohilmo

543

2179

1.28

6.38

1.4

6.57

6.81

g/l

0.75

365

1539

Glaucoma suspect

189

1277

1.49

6.33

1.3

1.4

6.74

6.87

g/l

0.20

127

885

Substance abuse

351

2519

1.34

6.31

1.3

1.4

6.28

6.86

g/l

2.68

236

1717

Complications following infusion, transfusion and therapeutic injection

4.51

6.27

1.5

1.3

8.82

6.97

g/l

—

Acne

386

1.90

6.27

1.3

6.47

6.62

g/l

0.14

268

Hard cardiovascular diseases

454

2254

1.30

6.22

1.3

1.4

7.11

6.79

g/l

0.77

328

1524

Other specified and unspecified retinal disorders

3.09

6.21

1.6

1.2

7.20

7.12

g/l

0.03

Dental pulpitis 2

441

1731

1.31

6.21

1.4

1.3

6.63

6.73

g/l

0.21

298

1214

Tuberculosis

132

2.60

6.21

1.9

1.3

7.35

7.24

g/l

0.06

Anogenital herpesviral [herpes simplex] infection

225

2.20

6.20

1.5

1.4

6.42

6.48

g/l

0.04

154

Perforation of tympanic membrane

305

2.02

6.18

1.3

1.4

6.64

6.89

g/l

0.22

214

Lesion of lateral popliteal nerve

139

2.55

6.12

1.4

1.3

6.78

6.96

g/l

0.09

Prurigo nodularis

3.81

6.11

1.1

1.4

7.04

6.86

g/l

0.08

Abnormal blood-pressure reading, without diagnosis

2.86

6.11

1.5

1.4

5.37

6.81

g/l

1.44

Lateral epicondylitis

462

1.81

6.09

1.5

1.3

6.02

6.97

g/l

2.06

313

Dental pulpitis 2, only avohilmo

450

1776

1.30

6.08

1.4

1.3

6.66

6.71

g/l

0.11

303

1252

Mental and behavioural disorders due to tobacco

280

2.05

6.07

1.3

1.4

6.79

6.67

g/l

0.08

191

Autoimmune thyroiditis

3.66

6.07

1.3

1.2

6.71

6.80

g/l

0.03

Use of pramipexole

120

740

1.63

6.07

1.4

5.84

6.85

g/l

3.13

514

Oesophageal varices

2.91

6.06

1.7

1.3

11.50

6.49

g/l

2.01

Acute peritonitis

164

2.40

6.05

1.5

1.3

7.83

7.15

g/l

0.20

116

Mental and behavioural disorders due to psychoactive substance use

361

2586

1.32

6.03

1.3

1.4

6.31

6.85

g/l

2.37

239

1771

Other and unspecified glaucoma

152

2.45

6.03

1.5

1.3

6.74

7.21

g/l

0.28

105

Heterophoria

295

2.02

5.99

1.6

1.5

6.59

6.54

g/l

0.04

203

Other disorders of eyelid

222

1510

1.42

5.98

1.5

1.3

6.75

6.90

g/l

0.26

160

1054

Other aneurysm

123

2.63

5.98

1.6

1.3

7.22

7.06

g/l

0.07

Smoking dependency

282

2.04

5.96

1.3

1.4

6.79

6.62

g/l

0.12

192

Peripheral artery disease

200

1107

1.46

5.96

1.4

7.20

7.00

g/l

0.25

153

752

Sudden idiopathic hearing loss

297

2.00

5.88

1.8

1.3

6.09

6.92

g/l

1.15

211

Atypical facial pain

148

2.46

5.88

1.6

1.4

5.61

6.79

g/l

1.84

105

Barrett oesophagus

107

2.74

5.87

1.5

1.2

7.51

7.31

g/l

0.09

Disturbance of activity and attention

440

1.81

5.86

1.4

6.46

6.47

g/l

0.01

317

Corneal ulcer

114

701

1.64

5.85

1.6

1.3

6.91

6.69

g/l

0.28

489

Crohn disease (strict definition, all UC cases excluded)

173

2.34

5.85

1.1

1.3

5.59

6.64

g/l

1.21

123

Polyuria

123

771

1.60

5.84

1.4

1.3

6.95

6.99

g/l

0.04

537

Open wound of lower leg

491

1.76

5.81

1.5

1.3

6.01

6.69

g/l

1.51

342

Neovascular glaucoma

2.89

5.79

1.4

1.3

6.88

6.42

g/l

0.26

Atherosclerosis, excluding cerebral and coronary sclerosis

184

1001

1.47

5.78

1.4

7.08

6.98

g/l

0.10

137

689

Elevated blood glucose level

245

2.10

5.78

2.1

1.3

7.01

6.58

g/l

0.31

165

Trigeminal neuralgia

174

2.32

5.77

1.7

1.4

5.77

6.74

g/l

1.60

122

Idiopathic gout

232

2.13

5.76

1.4

1.3

6.84

6.92

g/l

0.05

161

Appendicitis, broad definition

465

3358

1.27

5.73

1.4

6.62

6.79

g/l

0.45

307

2332

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

144

2.46

5.72

1.3

1.4

6.42

6.12

g/l

0.18

107

Other sleep disorders

342

1.91

5.71

1.4

6.43

6.71

g/l

0.38

248

Other diseases of gallbladder

2.99

5.69

1.2

1.3

6.13

6.89

g/l

0.75

Other disorders of optic [2nd] nerve and visual pathways

188

2.26

5.68

1.5

1.3

6.32

6.70

g/l

0.23

134

Drug-induced neutropenia

214

2.17

5.67

1.4

1.5

6.27

6.83

g/l

0.34

146

Diseases of appendix

467

3369

1.27

5.65

1.4

6.60

6.79

g/l

0.56

309

2340

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

566

2689

1.25

5.64

1.3

1.4

6.95

6.74

g/l

0.46

379

1887

Acute appendicitis, no complications

353

2695

1.31

5.63

1.4

6.61

6.76

g/l

0.34

233

1870

Familial hypercholesterolemia

459

1.77

5.63

1.6

1.4

6.59

7.08

g/l

0.49

315

Malignant neoplasm, wide definition for exclusion

566

2690

1.25

5.62

1.3

1.4

6.95

6.74

g/l

0.46

379

1887

Iron deficiency

3.34

5.61

1.2

5.72

6.13

g/l

0.33

Other and unspecified diseases of blood and blood-forming organs

3.33

5.61

1.4

1.3

10.56

7.60

g/l

0.53

Intestinal adhesions without obstruction

202

2.19

5.59

1.7

1.4

6.02

7.14

g/l

1.42

143

Lichen simplex chronicus

2.96

5.59

1.2

1.3

7.72

7.30

g/l

0.14

Other psoriatic arthropathies

388

1.84

5.57

1.3

1.4

6.56

6.82

g/l

0.25

269

Other and unspecified acquired haemolytic anaemias

5.39

5.56

2.0

1.2

6.14

6.47

g/l

—

Dialysis

128

2.53

5.55

1.4

1.3

6.14

6.90

g/l

0.43

Other extrapyramidal and movement disorders in other diseases

124

789

1.58

5.55

1.5

1.3

6.17

6.66

g/l

1.13

549

Otitis externa

136

884

1.55

5.54

1.3

6.86

6.68

g/l

0.31

107

619

Infections with a predominantly sexual mode of transmission

199

1395

1.43

5.54

1.3

1.4

6.83

6.69

g/l

0.23

143

951

Correction of physiology of bite - very demanding therapy visit

2.88

5.54

1.4

5.60

7.11

g/l

1.45

Impetigo

153

2.38

5.49

1.4

1.2

7.33

6.50

g/l

0.62

114

Type 1 diabetes

160

1077

1.49

5.49

1.4

1.3

6.75

6.80

g/l

0.05

109

759

Disorder of the sleep-wake schedule

3.53

5.48

1.3

7.21

6.96

g/l

0.11

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

564

2689

1.24

5.46

1.3

1.4

6.95

6.74

g/l

0.46

377

1886

Erosion of teeth, including avohilmo

126

780

1.57

5.45

1.3

1.4

7.16

6.64

g/l

0.48

528

Superficial injury of hip and thigh

405

1.81

5.44

1.3

6.76

6.80

g/l

0.03

282

Specific personality disorders

158

1065

1.49

5.44

1.3

1.4

6.18

6.56

g/l

1.04

113

733

Desensitization to allergens

218

2.13

5.43

1.3

1.4

6.66

6.24

g/l

0.37

150

Ganglion

121

770

1.58

5.42

1.5

1.3

6.13

6.80

g/l

2.03

526

Contact with and exposure to communicable diseases

215

1531

1.40

5.39

1.4

6.26

6.62

g/l

0.74

110

1091

Dislocation, sprain and strain of joints and ligaments of knee

382

2759

1.29

5.39

1.4

1.3

6.48

6.75

g/l

0.90

265

1890

Localized scleroderma [morphea]

4.20

5.39

1.5

1.2

6.80

7.03

g/l

—

Glaucoma secondary to other eye disorders

2.77

5.38

1.4

1.3

6.88

6.50

g/l

0.21

Injuries to the head

691

3720

1.21

5.37

1.5

1.3

6.70

6.75

g/l

0.10

480

2592

Benign neoplasm of mouth and pharynx

357

1.86

5.36

1.4

1.3

5.76

6.79

g/l

1.64

246

Abrasion of teeth

171

856

1.47

5.35

1.3

1.4

7.06

6.73

g/l

0.48

121

573

Artificial joint operation, meniscal resection

527

2820

1.25

5.35

1.4

6.54

6.87

g/l

1.25

353

1960

Myeloid leukaemia

3.32

5.32

1.5

1.3

5.60

7.51

g/l

0.95

Haemorrhage in early pregnancy

180

1219

1.45

5.32

1.2

1.4

6.05

6.71

g/l

2.09

135

864

Other and unspecified myopathies

213

2.13

5.32

1.5

1.4

6.32

6.92

g/l

0.63

148

Benign neoplasm of mouth and pharynx

358

1.86

5.32

1.4

5.76

6.86

g/l

1.77

246

Generalized anxiety disorder

588

1.66

5.31

1.3

6.36

6.69

g/l

0.48

396

Other maternal disorders predominantly related to pregnancy

365

1765

1.30

5.30

1.2

1.4

6.37

6.73

g/l

1.32

264

1254

Acne vulgaris

289

1.95

5.25

1.2

1.3

6.29

6.43

g/l

0.12

200

Benign neoplasm: Rectum, anus and anal canal

101

621

1.63

5.23

1.5

1.4

6.91

g/l

0.01

437

Mature T/NK-cell lymphomas, hilmo

4.09

5.20

1.3

1.2

6.61

6.98

g/l

—

Papilloedema, unspecified

3.27

5.19

1.4

5.42

6.74

g/l

1.41

Hyperkinetic disorders

487

1.71

5.18

1.3

1.4

6.52

6.46

g/l

0.06

354

Gonarthrosis,primary

500

2522

1.25

5.18

1.3

1.4

6.71

6.87

g/l

0.44

353

1751

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

263

1.99

5.17

1.3

5.93

6.63

g/l

0.60

179

Myocardial infarction

251

1321

1.37

5.17

1.3

1.4

6.85

6.92

g/l

0.10

177

875

Chronic Coagulation defects

2.98

5.17

1.7

1.3

5.94

6.91

g/l

0.72

Dermatophytosis

420

1.77

5.16

1.6

1.4

6.52

6.76

g/l

0.27

296

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

172

1194

1.45

5.11

1.3

6.69

6.82

g/l

0.15

121

816

Normotensive glaucoma

184

2.19

5.09

1.5

1.3

6.56

7.14

g/l

0.47

132

Testicular hypofunction

104

2.63

5.08

1.4

1.2

6.80

7.32

g/l

0.14

Atrophic disorders of skin

504

1.70

5.08

1.5

1.4

7.34

6.74

g/l

0.55

350

Other hammer toe(s) (acquired)

464

1.70

5.08

1.5

6.60

6.88

g/l

0.34

317

Superficial injury of wrist and hand

128

839

1.53

5.07

1.4

6.21

6.63

g/l

0.93

585

Urethritis and urethral syndrome

3.45

5.04

1.4

1.3

7.39

7.45

g/l

—

Oral lichen ruber planus, including avohilmo

185

2.18

5.04

1.5

6.22

7.15

g/l

1.08

130

Pacemaker

141

917

1.50

5.03

1.2

1.4

7.35

7.08

g/l

0.27

647

Squamous cell neoplasms and carcinomas of the skin

245

2.01

5.02

1.1

1.3

6.38

7.02

g/l

0.56

176

Plantar fascial fibromatosis

294

1.92

5.01

1.4

1.3

6.74

g/l

0.00

205

Injuries to the shoulder and upper arm

491

3327

1.24

4.96

1.4

6.61

6.82

g/l

0.57

351

2295

Extrapyramidal and movement disorders

187

1327

1.41

4.94

1.5

1.4

6.50

6.90

g/l

0.64

127

910

Myeloid leukaemia

3.16

4.93

1.5

1.3

5.60

7.44

g/l

0.92

Malignant neoplasm of breast

155

1615

0.69

4.93

1.2

1.4

6.65

6.66

g/l

0.01

1152

Benign neoplasm: Parotid gland

227

2.04

4.91

1.5

1.4

7.45

6.81

g/l

0.38

159

Valvular operations

397

1.77

4.90

1.5

1.3

8.34

6.92

g/l

1.01

283

Other and unspecified coagulation defects

155

2.28

4.90

1.5

1.4

6.71

6.92

g/l

0.13

109

Contusion of toe(s) without damage to nail

2.96

4.89

1.2

5.52

6.32

g/l

0.45

Diseases of peritoneum

311

1.88

4.88

1.5

1.4

7.42

6.86

g/l

0.25

217

Benign neoplasm: Parotid gland

228

2.03

4.86

1.5

1.4

7.45

6.90

g/l

0.31

156

Arthropathies in other diseases classified elsewhere

2.73

4.86

1.4

1.3

5.85

7.33

g/l

1.09

Paralytic strabismus

188

2.14

4.85

1.7

1.4

6.13

7.01

g/l

0.80

130

AV-block

380

1.75

4.85

1.2

1.3

7.82

6.89

g/l

0.80

274

Visual impairment including blindness (binocular or monocular)

162

2.24

4.85

1.1

1.3

6.09

7.05

g/l

1.06

119

Benign neoplasm: Rectum

557

1.64

4.84

1.5

1.4

6.74

6.85

g/l

0.11

391

Anti-inflammatory and antirheumatic products, non-steroids

175

606

1.46

4.83

1.3

6.40

7.28

g/l

1.90

128

424

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

249

1.98

4.81

1.1

1.4

6.38

7.11

g/l

0.69

180

Other epidermal thickening

119

2.46

4.81

1.4

1.3

6.15

7.16

g/l

0.97

Other disorders of bladder

327

1.85

4.80

1.3

1.2

7.63

6.87

g/l

0.48

228

Respiratory tuberculosis, confirmed and not-confirmed

119

2.46

4.80

2.1

1.3

7.61

7.09

g/l

0.28

Respiratory tuberculosis

119

2.46

4.80

2.1

1.3

7.61

7.09

g/l

0.28

Female infertility

184

798

1.43

4.80

1.4

6.16

6.84

g/l

1.87

135

549

Other superficial mycoses

3.21

4.79

1.6

1.3

6.57

6.90

g/l

0.18

Abdominal aortic aneurysm (AAA)

207

2.07

4.78

1.3

1.2

8.04

6.89

g/l

0.45

148

Injury of muscle and tendon at forearm level

3.33

4.77

1.3

8.30

7.18

g/l

0.33

Benign neoplasm: Pituitary gland, craniopharyngeal duct

157

2.25

4.76

1.4

1.3

6.00

6.93

g/l

0.89

111

Opening and dilatation of root channel of tooth

217

2.05

4.72

1.8

1.3

7.76

6.75

g/l

0.54

152

Unspecific neurodegenerative disorder

759

0.57

4.72

1.2

1.4

6.79

7.18

g/l

0.36

526

Otitis externa, unspecified

395

1.76

4.71

1.4

6.82

6.63

g/l

0.20

277

Unspecified nephritic syndrome

3.06

4.69

1.5

1.3

8.91

6.76

g/l

0.72

Injuries to the neck

138

935

1.48

4.69

1.4

1.3

6.44

6.62

g/l

0.21

102

640

Impingement syndrome of shoulder

130

870

1.50

4.69

1.4

1.3

6.13

7.12

g/l

1.91

597

Chronic mastoiditis

3.06

4.69

1.9

1.3

6.99

7.66

g/l

0.29

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

208

1329

1.38

4.68

1.3

1.4

6.67

6.85

g/l

0.24

135

929

Hypertrophic disorders of skin

191

2.11

4.68

1.3

1.4

6.46

6.69

g/l

0.16

136

Heart failure and hypertrophic cardiomyopathy

3.75

4.67

1.4

1.1

5.86

7.34

g/l

—

Other abnormal uterine and vaginal bleeding

133

632

1.51

4.66

1.2

1.4

6.56

6.69

g/l

0.13

430

Other disorders starting during childhood or adolecense, excluding more controls

184

2.12

4.66

1.3

5.91

6.23

g/l

0.34

140

Allergic contact dermatitis

503

1.66

4.61

1.3

1.4

5.98

6.83

g/l

1.88

352

Myocardial infarction, without ST-elevation

174

1138

1.41

4.60

1.3

1.4

6.91

7.09

g/l

0.27

133

773

Convalescence

166

2.19

4.60

1.5

1.4

6.49

6.68

g/l

0.12

116

Acute appendicitis

426

3235

1.24

4.58

1.4

6.52

6.77

g/l

0.78

284

2254

Other/unspecified enthesopathies, not elsewhere classified

254

1.94

4.58

1.8

1.3

6.07

7.03

g/l

1.00

181

Disorder of lipoprotein metabolism, unspecified

391

1.75

4.57

1.3

1.4

6.42

6.80

g/l

0.39

267

Speech and linguistic disorders, excluding more controls

272

1.88

4.56

1.2

1.3

6.87

6.41

g/l

0.53

193

Sleep disorders, other/unspecified

110

2.49

4.56

1.2

1.3

5.94

6.50

g/l

0.40

Benign neoplasm: Rectum

566

1.62

4.56

1.5

1.3

6.74

6.88

g/l

0.14

387

Convergence insufficiency and excess

3.89

4.56

1.2

1.4

6.42

5.80

g/l

—

Acute gastritis

193

2.09

4.55

1.5

1.4

6.11

6.98

g/l

1.18

134

Congenital malformations of the urinary system

200

2.07

4.55

1.2

1.3

7.22

6.76

g/l

0.33

146

Arterial embolism and thrombosis

116

2.43

4.54

1.3

1.2

5.20

7.14

g/l

2.24

Lichen ruber planus, wide definition including periferal and oral lichen planus

116

764

1.53

4.54

1.7

1.4

6.70

6.84

g/l

0.15

522

Osteomyelitis

167

2.17

4.53

1.6

1.2

7.29

6.86

g/l

0.23

120

Other disorders of the musculoskeletal system and connective tissue

506

1.65

4.51

1.5

1.3

6.27

6.80

g/l

0.71

359

Pure hyperglyceridaemia

3.19

4.50

1.5

6.74

6.46

g/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

105

678

1.56

4.50

1.4

6.38

6.60

g/l

0.23

465

Striking against or struck by other objects

198

1443

1.38

4.50

1.4

1.3

6.47

6.70

g/l

0.37

131

998

Panniculitis affecting regions of neck and back

2.67

4.50

1.6

1.4

6.33

7.26

g/l

0.67

Maternal care for other conditions predominantly related to pregnancy

137

923

1.47

4.49

1.2

1.4

6.55

6.77

g/l

0.33

659

Alcohol abuse, main dg, excluding more controls

522

1.64

4.49

1.3

6.13

6.75

g/l

0.93

348

Other disorders of gingiva or/and edentulous alveolar ridge

142

2.27

4.48

1.2

1.4

6.78

6.61

g/l

0.06

101

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

214

1226

1.36

4.48

1.4

6.80

6.90

g/l

0.13

139

858

Benign neoplasm: Rectum, anus and anal canal

101

647

1.57

4.48

1.5

1.3

6.91

6.81

g/l

0.10

450

Malignant neoplasm of breast, HER2-negative

152

1588

0.70

4.48

1.2

1.4

6.67

6.65

g/l

0.03

1136

Endometriosis ASRM stages 1,2

116

767

1.52

4.47

1.4

6.26

6.65

g/l

0.52

533

Other and unspecified epidermal thickening

2.80

4.47

1.4

1.3

5.85

7.56

g/l

1.22

2.97

4.46

1.2

1.3

6.11

5.64

g/l

0.21

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

4.08

4.46

2.2

1.2

5.39

6.59

g/l

—

Other specified/unspecified dorsopathies

2.79

4.46

1.6

1.7

6.82

7.22

g/l

0.14

Other disorders of patella

100

640

1.57

4.45

1.2

1.4

6.92

6.73

g/l

0.24

430

Bell's palsy

402

1.73

4.45

1.4

1.3

5.46

6.85

g/l

2.51

281

Hyperfunction of pituitary gland

162

2.18

4.44

1.3

6.18

6.76

g/l

0.45

111

Recurrent dislocation of patella

162

2.18

4.44

1.1

1.4

7.59

6.48

g/l

0.90

108

Autoimmune hyperthyroidism

162

2.18

4.43

1.3

1.4

6.20

6.40

g/l

0.20

117

Trigger finger

463

1.67

4.42

1.3

6.62

6.76

g/l

0.16

319

Other acquired deformities of musculoskeletal system and connective tissue

143

2.26

4.42

1.9

1.3

6.81

6.89

g/l

0.03

Schizophrenia

682

0.48

4.41

1.1

1.4

6.26

6.74

g/l

0.52

460

Presbycusis

270

1.89

4.41

1.5

1.2

5.46

7.34

g/l

2.33

189

Fracture at wrist and hand level

203

1491

1.36

4.40

1.3

1.4

6.95

6.72

g/l

0.27

136

1015

Follicular lymphoma

112

2.44

4.40

1.7

1.4

4.71

6.98

g/l

2.54

Oral leukoplakia and related diseases, including avohilmo

265

1.90

4.40

1.3

1.4

7.96

6.79

g/l

0.69

182

Right bundle-branch block

2.84

4.40

1.1

1.2

7.48

6.93

g/l

0.21

Benign neoplasm: Pituitary gland, craniopharyngeal duct

163

2.17

4.38

1.4

6.00

6.62

g/l

0.52

115

Cholesteatoma of middle ear

131

2.31

4.36

1.9

1.3

6.56

7.20

g/l

0.61

Psychotic depression

170

2.13

4.34

1.2

1.5

7.40

6.91

g/l

0.17

111

Scar conditions and fibrosis of skin

119

2.38

4.33

1.2

1.4

8.58

6.86

g/l

0.62

Female infertility, cervigal, vaginal, other or unspecified origin

166

784

1.42

4.33

1.4

6.19

6.86

g/l

1.69

124

539

Ptosis of eyelid

295

1.84

4.33

1.8

1.4

7.10

6.81

g/l

0.19

204

Other (not insulin) diabetes medications

571

2856

1.21

4.32

1.3

1.4

6.70

6.84

g/l

0.31

399

1990

Tubulo-interstitial nephritis, not specified as acute or chronic

164

2.15

4.31

1.2

1.3

9.62

6.56

g/l

1.61

115

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

277

1866

1.30

4.29

1.5

1.4

6.53

6.68

g/l

0.29

203

1331

Amenorrhoea

268

1.88

4.26

1.8

1.4

6.60

6.90

g/l

0.26

183

Intracranial injury

323

2457

1.27

4.26

1.6

1.4

6.77

6.78

g/l

0.02

228

1691

Follicular lymphoma, hilmo

114

2.39

4.24

1.7

1.4

4.71

7.26

g/l

2.92

Primary open-angle glaucoma, strict

113

750

1.51

4.24

1.3

1.4

6.31

7.05

g/l

1.45

519

Mixed and other personality disorders

319

1.80

4.24

1.5

1.4

6.22

6.63

g/l

0.51

229

Alcoholic liver disease

290

1.84

4.24

1.2

1.3

7.77

6.49

g/l

1.24

202

Acute posthaemorrhagic anaemia

2.86

4.23

1.3

1.2

6.22

7.47

g/l

—

Gluteal tendinitis

2.58

4.23

1.4

1.7

7.09

7.05

g/l

0.02

Bruxism

2.79

4.21

1.3

1.4

6.79

6.29

g/l

0.26

Primary open-angle glaucoma

137

924

1.45

4.20

1.3

1.4

6.41

7.00

g/l

1.23

635

Other disorders of nervous system

186

2.06

4.20

1.4

1.5

5.52

6.76

g/l

1.54

133

Other specified disorders of muscle

2.93

4.18

1.6

1.2

6.00

6.81

g/l

0.48

Left ventricular outflow tract obstruction (LVOTO), broad definition

395

1.71

4.17

1.6

1.3

7.56

6.56

g/l

0.56

280

Endometriosis of rectovaginal septum and vagina

256

1.89

4.16

1.5

1.3

5.82

6.77

g/l

1.45

172

Other erythematous conditions

2.50

4.14

1.3

1.4

6.74

6.81

g/l

0.03

Persistent mood disorders

111

740

1.51

4.14

1.3

6.43

6.73

g/l

0.51

498

Benign neoplasm of other and unspecified endocrine glands

449

1.66

4.14

1.4

6.49

6.95

g/l

0.50

313

Angina pectoris

296

1554

1.29

4.12

1.5

1.4

6.61

6.86

g/l

0.47

197

1042

DVT of lower extremities

613

1.56

4.12

1.4

1.3

6.83

6.64

g/l

0.17

428

Other and unspecified aplastic anaemias

3.84

4.11

1.4

1.3

7.90

6.24

g/l

—

Propionic acid derivatives

170

606

1.41

4.09

1.3

6.24

7.28

g/l

2.58

123

424

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

10.61

4.07

2.4

1.3

5.83

6.01

g/l

—

Viral hepatitis, IBD co-morbidity

110

2.38

4.07

1.0

1.2

6.60

6.48

g/l

0.06

Other local infections of skin and subcutaneous tissue

316

1.78

4.06

1.4

1.3

7.44

6.76

g/l

0.41

221

Other symptoms and signs involving general sensations and perceptions

2.58

4.06

1.2

1.3

6.05

7.32

g/l

0.88

Type 1 diabetes, wide definition, subgroup 1

122

832

1.47

4.05

1.4

1.3

6.71

6.84

g/l

0.11

613

Benign neoplasm: Sigmoid colon

568

1.57

4.05

1.4

6.57

6.84

g/l

0.33

402

Testicular dysfunction

123

2.30

4.05

1.4

1.2

6.71

7.21

g/l

0.15

Injuries to the hip and thigh

228

1580

1.32

4.04

1.3

1.4

6.73

6.90

g/l

0.28

173

1080

Poisoning by medicine

134

933

1.44

4.03

1.2

1.4

5.94

6.52

g/l

1.71

634

Scoliosis

259

1.86

4.02

1.3

1.4

6.99

6.76

g/l

0.17

180

Open wound of ankle and foot

347

1.74

4.01

1.3

6.26

6.65

g/l

0.37

241

Spontaneous rupture of synovium and tendon

217

1.95

4.01

1.9

1.3

7.07

6.96

g/l

0.05

151

Vitamin B12 deficiency anaemia

260

1.85

3.97

1.1

1.4

7.11

6.90

g/l

0.15

181

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

139

1283

0.71

3.96

1.1

1.4

6.54

6.72

g/l

0.26

919

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

139

1283

0.71

3.96

1.1

1.4

6.54

6.72

g/l

0.26

919

Problems related to lifestyle

356

1.72

3.95

1.3

7.01

6.43

g/l

0.53

243

Other and unspecified local infections of skin and subcutaneous tissue

297

1.80

3.95

1.4

1.3

6.88

6.74

g/l

0.09

207

2.53

3.93

1.3

1.2

7.86

6.70

g/l

0.67

Mixed conductive and sensorineural hearing loss

349

1.73

3.93

1.3

7.02

6.95

g/l

0.05

244

Thyrotoxicosis

136

954

1.43

3.93

1.5

1.4

6.28

6.77

g/l

1.07

655

Alzheimer disease, including avohilmo

607

0.56

3.92

1.2

1.3

6.54

7.17

g/l

0.58

423

Radial styloid tenosynovitis [de Quervain]

164

2.09

3.92

1.7

1.3

5.56

6.73

g/l

1.91

115

Sequelae of injuries, of poisoning and of other consequences of external causes

137

963

1.43

3.92

1.4

1.3

7.13

6.69

g/l

0.34

664

Benign neoplasm of other and unspecified endocrine glands

456

1.63

3.92

1.4

1.3

6.49

6.61

g/l

0.11

323

Melanocytic naevi

163

1181

1.38

3.91

1.4

6.12

6.68

g/l

1.93

131

840

Hypertrophic cardiomyopathy

106

2.38

3.91

1.4

1.3

5.34

7.23

g/l

2.28

Speech therapy

145

1030

1.41

3.91

1.5

1.3

6.48

6.68

g/l

0.26

135

705

Herpesviral keratitis and keratoconjunctivitis

106

2.38

3.91

1.6

1.3

7.59

7.00

g/l

0.21

Ventral hernia

123

848

1.46

3.90

1.4

1.3

6.33

6.75

g/l

0.61

585

Occupational exposure to risk-factors

2.53

3.89

1.7

1.3

6.44

6.81

g/l

0.23

Respiratory tuberculosis, not confirmed

2.58

3.89

2.3

1.3

7.88

7.16

g/l

0.34

Nonischemic cardiomyopathy

158

2.11

3.88

1.3

7.94

6.67

g/l

0.93

113

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

488

1.61

3.88

1.4

6.94

6.83

g/l

0.07

342

Poisoning by drugs, medicaments and biological substances

147

1049

1.41

3.87

1.3

1.4

6.18

6.59

g/l

0.92

104

723

Hemiplegia

132

2.21

3.86

1.3

6.90

7.01

g/l

0.04

Hydronephrosis

307

1.77

3.84

1.5

1.4

7.91

6.60

g/l

1.72

222

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

180

1330

1.36

3.84

1.2

1.4

6.12

6.76

g/l

2.24

124

928

Other diseases of spinal cord

2.70

3.83

1.3

5.12

6.89

g/l

1.02

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

101

2.40

3.82

2.1

1.3

6.95

7.15

g/l

0.10

Other/unspecified enthesopathies of lower limb, excluding foot

214

1.93

3.82

1.2

1.4

7.00

6.88

g/l

0.07

148

Myocardial infarction, strict

223

1234

1.32

3.81

1.3

1.4

6.90

6.99

g/l

0.13

158

817

KRA_PSY_EATING, excluding more controls

278

1.80

3.79

1.2

1.3

6.02

6.86

g/l

1.31

190

Chronic periodontitis, complicated

309

1.76

3.77

1.4

7.46

6.82

g/l

0.40

216

Campylobacter enteritis

2.67

3.74

1.3

1.4

7.46

6.88

g/l

0.26

Dental caries 2 and operation codes

474

3134

1.20

3.69

1.4

1.3

6.91

6.67

g/l

0.76

360

2175

Other problems related to primary support group, including family circumstances

505

1.57

3.69

1.4

6.07

6.53

g/l

0.93

370

Flat foot [pes planus] (acquired)

267

1.81

3.68

1.2

1.4

7.25

6.91

g/l

0.18

184

D07AA Corticosteroids, weak (group I)

654

1.50

3.67

1.4

6.37

6.58

g/l

0.32

473

Hyperaldosteronism

2.72

3.67

1.4

1.2

6.26

7.01

g/l

0.45

Hidradenitis suppurativa

129

2.19

3.65

1.3

6.39

6.42

g/l

0.02

174

1212

1.35

3.64

1.5

1.4

6.44

7.02

g/l

1.14

124

823

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.44

3.64

1.5

1.2

7.60

7.49

g/l

0.02

Visual field defects

232

1.86

3.64

1.5

1.3

6.27

6.99

g/l

0.82

162

Impotence

149

2.10

3.63

1.4

1.3

6.35

6.93

g/l

0.56

Chromosomal abnormalities, not elsewhere classified

104

2.34

3.60

1.4

1.3

7.00

5.97

g/l

0.95

Lichen planus, including avohilmo

658

1.50

3.59

1.8

1.4

6.65

6.79

g/l

0.14

447

Superficial injury of ankle and foot

467

1.59

3.59

1.5

1.3

6.96

6.54

g/l

0.36

324

Abnormalities of gait and mobility

329

1.71

3.58

1.4

1.3

6.35

6.93

g/l

0.53

239

Thyrotoxicosis, other and/or unspecified

107

732

1.47

3.57

1.4

6.22

6.81

g/l

1.15

509

Strabismus

158

1157

1.37

3.56

1.7

1.3

6.44

6.57

g/l

0.20

107

814

Benign neoplasm: Sigmoid colon

587

1.52

3.55

1.4

1.3

6.57

6.83

g/l

0.30

410

Artificial joint re-operation

164

2.03

3.55

1.3

1.5

7.06

7.25

g/l

0.13

117

Skin changes due to chronic exposure to nonionizing radiation

159

1104

1.37

3.54

1.5

1.3

6.24

7.10

g/l

2.77

112

746

Other condition

524

1.55

3.54

1.7

1.3

6.12

6.73

g/l

1.10

363

435

1.59

3.54

1.3

6.82

7.12

g/l

0.30

311

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

105

2.31

3.53

2.1

1.2

6.95

6.78

g/l

0.09

Actinic keratosis

153

1060

1.37

3.53

1.5

1.3

6.19

7.13

g/l

3.13

109

712

Epilepsy

159

1166

1.36

3.52

1.3

1.4

7.16

6.87

g/l

0.29

124

831

Cysts of oral region, not elsewhere classified

118

2.22

3.51

1.8

1.4

6.58

6.76

g/l

0.13

Spirochaetal infections, other/unspecified

257

1.80

3.50

1.2

1.4

6.61

6.80

g/l

0.10

174

Deep endometriosis

347

1.68

3.48

1.5

1.4

6.10

6.57

g/l

0.49

241

Other specified and unspecified personality disorders

347

1.68

3.48

1.3

1.4

6.04

6.54

g/l

0.75

242

Other disorders of glucose regulation and pancreatic internal secretion

265

1.78

3.47

1.7

1.3

7.19

6.58

g/l

0.47

183

Ankylosing spondylitis, strict definition

159

2.03

3.46

1.2

1.3

7.12

6.63

g/l

0.44

114

Malignant neoplasm of breast, HER-positive

1358

0.68

3.46

1.2

1.4

6.76

6.68

g/l

0.08

959

Leisure time condition

672

1.48

3.46

1.5

1.3

6.46

6.77

g/l

0.43

478

Benign neoplasm of eye and adnexa

296

1.73

3.42

1.7

1.4

5.54

6.95

g/l

2.43

208

Tuberculosis of other organs, strict

3.01

3.42

2.1

1.3

8.61

7.95

g/l

—

Other peripheral vertigo

274

1.76

3.41

1.5

1.4

6.33

7.07

g/l

0.76

193

Statin medication

453

2113

1.20

3.41

1.4

6.65

6.86

g/l

0.50

320

1435

Early lumbar disc prolapse, operated

365

1.65

3.39

1.2

1.3

6.55

6.51

g/l

0.03

240

Delirium, not induced by alcohol and other psychoactive substances

245

1.80

3.38

1.2

1.3

7.36

6.87

g/l

0.25

172

Left hemicolectomy

2.86

3.37

1.3

1.2

7.10

8.05

g/l

—

Tinnitus

122

866

1.41

3.37

1.4

1.3

6.42

6.80

g/l

0.66

597

Thyroiditis, unspecified

3.29

3.36

1.7

1.2

6.72

7.54

g/l

0.30

Benign lipomatous neoplasm of other sites/unspecified

246

1.80

3.35

1.2

1.4

6.56

6.88

g/l

0.19

173

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

555

1.52

3.35

1.3

1.4

6.65

6.83

g/l

0.16

390

Other and unspecified injuries of lower leg

254

1.78

3.33

1.5

1.3

7.32

6.82

g/l

0.37

171

Myopia

508

1.54

3.33

1.3

1.4

5.99

6.52

g/l

1.36

351

Benign neoplasm of middle ear and respiratory system

225

1.83

3.32

1.8

1.3

6.84

6.86

g/l

0.01

153

Event of undetermined intent

218

1.85

3.32

1.2

1.3

6.95

6.53

g/l

0.26

152

Benign lipomatous neoplasm of other sites/unspecified

247

1.79

3.31

1.2

1.4

6.56

6.95

g/l

0.24

173

Social phobias

299

1.72

3.31

1.5

1.3

6.63

6.68

g/l

0.05

204

Muscle strain

2.56

3.30

1.2

6.42

7.21

g/l

—

Disorders of psychological development

456

1.55

3.29

1.3

1.4

6.44

6.43

g/l

0.01

324

Other and unspecified disorders of skin and subcutaneous tissue

176

1.94

3.29

1.5

1.4

5.78

7.08

g/l

1.77

124

Disorders of tooth development and eruption

192

1.89

3.27

1.3

5.59

6.40

g/l

0.89

146

Chondrocostal junction syndrome [Tietze]

2.31

3.27

1.5

1.3

5.81

6.73

g/l

0.72

Tuberculosis of other organs

3.06

3.26

2.2

1.3

8.49

7.22

g/l

—

Other dialysis

2.36

3.26

1.3

6.44

6.66

g/l

0.11

Bacterial, viral and other infectious agents

331

1.67

3.26

1.3

6.73

6.74

g/l

0.01

227

Pain associated with micturition

377

1.63

3.25

1.3

6.15

6.93

g/l

0.78

264

Benign neoplasm: Rectosigmoid junction

2.35

3.25

1.2

1.3

7.25

7.51

g/l

0.08

Other shoulder lesions

301

1.70

3.24

1.4

1.3

5.94

6.88

g/l

1.17

209

Sequelae of injuries of neck and trunk

2.41

3.24

1.6

1.3

7.10

7.28

g/l

0.05

Fracture of foot, except ankle

138

1008

1.37

3.23

1.4

1.3

6.71

6.65

g/l

0.07

103

687

Suppurative otitis media, unspecified

2.69

3.23

1.8

1.4

6.49

6.86

g/l

0.12

Hypertrophy of breast in women and men

115

815

1.42

3.22

1.4

1.3

6.15

6.74

g/l

1.16

566

Cardiac arrest

116

2.09

3.22

1.1

1.3

7.36

7.21

g/l

0.06

Degenerative diseases of the nervous system

633

0.61

3.21

1.2

1.3

6.73

7.11

g/l

0.33

443

Benign neoplasm of eye and adnexa

302

1.70

3.21

1.7

1.4

5.54

6.76

g/l

1.99

216

Dental caries 2

477

3167

1.19

3.20

1.4

1.3

6.90

6.66

g/l

0.73

364

2198

Melanocytic naevi

163

1224

1.34

3.20

1.4

1.3

6.12

6.67

g/l

1.80

131

853

Monoamine oxidase A inhibitors

411

1.59

3.17

1.2

1.3

6.26

6.92

g/l

1.07

278

Alzheimer disease

508

0.56

3.17

1.2

1.3

6.78

7.15

g/l

0.25

356

Unspecified privation

349

1.64

3.17

1.7

1.3

6.85

6.70

g/l

0.09

243

Other degenerative diseases of the nervous system

119

641

1.41

3.16

1.4

1.3

6.42

7.22

g/l

1.62

441

Persons encountering health services in circumstances related to reproduction

367

2051

1.21

3.16

1.3

1.4

6.54

6.64

g/l

0.18

257

1425

Amiodarone users

266

1.74

3.15

1.2

1.3

8.36

6.92

g/l

1.00

188

Aortic valve malfunction, age under 60 years

350

1.64

3.14

1.6

1.3

8.15

6.62

g/l

0.82

247

Major coronary heart disease event

353

1935

1.22

3.14

1.4

7.03

6.82

g/l

0.38

256

1307

Golimumab

111

2.18

3.14

1.0

1.3

8.11

6.70

g/l

1.01

Oligomenorrhoea

111

2.18

3.13

1.6

1.4

6.28

6.78

g/l

0.36

Pilonidal cyst

335

1.65

3.12

1.4

1.3

6.44

6.43

g/l

0.01

226

Respiratory conditions due to other external agents

3.11

3.10

1.5

1.2

4.96

7.09

g/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.35

3.09

1.2

1.3

5.74

6.37

g/l

0.68

Calculus of kidney and ureter

148

1104

1.34

3.05

1.4

1.3

6.53

7.02

g/l

1.24

101

765

Other disorders of binocular movement

2.53

3.05

1.5

1.3

6.51

5.80

g/l

0.51

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

284

1.70

3.05

1.7

1.4

7.10

6.72

g/l

0.28

198

Abscess of anal and rectal regions

284

1.70

3.05

1.3

6.29

6.84

g/l

0.60

191

Oesophageal obstruction

2.52

3.05

1.2

7.43

7.76

g/l

0.11

Chondropathies

625

1.46

3.04

1.5

1.4

5.91

6.70

g/l

2.06

427

Use of antiglaucoma preparations and miotics

167

1.93

3.04

1.3

6.53

7.09

g/l

0.43

118

Gonarthrosis, primary, with knee surgery

267

1752

1.25

3.04

1.4

6.76

6.95

g/l

0.33

185

1215

Routine general health check-up of defined subpopulation

2.92

3.03

1.2

1.4

6.25

7.38

g/l

0.36

Injuries to unspecified part of trunk, limb or body region

315

1.66

3.02

1.6

1.4

6.08

6.80

g/l

0.91

220

Artificial opening status

147

1.99

3.00

1.4

7.29

6.96

g/l

0.12

108

Benign neoplasm of middle ear and respiratory system

233

1.77

3.00

1.8

1.4

6.84

6.81

g/l

0.02

170

Malignant neoplasm

532

2699

1.17

2.99

1.3

1.4

7.07

6.74

g/l

0.70

355

1899

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

2.49

2.97

1.1

1.2

6.30

6.91

g/l

—

Gestational [pregnancy-induced] hypertension

150

1125

1.33

2.96

1.6

1.4

6.54

6.64

g/l

0.14

108

792

Other female pelvic inflammatory diseases

621

1.46

2.95

1.2

1.4

6.32

6.69

g/l

0.36

428

Seborrhoeic dermatitis

302

1.66

2.95

1.4

1.3

6.74

6.93

g/l

0.14

221

Contusion of other and unspecified parts of foot

162

1.93

2.95

1.2

1.3

7.46

6.36

g/l

0.63

109

Other menopausal disorders

152

652

1.35

2.95

1.7

1.4

6.25

6.70

g/l

1.09

107

447

N06DA Anticholinesterases

634

0.61

2.94

1.2

1.3

6.89

7.17

g/l

0.19

440

Use of anticholinesterases

634

0.61

2.94

1.2

1.3

6.89

7.17

g/l

0.19

440

Other benign neoplasms of skin

179

1354

1.30

2.93

1.7

1.4

6.52

6.80

g/l

0.55

128

940

2.34

2.92

1.8

1.3

6.65

6.62

g/l

0.01

Ingrowing nail

177

1.88

2.91

1.2

1.3

5.88

7.11

g/l

1.49

126

Medicines for HER+ breast cancer

105

1420

0.72

2.91

1.2

1.4

6.57

6.70

g/l

0.16

1002

Embedded teeth, including avohilmo

342

1.62

2.90

1.4

6.31

6.40

g/l

0.10

237

Dislocation, sprain and strain of joints and ligaments at neck level

615

1.45

2.90

1.5

1.4

6.24

6.61

g/l

0.62

414

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

218

1724

1.27

2.90

1.4

1.3

6.32

6.71

g/l

1.22

169

1184

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

101

692

1.42

2.88

1.3

1.4

7.24

6.67

g/l

0.65

505

Melanocytic naevi, other sites/unspecified

259

1.71

2.87

1.7

1.4

5.94

6.49

g/l

0.66

187

Sequelae of other external causes

150

1.95

2.85

1.6

1.3

6.99

6.86

g/l

0.05

105

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

252

1.72

2.85

1.7

1.4

7.04

6.69

g/l

0.23

174

Major coronary heart disease event excluding revascularizations

313

1775

1.22

2.84

1.3

1.4

6.83

6.85

g/l

0.03

222

1190

Urolithiasis

155

1178

1.32

2.84

1.4

1.3

6.50

7.00

g/l

1.32

103

818

Degeneration of macula and posterior pole

195

1256

1.28

2.84

1.4

7.00

7.01

g/l

0.01

133

873

Other specified/unspecified hearing loss

215

1.78

2.84

1.6

1.3

6.11

6.94

g/l

1.22

152

Melanocytic naevi, other sites/unspecified

260

1.70

2.83

1.7

1.4

5.94

6.70

g/l

1.02

180

Other facial nerve disorders

2.36

2.83

1.5

1.3

7.01

7.18

g/l

—

Sub-endpoint used in defining T1D endpoints

161

1211

1.31

2.82

1.4

1.3

6.65

6.71

g/l

0.05

112

849

Speech and linguistic disorders

361

1.58

2.81

1.4

1.3

6.64

6.34

g/l

0.34

267

Mental and behavioural disorders due to alcohol

273

2166

1.23

2.81

1.2

1.4

6.42

6.84

g/l

1.20

176

1469

Use of donepezil

384

0.47

2.80

1.2

6.18

7.05

g/l

0.54

273

Chalazion

393

1.56

2.79

1.7

1.4

6.92

6.83

g/l

0.09

269

Medial epicondylitis

110

2.11

2.79

1.4

5.96

6.77

g/l

0.71

Salpingitis and oophoritis

102

729

1.40

2.78

1.4

6.50

6.76

g/l

0.37

503

Crossbite

277

1.65

2.78

1.2

1.4

6.25

6.58

g/l

0.37

215

Benign neoplasm: Skin, unspecified

117

2.07

2.78

1.2

1.4

6.27

6.90

g/l

0.33

Other appendicitis

300

1.64

2.77

1.2

1.4

7.25

6.59

g/l

0.52

204

Dissociative [conversion] disorders

124

2.03

2.76

1.2

1.3

5.44

6.44

g/l

1.33

Other and unspecified trigeminal disorders

2.90

2.76

1.2

1.5

5.93

6.04

g/l

—

L02BG Aromatase inhibitors

1128

0.69

2.76

1.2

1.4

6.32

6.76

g/l

0.61

790

L01XX Other antineoplastic agents

124

2.03

2.76

1.2

1.4

6.25

7.37

g/l

0.57

Tooth eruption problems

599

1.44

2.76

1.4

1.3

6.20

6.51

g/l

0.52

434

Dislocation, sprain and strain of joints and ligaments of head

145

1.95

2.75

1.5

1.3

5.50

6.66

g/l

1.08

101

Disorders of breast

269

2033

1.23

2.75

1.5

1.4

6.06

6.74

g/l

3.54

197

1432

Suicide or other Intentional self-harm

141

1063

1.33

2.75

1.3

1.4

6.05

6.67

g/l

2.06

735

Other predominantly sexually transmitted diseases, not elsewhere classified

106

765

1.39

2.74

1.2

1.4

6.98

6.66

g/l

0.44

529

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

218

1.75

2.72

1.8

1.4

7.21

6.73

g/l

0.29

146

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

252

1.69

2.72

1.3

5.82

5.98

g/l

0.15

193

Type 1 diabetes, wide definition

128

952

1.35

2.72

1.4

1.3

6.66

6.76

g/l

0.10

678

Biomechanical lesions, not elsewhere classified

125

2.01

2.71

1.2

1.4

6.03

7.12

g/l

0.93

Other disorders of bone density and structure

2.52

2.71

1.3

6.84

6.62

g/l

—

Oral leukoplakia and related diseases

146

1.93

2.70

1.4

8.00

7.03

g/l

0.34

Drug-induced systemic lupus erythematosus

3.85

2.70

1.4

1.3

7.84

6.57

g/l

—

Cerebrovascular diseases

370

2227

1.19

2.69

1.3

1.4

7.09

6.78

g/l

0.63

271

1511

Other chondrocalcinosis

3.81

2.69

2.0

1.2

5.81

6.29

g/l

—

Speech disturbances, not elsewhere classified

219

1.74

2.68

1.3

1.4

6.97

7.02

g/l

0.02

150

Benign neoplasm: Skin, unspecified

119

2.03

2.67

1.2

1.4

6.27

6.43

g/l

0.07

Benign neoplasm: Rectosigmoid junction

2.14

2.65

1.2

1.4

7.25

7.10

g/l

0.05

IgA nephropathy (IgA glomerulonephritis)

2.41

2.64

1.4

6.10

7.03

g/l

—

Other symptoms and signs involving the urinary system

304

1.62

2.64

1.5

1.3

6.74

6.73

g/l

0.01

208

Idiopathic urticaria

2.49

2.63

1.3

5.29

6.44

g/l

1.57

Malignant neoplasm of endocrine gland

228

1.72

2.63

1.8

1.5

7.33

6.84

g/l

0.32

160

Obsessive-compulsive disorder

213

1.75

2.63

1.4

1.3

5.68

6.55

g/l

1.59

145

Dronedarone medication

2.48

2.62

1.3

1.1

5.92

7.24

g/l

—

Retinal vascular occlusion

289

1.63

2.62

1.2

1.3

6.38

6.97

g/l

0.50

206

Tobacco use

162

1.87

2.62

1.4

1.3

7.34

6.94

g/l

0.22

111

Hyperprolactinaemia

113

2.05

2.62

1.3

1.2

6.18

6.72

g/l

0.39

Psoriasis (vulgaris), strict definition

2.27

2.61

1.1

1.3

6.20

6.94

g/l

0.48

Certain conditions originating in the perinatal period

346

1.54

2.61

1.3

6.08

6.41

g/l

0.42

256

L01XE Protein kinase inhibitors

148

1.90

2.61

1.4

7.87

6.81

g/l

0.49

102

Urethral stricture

127

1.98

2.60

1.2

7.94

6.93

g/l

0.48

Diseases of male genital organs

299

1244

1.22

2.58

1.3

1.4

6.75

6.88

g/l

0.25

203

841

Other specified disorders of kidney and ureter

2.20

2.58

1.5

1.3

6.58

7.31

g/l

0.43

Malignant neoplasm of thyroid gland

207

1.75

2.58

1.8

1.5

7.33

6.86

g/l

0.30

149

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1056

0.72

2.57

1.2

1.4

6.76

6.71

g/l

0.05

754

Coxarthrosis, primary

274

1957

1.22

2.57

1.3

1.4

6.69

6.99

g/l

0.74

216

1345

Other secondary gonarthrosis

142

1.91

2.56

1.2

1.5

5.75

7.14

g/l

1.26

Benign neoplasm: Skin of eyelid, including canthus

483

1.48

2.55

1.7

1.4

6.80

6.68

g/l

0.12

342

Other puerperal infections

315

1.60

2.55

1.4

6.38

6.44

g/l

0.05

222

Pregnancy hypertension

238

1743

1.23

2.55

1.5

1.4

6.49

6.62

g/l

0.27

173

1243

Congenital malformations of ovaries, fallopian tubes and broad ligaments

208

1.74

2.54

1.2

1.4

7.32

6.59

g/l

0.61

146

Achilles tendinitis

323

1.59

2.54

1.8

1.3

6.12

6.95

g/l

1.11

225

Acute nephritic syndrome

2.63

2.54

1.2

5.83

7.24

g/l

—

Impacted teeth

109

745

1.37

2.53

1.3

6.57

6.61

g/l

0.05

518

Other/unspecified disorders of vestibular function

101

2.10

2.53

1.1

1.5

5.57

7.18

g/l

1.51

Benign neoplasm of meninges

300

1.61

2.53

1.6

1.4

5.94

7.05

g/l

1.90

211

Use of other anti-dementia drugs

459

0.57

2.52

1.1

1.3

6.82

7.12

g/l

0.19

320

Use of memantine

459

0.57

2.52

1.1

1.3

6.83

7.12

g/l

0.19

320

Disturbances of smell and taste

108

2.05

2.52

1.3

1.6

6.75

6.95

g/l

0.10

Follicular cysts of skin and subcutaneous tissue

701

1.39

2.52

1.4

1.3

5.71

6.86

g/l

3.05

488

Pustular psoriasis

143

1.90

2.51

1.2

1.5

6.71

6.95

g/l

0.15

Other congenital malformations of skin

136

1.93

2.51

1.3

6.35

6.84

g/l

0.46

101

Dysplasia of cervi uteri

127

737

1.34

2.51

1.3

1.4

6.99

6.88

g/l

0.10

511

Benign neoplasm: Skin of trunk

122

1.98

2.51

2.2

1.3

7.12

7.11

g/l

0.00

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

136

1.93

2.50

1.3

1.4

5.85

6.28

g/l

0.42

104

Open wound of wrist and hand

242

1957

1.23

2.50

1.3

1.4

6.58

6.81

g/l

0.39

178

1335

Cystic kidney disease

2.12

2.49

1.3

6.38

7.28

g/l

0.53

Family history of other conditions

2.86

2.49

1.1

1.4

5.82

6.75

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

317

1.58

2.49

1.4

1.3

6.44

6.79

g/l

0.39

221

Papillary adenocarcinoma of thyroid gland

158

1.85

2.48

2.0

1.5

7.38

6.69

g/l

0.40

112

Emotionally unstable personality disorder

511

1.45

2.48

1.3

1.4

6.31

6.46

g/l

0.17

353

Retinal vascular disorders

294

1.60

2.47

1.2

1.3

6.38

6.96

g/l

0.49

209

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

123

1.97

2.46

1.3

7.36

6.86

g/l

0.24

Secondary polycythaemia

2.48

2.46

1.4

5.72

6.82

g/l

—

Other disorders of veins

199

1594

1.25

2.45

1.3

1.4

7.47

6.74

g/l

0.94

131

1122

Hypoglycaemia, other or unspecified

203

1.73

2.44

1.9

1.3

6.50

6.63

g/l

0.11

139

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

159

1242

1.28

2.44

1.2

1.3

6.58

6.69

g/l

0.14

115

859

Hallux rigidus

407

1.50

2.42

1.3

1.5

7.43

6.99

g/l

0.39

283

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

604

1.38

2.42

1.2

1.4

6.37

6.92

g/l

0.77

422

Embedded and impacted teeth

156

1032

1.29

2.42

1.4

1.3

6.44

6.67

g/l

0.47

121

714

Benign neoplasm of bone and articular cartilage

296

1.60

2.41

2.1

1.4

5.72

6.49

g/l

1.19

211

Transport accidents

260

1904

1.21

2.39

1.5

1.3

6.66

6.81

g/l

0.27

180

1319

Discitis, unspecified

2.78

2.38

1.5

1.3

10.94

7.48

g/l

—

Benign neoplasm: Choroid

153

1.84

2.38

1.2

1.5

5.90

7.07

g/l

1.00

106

Hypertrophic scar

175

1.78

2.38

1.4

1.3

6.40

6.68

g/l

0.17

125

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

100

735

1.37

2.36

1.3

1.4

5.87

6.67

g/l

2.38

499

Personal history of other diseases and conditions

465

1.46

2.36

1.5

1.4

5.74

6.42

g/l

1.73

347

Inflammatory disease of uterus

575

1.41

2.36

1.4

1.3

5.51

6.55

g/l

2.61

396

Contraceptive management

255

1476

1.22

2.35

1.3

1.4

6.72

6.70

g/l

0.03

179

1029

Foreign body in respiratory tract

161

1.81

2.35

1.5

1.4

7.37

6.85

g/l

0.28

115

Unspecified event, undetermined intent

2.28

2.35

1.5

1.3

5.80

6.86

g/l

—

102

665

1.36

2.35

1.2

1.4

6.89

7.29

g/l

0.54

466

Other disorders starting during childhood or adolescence

242

1.65

2.34

1.3

1.4

5.91

6.01

g/l

0.09

185

Astigmatism

229

1.67

2.32

1.2

1.3

6.92

6.36

g/l

0.49

166

Contact with other hot fluids

2.06

2.32

1.5

1.2

6.15

6.44

g/l

0.17

Autism spe, excluding more controls

2.33

2.32

1.3

1.4

4.68

6.19

g/l

—

Other otitis externa (chronic)

199

1.72

2.32

1.2

1.4

6.51

6.73

g/l

0.14

144

Alcohol abuse, main dg

611

1.40

2.31

1.3

6.13

6.63

g/l

0.69

413

Other and unspecified mood [affective] disorders

245

1.64

2.31

1.2

1.4

6.28

6.68

g/l

0.36

165

Malignant neoplasm of eye, brain and central nervous system

112

1.98

2.31

1.6

1.2

5.87

6.79

g/l

0.73

Use of glatiramer acetate

2.40

2.30

1.4

6.07

6.06

g/l

—

Glaucoma-related operations

119

1.94

2.30

1.5

1.4

6.05

7.11

g/l

0.84

Thyrotoxicosis with diffuse goitre

511

1.43

2.30

1.5

1.3

6.03

6.71

g/l

1.57

358

Benign neoplasm: Choroid

155

1.82

2.30

1.2

1.5

5.90

6.89

g/l

0.81

111

Benign neoplasm of meninges

308

1.57

2.29

1.6

1.4

5.94

6.74

g/l

1.28

216

Benign neoplasm: Cerebral meninges

269

1.61

2.29

1.7

1.4

5.88

6.74

g/l

1.23

188

Exposure to other and unspecified inanimate mechanical forces

246

1.64

2.28

1.4

1.3

6.86

6.73

g/l

0.09

177

Acidosis

2.58

2.28

1.2

1.3

12.24

7.94

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

148

1.83

2.27

1.5

1.3

6.63

7.21

g/l

0.37

106

Superficial injury of forearm

357

1.52

2.27

1.4

1.3

6.85

6.64

g/l

0.12

245

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

231

1.65

2.26

1.4

1.3

5.76

6.70

g/l

1.25

162

Pustulosis palmaris et plantaris

127

1.90

2.26

1.1

1.5

6.79

7.00

g/l

0.12

Malignant neoplasm of oesophagus

0.00

2.25

0.0

1.3

—

7.40

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

247

1.63

2.24

1.5

1.3

6.50

6.87

g/l

0.36

168

Diabetic retinopathy, excluding more controls

130

558

1.32

2.24

1.5

1.4

6.47

6.48

g/l

0.01

360

malignant neoplasm of male genital organs

107

903

0.75

2.23

1.3

1.4

7.75

7.08

g/l

0.68

629

Hypertrophy of breast

726

1.35

2.23

1.4

1.3

6.06

6.69

g/l

1.06

504

Mental and behavioural disorders due to sedatives or hypnotics

240

1.63

2.22

1.3

1.4

5.69

6.75

g/l

1.68

170

Dementia

853

0.74

2.22

1.2

1.4

7.36

7.18

g/l

0.14

586

Other other unspecified disorders of the circulatory system

2.06

2.22

1.8

1.3

5.96

6.96

g/l

0.42

Benign neoplasm: Skin of trunk

128

1.89

2.22

2.2

1.3

7.12

6.62

g/l

0.31

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

126

969

1.30

2.21

1.2

1.4

6.24

6.85

g/l

1.28

657

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

2.05

2.21

1.4

5.63

7.05

g/l

1.10

Background retinopathy and retinal vascular changes

2.52

2.19

1.3

1.4

5.92

6.57

g/l

—

Palmar fascial fibromatosis [Dupuytren]

425

1.46

2.19

1.4

1.2

6.75

7.50

g/l

0.65

289

Dementia, including avohilmo

101

929

0.75

2.19

1.2

1.4

7.39

7.15

g/l

0.21

635

Prolonged pregnancy

627

0.65

2.18

1.2

1.4

6.55

6.43

g/l

0.07

448

Major anomalies of jaw size

2.04

2.17

1.4

1.3

7.35

6.59

g/l

0.39

Benign neoplasm of bone and articular cartilage

305

1.55

2.16

2.1

1.4

5.72

6.58

g/l

1.36

213

Female genital prolapse

154

697

1.28

2.16

1.5

1.4

6.43

6.74

g/l

0.52

109

478

Benign neoplasm: Long bones of lower limb

101

2.00

2.16

1.9

1.3

5.50

6.99

g/l

—

Alzheimer’s disease, wide definition

410

0.59

2.15

1.1

1.3

6.53

7.19

g/l

0.54

290

Benign neoplasm: Cerebral meninges

274

1.58

2.14

1.7

1.4

5.88

6.99

g/l

1.77

194

Presence of other devices

662

1.36

2.14

1.3

1.4

7.11

6.88

g/l

0.27

481

Congenital malformations of eye, ear, face and neck

251

1.60

2.12

1.3

6.72

6.54

g/l

0.12

178

Disorders of synovium and tendon in diseases classified elsewhere

2.47

2.11

1.4

1.3

7.68

7.07

g/l

—

Somnolence, stupor and coma

109

1.94

2.10

1.3

1.4

5.92

6.92

g/l

0.60

Cardiomyopathy, Hypertrophic obstructive

2.58

2.10

1.5

1.2

5.70

7.73

g/l

—

Emotional disorders and disorders of social functioning with onset specific to childhood

195

1.68

2.09

1.4

6.47

6.22

g/l

0.28

145

Coronary angioplasty

156

950

1.26

2.09

1.3

1.4

7.63

7.02

g/l

0.75

121

638

Injury of muscle and tendon at shoulder and upper arm level

169

1359

1.25

2.09

1.4

6.45

6.96

g/l

1.24

116

928

Dental pulpitis 3

427

1.39

2.08

1.2

1.3

6.21

6.40

g/l

0.22

306

Superficial injury of head

110

838

1.32

2.08

1.6

1.3

6.77

6.60

g/l

0.17

574

Mental and behavioural disorders due to opioids

131

1.85

2.08

1.4

1.3

5.97

6.42

g/l

0.18

Other and unspecified injuries of ankle and foot

124

1.87

2.07

1.8

1.2

7.65

6.29

g/l

0.97

Bicipital tendinitis

124

1.87

2.07

1.3

6.64

7.04

g/l

0.21

Dental caries 2, only avohilmo

454

3136

1.14

2.06

1.4

6.82

6.69

g/l

0.34

345

2180

Other benign neoplasms of connective and other soft tissue

333

1.51

2.06

1.5

1.4

6.63

6.83

g/l

0.07

232

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

316

2200

1.17

2.05

1.4

6.76

6.69

g/l

0.10

211

1574

Familial hypercholesterolemia, with ischemic heart disease

222

1.63

2.05

1.3

6.56

7.00

g/l

0.22

154

Arterial embolism and thrombosis of lower extremity artery

2.19

2.04

1.1

1.2

5.21

6.57

g/l

—

Peripheral artery operations in Hilmo

301

1.53

2.04

1.3

8.31

6.71

g/l

0.74

208

Primary gonarthrosis, bilateral

233

1696

1.20

2.04

1.3

1.4

6.73

6.97

g/l

0.44

173

1182

Medical abortion

362

1690

1.17

2.04

1.3

1.4

6.47

6.68

g/l

0.56

255

1191

UC patients in KELA-register (code 208), prior to 1994

132

1.83

2.04

1.6

1.3

6.61

6.90

g/l

0.18

Alzheimer’s disease, wide definition, excluding more controls

269

0.55

2.04

1.1

1.5

6.80

7.40

g/l

0.37

172

Emotional disorders starting during childhood or adolecense, excluding more controls

158

1.74

2.04

1.4

1.3

6.42

6.26

g/l

0.14

111

Left bundle-branch block

154

1.76

2.04

1.4

1.3

6.69

6.65

g/l

0.02

106

Fall on same level involving ice and snow

298

2539

1.18

2.03

1.6

1.4

6.81

6.78

g/l

0.03

212

1764

Degenerative macular diseases

294

1.54

2.02

1.4

1.3

7.42

7.01

g/l

0.36

202

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.24

2.01

1.5

1.4

4.79

7.36

g/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

107

817

1.31

2.01

1.8

1.4

5.92

6.71

g/l

1.97

563

Varicella [chickenpox]

185

1.69

2.01

1.2

1.3

6.94

6.56

g/l

0.32

131

Sixth [abducent] nerve palsy

2.02

2.01

1.6

1.3

5.87

7.38

g/l

0.95

Benign neoplasm: Long bones of lower limb

104

1.94

2.01

1.9

1.3

5.50

6.56

g/l

—

Unspecified urinary incontinence

247

1.59

2.01

1.4

7.14

7.01

g/l

0.07

168

Congenital malformations of genital organs

423

1.44

2.00

1.2

1.4

6.81

6.41

g/l

0.49

315

Benign neoplasm: Skin of eyelid, including canthus

509

1.40

2.00

1.7

1.4

6.80

6.77

g/l

0.03

350

Any dementia

709

0.72

2.00

1.2

1.4

7.26

7.14

g/l

0.08

496

Congenital malformations of the circulatory system

600

1.36

1.99

1.6

1.4

7.57

6.54

g/l

1.25

439

Other strabismus

124

967

1.28

1.96

1.6

1.3

6.72

6.58

g/l

0.18

679

Glucosamine medication

224

1487

1.20

1.96

1.3

1.4

6.92

6.96

g/l

0.05

154

1037

Complications of other internal prosthetic devices, implants and grafts

2.04

1.96

1.1

1.2

6.89

7.42

g/l

0.20

Meralgia paraesthetica

1.99

1.95

1.2

1.4

5.85

7.12

g/l

1.20

Lesion of sciatic nerve

1.99

1.95

1.3

7.19

7.39

g/l

0.10

Allergic contact dermatitis due to drugs in contact with skin

2.21

1.95

1.3

5.60

7.18

g/l

—

Other noninflammatory disorders of vagina

249

1.57

1.95

1.3

7.46

6.70

g/l

0.51

169

Other eating disorders

187

1.67

1.94

1.2

1.4

6.28

6.13

g/l

0.14

125

Disorders of porphyrin and bilirubin metabolism

2.76

1.94

2.0

1.3

7.09

7.01

g/l

—

Laparoscopic right hemicolectomy

127

1.82

1.94

1.1

1.4

7.95

7.35

g/l

0.24

Other benign neoplasms of connective and other soft tissue

338

1.49

1.93

1.5

1.4

6.63

6.69

g/l

0.02

242

Malignant neoplasm of small intestine

2.47

1.93

1.1

1.2

6.27

7.37

g/l

—

Corns and callosities

195

1.65

1.93

1.2

1.4

7.29

6.81

g/l

0.19

139

Amputation

226

1.60

1.92

1.3

1.2

8.35

6.96

g/l

0.45

157

Parkinson's disease

398

0.58

1.92

1.3

7.72

6.98

g/l

0.31

271

Hypermetropia

266

1.55

1.92

1.5

1.4

7.28

6.51

g/l

0.97

192

Fracture of neck

135

1.79

1.91

1.1

1.3

6.94

6.98

g/l

0.01

Other benign neoplasms of skin

179

1465

1.22

1.91

1.7

1.3

6.52

6.85

g/l

0.67

128

1009

Maltreatment syndromes

188

1.66

1.91

1.2

1.3

6.71

6.39

g/l

0.32

135

Residual foreign body in soft tissue

150

1.74

1.91

1.4

1.3

6.24

6.94

g/l

0.53

Injury of unspecified body region

227

1.59

1.90

1.6

1.3

6.21

6.76

g/l

0.44

159

Haemangioma and lymphangioma, any site

307

1.50

1.90

1.6

1.4

7.01

6.58

g/l

0.53

215

Lesion of femoral nerve

3.24

1.89

1.1

1.4

6.43

6.50

g/l

—

Fracture of femur

641

1.33

1.89

1.3

6.44

7.02

g/l

0.84

447

Malignant neoplasm of prostate

106

866

0.77

1.88

1.3

1.4

7.70

7.09

g/l

0.59

602

Myeloproliferative diseases

228

1.59

1.87

1.1

1.4

6.50

7.22

g/l

0.48

158

Other disorders of cornea

284

1.52

1.87

1.1

1.4

7.36

6.70

g/l

0.42

201

Postmenopausal bleeding

129

555

1.28

1.86

1.4

1.3

6.68

6.73

g/l

0.05

379

Coxarthrosis, primary, with hip surgery

199

1564

1.21

1.86

1.3

1.4

6.66

6.94

g/l

0.56

157

1062

False labour

181

929

1.23

1.85

1.3

6.57

6.46

g/l

0.19

126

667

Alcohol use disorder, ICD-based

212

1770

1.20

1.85

1.2

1.4

6.39

6.89

g/l

1.40

136

1214

Blepharochalasis

122

960

1.27

1.85

1.5

1.4

6.78

6.79

g/l

0.01

661

Essential (haemorrhagic) thrombocythaemia

1.95

1.85

1.1

1.4

6.95

7.19

g/l

—

Other conjunctival vascular disorders and cysts

2.22

1.85

1.7

1.3

6.25

7.36

g/l

—

Presbyopia

229

1.58

1.85

1.4

6.15

6.73

g/l

0.52

159

Diabetic nephropathy, excluding more controls

409

1.39

1.84

1.4

1.5

7.34

6.57

g/l

0.84

259

Implicit parasitic Sepsis

4.26

1.83

1.6

1.2

6.95

6.69

g/l

—

Endometriosis of ovary

645

1.33

1.83

1.3

1.4

6.67

6.77

g/l

0.09

444

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.14

1.82

1.5

1.3

4.79

7.16

g/l

—

Infective bursitis

2.14

1.82

1.3

1.4

6.66

7.25

g/l

—

Cerebral aneurysm, nonruptured

286

1.51

1.82

1.4

6.15

6.80

g/l

0.60

193

Eating disorders

426

1.41

1.81

1.2

1.4

6.18

6.51

g/l

0.33

298

Benign lipomatous neoplasm

137

1097

1.25

1.81

1.2

1.4

6.26

6.83

g/l

1.27

768

Haemangioma and lymphangioma, any site

311

1.49

1.80

1.6

1.3

7.00

6.66

g/l

0.41

222

Alzheimer disease, excluding more controls

304

0.61

1.80

1.3

1.4

6.91

7.36

g/l

0.22

198

Varicose veins

309

2012

1.16

1.80

1.5

1.4

6.83

6.80

g/l

0.05

206

1425

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

263

1.53

1.78

1.3

1.4

6.64

6.74

g/l

0.07

183

Parkinson's disease, strict definition

351

0.57

1.78

1.4

1.3

7.94

6.97

g/l

0.37

243

Endometriosis ASRM stages 3,4

120

949

1.27

1.77

1.3

1.4

6.29

6.75

g/l

0.79

655

Stroke, excluding SAH

271

1720

1.17

1.77

1.3

1.4

7.26

6.90

g/l

0.59

195

1171

Unstable angina pectoris

155

1044

1.23

1.75

1.3

1.4

6.82

7.05

g/l

0.32

120

698

Other noninflammatory disorders of uterus, except cervix

104

548

1.30

1.75

1.5

1.4

7.21

6.68

g/l

0.42

374

Disorder of external ear, unspecified

1.99

1.75

1.6

1.3

6.61

6.94

g/l

—

Dementia in Alzheimer disease

288

0.56

1.74

1.1

1.3

6.50

7.05

g/l

0.19

210

Outcome of delivery

494

0.71

1.74

1.2

1.4

6.61

6.36

g/l

0.28

354

Effects of foreign body entering through natural orifice

127

1015

1.25

1.72

1.3

1.4

6.81

6.77

g/l

0.05

695

Brain meningioma, excluding all cancers (controls excluding all cancers)

140

1.72

1.5

5.67

6.69

g/l

1.29

Other vitreous opacities

103

1.86

1.72

1.4

1.3

7.99

7.03

g/l

0.47

Behavioural disorders, excluding more controls

2.14

1.71

1.3

1.4

6.87

6.23

g/l

—

Additional codes for the location of defect, injury or illness

163

1.66

1.71

1.2

1.3

7.65

6.83

g/l

0.32

112

Haemangioma, any site

282

1.50

1.71

1.6

1.3

7.10

6.60

g/l

0.58

195

Biguanides

527

2905

1.12

1.71

1.4

6.75

6.83

g/l

0.14

370

2012

Preterm labour and delivery

139

1123

1.24

1.71

1.4

6.72

6.67

g/l

0.04

795

Melanoma in situ

1.89

1.71

1.6

1.4

7.15

7.11

g/l

—

Acute alcohol intoxication, ICD10

100

777

1.29

1.71

1.3

1.4

6.17

6.63

g/l

0.68

536

Lichen sclerosus et atrophicus

308

1.47

1.68

1.6

1.4

7.04

6.96

g/l

0.05

217

Single spontaneous delivery

153

996

0.82

1.66

1.4

6.44

6.52

g/l

0.12

734

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

268

1.50

1.66

1.3

1.4

6.64

6.68

g/l

0.03

191

Myeloproliferative diseases (CML excluded)

196

1.59

1.65

1.1

1.4

6.81

7.15

g/l

0.18

134

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

150

1.68

1.64

1.6

1.3

6.78

6.61

g/l

0.08

114

Oral lichen ruber planus wide, hypothyreosis or thyroxin

150

1.68

1.63

2.4

1.5

5.67

7.18

g/l

2.25

106

Conductive hearing loss, unspecified

261

1.50

1.63

1.3

7.46

6.70

g/l

0.55

186

Melanoma in situ

1.85

1.62

1.6

1.3

7.15

7.29

g/l

—

Myocardial infarction, with ST-elevation

496

1.35

1.61

1.2

1.4

6.70

7.17

g/l

0.45

345

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

219

1272

1.18

1.60

1.6

1.4

6.10

6.87

g/l

3.24

155

888

Insulin, fast-acting (human)

549

1.33

1.59

1.3

6.48

6.74

g/l

0.30

375

Diffuse brain injury

1.96

1.59

1.1

1.4

8.98

7.19

g/l

—

Mental disorders, not otherwise specified

312

1.45

1.59

1.3

1.4

6.56

6.58

g/l

0.01

222

Amputation of toe

167

1.62

1.58

1.1

1.2

7.07

7.15

g/l

0.03

114

Cyst of kidney

175

1.61

1.57

1.6

1.4

8.01

6.98

g/l

0.66

120

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

129

1.71

1.57

1.2

1.4

8.78

7.10

g/l

0.31

Early complications of trauma

114

1.76

1.56

1.3

6.94

6.74

g/l

0.12

!Aliquae complicationes praecoces traumatis

114

1.76

1.56

1.3

6.94

6.74

g/l

0.12

Intussusception

2.12

1.55

1.0

1.4

4.88

7.70

g/l

—

Alzheimer’s disease (Late onset), excluding more controls

234

0.60

1.55

1.1

1.4

6.82

7.20

g/l

0.20

152

Hereditary corneal dystrophies

1.94

1.54

1.1

1.3

6.73

7.41

g/l

—

Adenomyosis (Endometriosis of uterus)

466

1.36

1.54

1.2

1.5

6.43

6.57

g/l

0.14

318

Female infertility, associated with anovulation

314

1.44

1.54

1.6

1.5

6.35

6.73

g/l

0.47

219

Carcinoma in situ of skin of other and unspecified parts of face

145

1.66

1.54

1.1

1.3

6.98

7.01

g/l

0.01

108

Glaucoma, exfoliation

208

1.54

1.53

1.3

6.48

6.87

g/l

0.33

151

Stroke, including SAH

289

1861

1.15

1.53

1.3

1.4

7.25

6.87

g/l

0.67

210

1268

Alzheimer’s disease (Late onset)

361

0.64

1.52

1.1

1.3

6.44

7.19

g/l

0.56

260

Haemangioma, any site

290

1.45

1.52

1.6

1.3

7.10

6.64

g/l

0.53

207

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.62

1.52

1.0

1.2

6.27

6.70

g/l

—

Hydatidiform mole

0.00

1.52

0.0

1.5

—

6.11

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

616

0.77

1.51

1.3

1.4

6.98

6.99

g/l

0.01

424

Mental and behavioural disorders due to alcohol, excluding acute intoxication

224

1918

1.17

1.51

1.2

1.4

6.32

6.89

g/l

1.75

143

1311

Carcinoma in situ of skin of other and unspecified parts of face

146

1.65

1.50

1.1

1.3

6.98

7.45

g/l

0.13

106

Any dementia, excluding more controls

648

0.76

1.50

1.3

1.4

7.33

7.13

g/l

0.14

442

Malignant neoplasm of digestive organs

150

1222

1.21

1.50

1.3

1.4

6.67

7.10

g/l

0.62

838

Other disorders of breast

486

1.34

1.50

1.4

1.3

6.24

6.71

g/l

0.78

332

Other lesions of median nerve

2.08

1.49

1.1

1.3

6.74

7.25

g/l

—

Other congenital malformations of circulatory system

1.96

1.49

2.9

1.3

6.59

6.85

g/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

2.01

1.49

1.2

1.3

6.45

7.12

g/l

0.30

Primary coxarthrosis, bilateral

116

936

1.24

1.49

1.4

6.36

7.05

g/l

1.75

639

Transient ischemic attack

228

1622

1.17

1.48

1.4

6.49

6.88

g/l

0.89

160

1112

Postmenopausal atrophic vaginitis

119

576

1.25

1.47

1.4

1.3

6.24

6.76

g/l

0.97

394

Other spirochaetal diseases

124

1010

1.23

1.47

1.3

1.4

6.54

6.72

g/l

0.23

699

Complications predominantly related to the puerperium

142

1173

1.21

1.46

1.5

1.4

6.38

6.68

g/l

0.51

106

827

Vitreous haemorrhage

276

1.45

1.46

1.5

1.4

7.03

6.86

g/l

0.12

197

Coronary revascularization (ANGIO or CABG)

193

1139

1.18

1.46

1.4

7.43

6.96

g/l

0.61

144

756

Ménière disease

301

1.43

1.46

1.5

1.4

6.81

7.03

g/l

0.17

208

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

665

0.78

1.46

1.3

1.4

7.22

6.99

g/l

0.21

455

Benign neoplasm of ovary

619

1.30

1.46

1.2

1.4

6.68

6.62

g/l

0.05

423

Ischaemic Stroke, excluding all haemorrhages

247

1614

1.16

1.45

1.3

1.4

7.33

6.96

g/l

0.54

175

1097

Atlantoaxial subluxation

3.17

1.44

1.0

1.6

6.78

6.55

g/l

—

Parkinson's disease, including avohilmo

414

0.65

1.44

1.3

7.28

7.08

g/l

0.08

284

Inflammatory diseases of prostate (prostatitis)

412

1.36

1.44

1.2

1.3

6.73

7.28

g/l

0.68

277

Infectious mononucleosis

336

1.40

1.43

2.1

1.4

6.70

6.47

g/l

0.18

231

Dementia in other diseases classified elsewhere

1.80

1.43

1.2

7.51

7.57

g/l

—

Contact with heat and hot substances

180

1.56

1.43

1.4

1.3

5.79

6.83

g/l

1.25

127

Carcinoma in situ of breast, intraductal

290

0.58

1.42

1.2

1.4

6.96

6.85

g/l

—

202

Impacted cerumen

270

1.45

1.41

1.2

1.3

7.55

7.07

g/l

0.29

192

Benign neoplasm of urinary organs

118

1.70

1.41

1.2

1.3

6.63

7.12

g/l

0.23

Benign neoplasm: Kidney

1.86

1.40

1.3

6.58

7.43

g/l

—

Specific development disorders of scholastic skills

195

1.53

1.39

1.4

1.3

6.55

6.28

g/l

0.22

142

Sequelae of injuries of upper limb

355

1.38

1.39

1.2

1.4

6.59

6.67

g/l

0.04

250

Eating disorder

364

1.38

1.37

1.2

1.4

6.02

6.41

g/l

0.52

257

Benign neoplasm of ovary

625

1.28

1.37

1.2

1.5

6.68

6.76

g/l

0.08

436

Postprocedural musculoskeletal disorders, not elsewhere classified

190

1.53

1.37

1.3

1.5

5.93

7.02

g/l

1.16

132

Carcinoma in situ of skin

182

1.54

1.37

1.4

6.48

6.97

g/l

0.21

130

Nontoxic multinodular goitre

661

1.27

1.36

1.5

1.4

6.68

6.83

g/l

0.10

454

Macular pucker

408

1.35

1.36

1.7

1.4

7.11

7.13

g/l

0.02

292

Anomalies of dental arch relationship, including avohilmo

109

794

1.24

1.35

1.3

1.4

6.24

6.62

g/l

0.75

560

Carcinoma in situ of skin

183

1.54

1.34

1.4

1.3

6.48

7.24

g/l

0.35

132

Granulomatous disorders of skin and subcutaneous tissue

1.92

1.33

1.6

1.2

5.87

6.96

g/l

—

Use of interferon beta-1a

1.79

1.33

1.4

6.37

6.29

g/l

—

Wet age-related macular degeneration

360

1.37

1.32

1.2

1.3

7.28

7.05

g/l

0.16

262

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

208

1.50

1.32

1.4

6.14

6.95

g/l

0.82

151

Fracture of shoulder and upper arm

164

1388

1.18

1.32

1.5

1.3

6.46

6.73

g/l

0.48

122

957

Delivery

159

998

0.84

1.32

1.4

6.40

6.52

g/l

0.21

736

Pregnancy with abortive outcome

366

1706

1.12

1.32

1.3

1.4

6.26

6.68

g/l

1.64

256

1202

Carcinoma in situ of breast, intraductal

283

0.60

1.31

1.2

1.5

6.96

6.69

g/l

—

201

Sequelae of infectious and parasitic diseases

250

1.44

1.30

1.4

7.08

6.74

g/l

0.20

173

Anorexia (incl.atypical)

209

1.49

1.30

1.1

1.4

6.36

6.44

g/l

0.04

143

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

137

1.61

1.29

1.2

1.4

8.78

6.69

g/l

0.41

100

Congenital lens malformations

2.83

1.29

1.2

1.4

4.99

6.57

g/l

—

Wide developmental disorders, excluding more controls

105

1.71

1.29

1.3

1.4

4.82

6.11

g/l

1.68

Dental pulpitis 3, only avohilmo

395

1.30

1.27

1.2

1.3

6.39

6.46

g/l

0.06

282

Benign neoplasm: Brain, supratentorial

2.06

1.27

1.4

7.48

6.35

g/l

—

Benign lipomatous neoplasm

137

1148

1.20

1.26

1.2

1.4

6.26

6.77

g/l

1.07

800

Endometriosis diagnosis and infertility diagnosis occurring together

466

1.31

1.26

1.4

6.30

6.50

g/l

0.19

321

Motorcycle rider injured in other and unspecified transport accidents

211

1.48

1.25

1.5

1.2

5.86

6.68

g/l

1.19

146

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.42

1.25

1.7

1.2

5.47

6.88

g/l

—

Acute myeloid leukaemia, helper endpoint

2.42

1.25

1.7

1.2

5.47

6.88

g/l

—

Open wound of forearm

295

1.39

1.24

1.2

1.3

7.43

6.77

g/l

0.45

206

Calcific tendinitis of shoulder

179

1.51

1.23

1.1

1.4

6.20

6.96

g/l

0.57

121

Scabies

155

1.56

1.23

1.8

1.3

6.38

6.45

g/l

0.04

109

Other renal tubulo-interstitial diseases

1.92

1.23

1.1

1.3

9.11

5.75

g/l

—

Retinoschisis and retinal cysts

1.98

1.22

2.8

1.3

5.85

7.53

g/l

—

Bursitis of shoulder

1.98

1.22

1.5

5.92

7.47

g/l

—

Other and unspecified disorders of adult personality and behaviour

2.67

1.22

1.2

1.5

5.82

6.14

g/l

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

529

1.26

1.22

1.2

1.4

6.55

6.90

g/l

0.40

373

Delivery, wide proxy

125

799

0.83

1.22

1.4

6.21

6.50

g/l

0.47

574

Malignant neoplasm of respiratory system and intrathoracic organs

536

1.27

1.21

1.2

1.3

6.65

7.07

g/l

0.46

380

Infections of genitourinary tract in pregnancy

365

1.35

1.21

1.3

1.5

6.26

6.87

g/l

0.97

253

Malignant neoplasm of breast, HER-negative

752

0.77

1.21

1.2

1.4

6.55

6.68

g/l

0.10

534

Right hemicolectomy

132

1.60

1.20

1.2

1.3

7.74

7.33

g/l

0.18

Diabetic nephropathy

533

1.28

1.20

1.4

1.5

7.30

6.64

g/l

0.72

352

Acute alcohol intoxication

118

981

1.20

1.19

1.3

1.4

6.28

6.84

g/l

1.02

673

Other disorders of the genitourinary system

409

1.32

1.19

1.4

7.42

6.89

g/l

0.34

279

Fracture of lower leg, including ankle

276

2440

1.13

1.19

1.5

1.3

6.80

6.79

g/l

0.01

204

1681

Retinal detachments and breaks

147

1247

1.18

1.19

1.7

1.4

6.57

6.91

g/l

0.55

106

863

Female infertility, tubal origin

189

1.49

1.19

1.1

1.5

5.43

6.96

g/l

2.24

138

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

117

1.63

1.18

1.2

4.87

6.76

g/l

1.96

Parkinson's disease, excluding more controls

338

0.66

1.18

1.3

1.4

7.72

7.28

g/l

0.17

226

LSIL lesion of the cervix uteri, vagina or vulva

613

1.26

1.18

1.3

1.4

7.75

6.47

g/l

1.51

420

Congenital musculoskeletal deformities of head, face, spine and chest

2.02

1.17

1.6

1.3

6.02

6.03

g/l

—

Recurrent dislocation and subluxation of joint

248

1.42

1.16

1.2

1.4

6.40

6.71

g/l

0.22

164

Vestibular neuronitis

282

1.39

1.16

1.3

1.4

7.48

6.90

g/l

0.41

204

Benign neoplasm: Adrenal gland

215

1.45

1.16

1.2

1.5

6.73

6.84

g/l

0.04

150

Peripheral arterial reconstruction

420

1.31

1.15

1.2

1.3

6.64

7.10

g/l

0.41

304

Thyrotoxicosis with toxic single thyroid nodule

2.52

1.15

1.8

1.4

5.82

6.21

g/l

—

Colitis due to radiation

2.52

1.15

1.4

4.72

8.31

g/l

—

Conduct disorder

1.82

1.15

1.3

6.87

6.09

g/l

—

In situ neoplasms

153

1246

1.17

1.15

1.4

7.19

6.75

g/l

0.53

100

869

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

274

1.39

1.15

1.0

1.4

6.68

6.82

g/l

0.08

199

Lyme disease

119

995

1.20

1.15

1.3

1.4

6.55

6.74

g/l

0.23

690

Benign neoplasm of urinary organs

126

1.59

1.14

1.2

1.4

6.63

6.89

g/l

0.12

Polyp of the female genital tract

154

762

1.18

1.14

1.3

1.4

6.04

6.77

g/l

2.30

112

525

Erectile dysfunction

224

1.43

1.14

1.5

1.2

9.05

6.82

g/l

1.12

158

Parkinson's disease, strict definition, excluding more controls

302

0.65

1.14

1.4

7.94

7.27

g/l

0.24

202

Sequelae of injuries of lower limb

344

1.34

1.12

1.6

1.4

7.22

6.69

g/l

0.20

239

Early lumbar disc prolapse operation

476

1.29

1.11

1.2

1.3

6.98

6.54

g/l

0.33

317

Any event in cancer register

530

2890

1.09

1.10

1.3

1.4

7.10

6.72

g/l

0.93

359

2036

Melanocytic naevi of trunk

424

1.30

1.10

1.2

1.4

5.98

6.66

g/l

1.40

301

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

346

1.33

1.09

1.1

1.4

6.94

6.76

g/l

0.08

234

Superficial injury of thorax

513

1.27

1.08

1.5

1.4

6.34

6.68

g/l

0.30

363

Benign neoplasm: Kidney

1.69

1.08

1.3

1.5

6.58

6.74

g/l

—

Schizophrenia or delusion

121

1429

0.85

1.07

1.2

1.3

6.89

6.62

g/l

0.28

967

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

203

1226

1.14

1.07

1.7

1.4

6.14

6.86

g/l

2.66

146

856

Impacted maxillary molar

186

1.46

1.06

1.4

6.39

6.35

g/l

0.03

124

Basal cell carcinoma

223

1569

1.13

1.05

1.6

1.4

6.14

7.03

g/l

4.21

164

1069

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

814

0.80

1.05

1.2

1.4

6.29

6.73

g/l

0.49

575

Obstructed labour due to maternal pelvic abnormality

624

1.24

1.04

1.3

1.4

6.34

6.64

g/l

0.38

435

Gilbert syndrome

2.30

1.04

2.2

1.3

5.98

6.93

g/l

—

Other congenital malformations of heart

2.09

1.03

1.4

1.2

7.45

6.95

g/l

—

Schizophrenia, schizotypal and delusional disorders

122

1434

0.85

1.03

1.2

1.3

6.87

6.62

g/l

0.26

973

Injury of muscle and tendon at hip and thigh level

341

1.32

1.03

1.1

1.4

7.31

6.59

g/l

0.50

235

Benign neoplasm: Adrenal gland

221

1.41

1.02

1.2

1.4

6.73

6.81

g/l

0.03

160

Long labour

977

0.83

1.02

1.3

1.4

6.93

6.52

g/l

0.35

695

Peripheral retinal degeneration

1.70

1.01

1.4

1.3

3.18

6.93

g/l

—

Malignant neoplasm of brain

1.69

1.01

1.4

1.3

6.19

6.76

g/l

—

In situ neoplasms

153

1324

1.16

1.01

1.4

1.3

7.19

6.78

g/l

0.48

100

921

Migraine with aura, drug-induced

2.02

1.00

2.4

1.4

6.06

6.42

g/l

—

Sequelae of injuries of head

172

1.46

1.00

1.4

7.81

6.98

g/l

0.17

117

Chronic periodontitis, including avohilmo

476

3246

1.09

0.99

1.4

6.75

6.81

g/l

0.10

341

2232

Other disorders of pigmentation

115

1.57

0.99

1.4

1.3

8.71

7.31

g/l

0.35

Melanocytic naevi of trunk

431

1.28

0.99

1.2

1.4

5.98

6.63

g/l

1.33

309

Behavioural disorders

1.72

0.99

1.3

1.2

6.87

6.38

g/l

—

Benign neoplasm: Brain, supratentorial

1.85

0.99

1.4

1.3

7.48

6.05

g/l

—

LSIL lesion of the cervix uteri

476

1.26

0.98

1.3

1.4

7.83

6.38

g/l

1.33

333

Other and unspecified vascular occlusions

206

1.41

0.98

1.2

1.3

6.36

7.04

g/l

0.48

150

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.98

0.0

1.3

—

6.26

—

Bitten or struck by other mammals

423

1.28

0.98

1.4

5.90

6.63

g/l

1.39

295

Other malignant neoplasms of skin (=non-melanoma skin cancer)

218

1527

1.13

0.98

1.5

1.4

6.11

7.00

g/l

3.80

153

1043

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.2

—

6.45

—

Impacted maxillary canine

1.96

0.97

1.3

7.37

6.54

g/l

—

Benign neoplasm of thyroid gland

1.64

0.97

2.6

1.5

8.12

6.79

g/l

—

Benign neoplasm of thyroid gland

1.64

0.97

2.6

1.3

8.12

7.04

g/l

—

Other disorders of breast and lactation associated with childbirth

1.86

0.97

1.3

6.54

6.16

g/l

—

Complications of the puerperium, not elsewhere classified

157

1.47

0.96

1.3

1.4

6.07

6.40

g/l

0.32

111

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

182

1.43

0.96

1.6

1.4

7.46

6.82

g/l

0.32

131

Benign mammary dysplasia

505

1.25

0.95

1.5

1.4

5.71

6.79

g/l

2.57

342

Other and unspecified mononeuropathies, also in other diseases

1.70

0.95

1.4

1.3

5.09

7.31

g/l

2.09

Maternal care for other known or suspected fetal problems

134

738

1.17

0.94

1.3

1.4

6.38

6.44

g/l

0.08

537

Primary ovarian failure

1.79

0.94

1.2

1.3

5.27

6.66

g/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

285

1.34

0.94

1.4

6.91

6.84

g/l

0.03

199

Fracture of skull and facial bones

833

1.19

0.94

1.4

1.3

6.76

6.75

g/l

0.01

565

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

245

1498

1.12

0.94

1.6

1.4

6.31

6.82

g/l

1.22

172

1055

Vertical strabismus

101

1.59

0.93

1.4

1.3

7.85

7.19

g/l

0.24

Assault

534

1.24

0.93

1.2

1.3

6.44

6.58

g/l

0.11

361

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

286

1.33

0.93

1.2

1.4

6.41

6.90

g/l

0.42

185

Torticollis

1.74

0.92

1.1

1.3

6.08

6.42

g/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

205

1251

1.13

0.92

1.7

1.4

6.13

6.85

g/l

2.74

148

871

Contact with machinery

374

1.29

0.92

1.2

1.3

5.91

6.80

g/l

1.15

264

Pediculosis, acariasis and other infestations

201

1.40

0.91

1.7

1.3

7.08

6.51

g/l

0.30

139

Mental and behavioural disorders due to cannabinoids

102

1.58

0.90

1.1

1.3

6.32

6.31

g/l

—

Perineal laceration during delivery

661

0.81

0.89

1.7

1.4

6.54

6.38

g/l

0.14

461

L02BA Anti-estrogens

608

0.79

0.89

1.1

1.4

6.76

6.62

g/l

0.15

425

Malignant neoplasm of bronchus and lung

443

1.25

0.89

1.2

1.3

6.65

7.07

g/l

0.45

309

Inguinal hernia

292

1786

1.10

0.89

1.3

1.4

7.38

6.73

g/l

1.53

204

1199

Dental caries 1 and operation codes, only avohilmo

141

815

0.87

1.5

1.4

6.35

6.82

g/l

1.08

581

Varicose veins of other sites

203

1.38

0.87

1.2

1.3

8.05

6.79

g/l

0.50

141

Pedestrian injured in transport accident

212

1.37

0.86

1.2

1.3

6.73

6.80

g/l

0.02

144

Premature rupture of membranes

728

0.84

0.86

1.3

1.4

6.81

6.52

g/l

0.20

521

Emotional disorders starting during childhood or adolescence

202

1.38

0.86

1.4

6.42

6.24

g/l

0.16

155

Non-small cell lung cancer

414

1.26

0.85

1.2

1.3

6.83

7.09

g/l

0.26

290

Parodontitis

474

3246

1.08

0.85

1.4

6.76

6.81

g/l

0.09

342

2230

Overexertion and strenuous or repetitive movements

361

1.28

0.85

1.3

1.4

6.47

6.75

g/l

0.22

251

Graves disease, strict definition

370

1.27

0.85

1.4

1.5

5.77

6.81

g/l

1.81

261

Juvenile osteochondrosis

104

1.54

0.84

1.8

1.4

5.83

6.46

g/l

0.47

Other and unspecified injuries of abdomen, lower back and pelvis

1.95

0.84

1.0

1.1

5.59

5.92

g/l

—

Injury of eye and orbit

560

1.22

0.83

1.2

1.3

6.14

6.61

g/l

0.84

378

Parodontitis or operation codes

474

3247

1.08

0.83

1.4

6.76

6.81

g/l

0.09

342

2231

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

129

1.48

0.83

1.5

1.4

5.39

6.94

g/l

1.19

Male infertility

171

1.41

0.83

1.3

7.81

6.79

g/l

0.47

109

Diabetic retinopathy

151

836

1.14

0.83

1.5

1.4

6.58

6.62

g/l

0.05

565

Congenital malformations of great arteries

127

1.48

0.83

1.7

1.4

5.51

6.36

g/l

0.49

106

Leiomyoma of uterus

250

1273

1.11

0.82

1.4

6.51

6.67

g/l

0.29

164

930

Injuries to the elbow and forearm

364

3036

1.08

0.81

1.4

6.72

6.74

g/l

0.03

261

2124

Traumatic subdural haemorrhage

288

1.30

0.81

1.6

1.4

7.18

7.12

g/l

0.04

202

L02BB Anti-androgens

201

0.65

0.81

2.2

1.2

8.35

6.97

g/l

—

142

Basal cell carcinoma, including avohilmo

226

1605

1.11

0.81

1.6

1.4

6.12

7.03

g/l

4.33

166

1090

Fall on and from stairs and steps

113

977

1.16

0.81

1.4

1.3

6.75

6.65

g/l

0.08

679

Parodontitis and operation codes

446

3224

1.08

0.80

1.4

6.83

6.80

g/l

0.05

320

2220

Pre-eclampsia or poor fetal growth

157

1386

1.13

0.80

1.4

6.73

6.57

g/l

0.24

109

980

Hyperplasia of prostate

152

762

1.14

0.80

1.2

1.5

6.62

7.09

g/l

0.90

104

526

Dipeptidyl peptidase 4 (DPP-4) inhibitors

356

1.27

0.79

1.3

1.4

7.32

6.84

g/l

0.24

250

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.6

—

6.66

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.79

0.0

1.2

—

6.59

—

All dysplastic lesions of the cervix uteri, vagina or vulva

145

1270

1.14

0.79

1.3

1.4

7.11

6.50

g/l

0.96

103

896

Intracerebral haemorrhage

294

1.29

0.79

1.2

1.3

7.28

6.68

g/l

0.51

207

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

5.83

—

Graves ophthalmopathy, strict

1.68

0.79

1.3

5.89

7.04

g/l

0.73

Fitting and adjustment of other devices

130

1058

1.14

0.79

1.4

7.12

6.92

g/l

0.25

107

725

Autism

1.54

0.78

1.3

4.68

6.38

g/l

—

Oral leukoplakia, including avohilmo

1.63

0.78

1.4

1.3

5.40

7.67

g/l

—

Other and unspecified corneal deformities and disorders

1.56

0.78

1.2

1.4

8.06

7.02

g/l

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.78

0.0

1.3

—

6.79

—

Benign leiomyoma with endometriosis

538

1.21

0.77

1.2

1.5

6.10

6.74

g/l

1.20

374

Parodontitis, under 40 years and operation codes

349

1.26

0.77

1.3

6.82

6.58

g/l

0.16

244

Parodontitis, operation under 40 years and operation codes

349

1.26

0.77

1.3

6.82

6.58

g/l

0.16

244

Emergency coronary revascularization (for ACS)

214

1388

1.11

0.76

1.4

7.43

6.99

g/l

0.65

162

934

Autism spe

1.52

0.76

1.3

4.68

6.25

g/l

—

Parodontitis or/and operation codes

331

2134

0.92

0.76

1.3

1.4

6.50

6.77

g/l

0.72

241

1460

Ovarian dysfunction

279

1.29

0.75

1.4

5.50

6.62

g/l

1.92

194

Nontoxic goitre/thyroid nodule

127

1115

1.14

0.75

1.9

1.4

6.48

6.76

g/l

0.32

777

Cicatricial alopecia [scarring hair loss]

2.10

0.75

1.6

1.4

7.76

6.20

g/l

—

Nontoxic single thyroid nodule

227

1.32

0.74

2.1

1.3

5.72

7.16

g/l

1.64

157

Use of levodopa decarboxylase inhibitor

324

0.74

1.4

1.3

7.57

6.97

g/l

0.24

226

Pregnancy, childbirth and the puerperium

109

657

0.87

0.73

1.4

6.24

6.62

g/l

0.68

465

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

334

1.26

0.73

1.2

1.5

6.41

6.45

g/l

0.03

235

Unspecified maternal hypertension

1.81

0.73

1.1

1.4

7.14

5.95

g/l

—

Foreign body in alimentary tract

159

1.39

0.72

1.2

1.3

6.41

7.06

g/l

0.32

114

Sequelae of cerebrovascular disease

130

1006

1.14

0.72

1.3

1.4

7.56

6.90

g/l

0.74

101

682

Injury of muscle and tendon at wrist and hand level

516

1.20

0.71

1.3

1.4

6.53

6.92

g/l

0.29

361

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

378

0.77

0.71

1.3

1.4

5.91

6.88

g/l

0.76

269

Diabetic neuropathy

378

1.24

0.71

1.6

1.4

6.35

6.61

g/l

0.19

251

Pervasive developmental disorders excl. Autism + Asperger

1.58

0.71

1.0

1.2

5.10

6.20

g/l

—

Crushed, pushed or stepped on by crowd or human stampede

283

1.28

0.69

1.2

1.3

6.78

6.62

g/l

0.12

199

Other congenital malformations of the digestive system

177

1.35

0.68

1.5

1.3

6.90

6.36

g/l

0.31

138

Inflammatory disorders of breast

213

1.32

0.68

1.8

1.4

5.92

6.40

g/l

0.46

147

Other fall from one level to another

106

927

1.14

0.68

1.3

6.34

6.67

g/l

0.61

653

Bipolar affective disorders

797

1.16

0.68

1.3

6.57

6.71

g/l

0.16

530

Spontaneous abortion

239

1487

1.09

0.67

1.3

1.4

6.57

6.69

g/l

0.20

171

1056

Hydrocele

356

1.24

0.67

1.4

6.94

7.14

g/l

0.12

252

Sequelae of other and unspecified infectious and parasitic diseases

205

1.32

0.67

1.6

1.4

6.68

6.72

g/l

0.02

142

Focal brain injury

153

1.37

0.67

1.7

1.3

6.15

6.90

g/l

0.57

107

Vascular dementia

123

1.42

0.67

1.3

1.2

7.00

7.69

g/l

0.26

Other degenerative diseases of the basal ganglia

1.79

0.66

1.0

1.3

5.84

8.21

g/l

—

Organic, including symptomatic, mental disorders

153

1230

0.90

0.66

1.2

1.4

7.37

7.06

g/l

0.34

107

837

Toxic effect of contact with venomous animals

128

1.41

0.65

1.1

1.3

6.70

6.86

g/l

0.09

Benign neoplasm: Skin of other and unspecified parts of face

313

1.25

0.64

1.5

1.4

5.81

6.90

g/l

1.24

222

Bulimia nervosa (incl. atypical)

120

1.42

0.64

1.2

1.4

6.01

6.16

g/l

—

Intermittent heterotropia

233

1.29

0.64

1.4

6.21

6.49

g/l

0.24

167

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

406

1.21

0.64

1.2

1.4

6.83

7.04

g/l

0.21

287

Supervision of normal pregnancy

623

0.87

0.64

1.1

1.4

6.56

6.44

g/l

0.17

447

Open wound of head

241

2183

1.09

0.64

1.5

1.3

6.68

6.80

g/l

0.17

157

1492

Superficial injury of shoulder and upper arm

386

1.22

0.64

1.7

1.3

7.14

6.63

g/l

0.41

272

Alcohol dependence

120

1065

1.13

0.63

1.1

1.4

6.35

6.94

g/l

1.13

738

Malignant neoplasm of bladder

146

1.37

0.63

1.5

1.1

6.01

7.36

g/l

0.82

109

Inguinal or femoral hernia, bilateral

323

1.24

0.63

1.2

1.3

7.41

6.57

g/l

0.77

227

Pregnancy examination and test

487

1.16

0.63

1.6

1.4

6.26

6.39

g/l

0.18

349

Car occupant injured in other and unspecified transport accidents

775

1.15

0.63

1.6

1.4

6.76

6.70

g/l

0.05

537

Maternal care for known or suspected fetal abnormality and damage

640

0.85

0.62

1.4

6.73

6.54

g/l

0.19

456

Other osteochondropathies

261

1.27

0.62

1.5

1.3

6.19

6.65

g/l

0.40

179

Calculus of lower urinary tract

121

1.41

0.62

1.7

1.3

5.10

7.16

g/l

—

Sexual dysfunction

1.64

0.62

1.5

1.3

6.75

6.91

g/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

333

1.23

0.62

1.0

1.4

6.81

6.86

g/l

0.03

233

Inguinal hernia, bilateral

315

1.24

0.62

1.2

1.3

7.34

6.44

g/l

0.82

220

1.67

0.61

1.8

1.1

5.96

7.24

g/l

—

Puerperal sepsis

498

1.19

0.61

1.7

1.4

6.01

6.62

g/l

0.96

344

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

199

0.70

0.61

1.3

1.5

4.92

6.83

g/l

—

135

Aneurysms, operations, SAH

554

1.17

0.61

1.4

6.53

6.75

g/l

0.21

381

HSIL lesion of the cervix uteri, vagina or vulva

887

0.87

0.60

1.4

6.95

6.61

g/l

0.24

627

Other and unspecified nonorganic psychotic disorders

855

0.86

0.60

1.2

1.4

6.82

6.66

g/l

0.11

574

Traction detachment of retina

0.00

0.59

0.0

1.2

—

6.37

—

Epidural haemorrhage

0.00

0.59

0.0

1.4

—

7.82

—

Foreign body entering into or through eye or natural orifice

290

1.24

0.59

1.3

6.83

6.66

g/l

0.13

208

Postpartum haemorrhage due to retained placenta

542

0.83

0.59

1.2

1.3

6.73

6.56

g/l

0.15

378

Femoral hernia

106

1.42

0.57

1.4

1.2

6.71

6.92

g/l

—

Unspecified abortion

193

1.30

0.57

1.5

1.4

6.17

6.98

g/l

0.73

132

Other and unspecified mental retardation

0.56

1.0

1.4

5.94

5.83

g/l

—

Other abnormal products of conception

171

1038

1.10

0.56

1.4

1.3

5.98

6.69

g/l

3.07

118

741

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.56

1.0

1.2

5.88

7.05

g/l

—

HSIL lesion of the cervix uteri

817

0.87

0.55

1.4

6.92

6.60

g/l

0.22

575

Mandibular retrognathia

265

1.24

0.55

1.4

6.21

6.33

g/l

0.09

187

Congenital malformations of heart and great arteries

542

1.16

0.55

1.4

7.38

6.50

g/l

0.75

396

Foreign body on external eye

560

1.16

0.55

1.2

1.3

7.14

6.70

g/l

0.46

376

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

348

1.21

0.55

1.2

1.4

6.41

6.56

g/l

0.12

238

Retinal breaks without detachment

551

1.16

0.55

1.8

1.3

6.35

6.83

g/l

0.64

385

Xerosis cutis

1.59

0.54

1.3

1.2

6.06

6.35

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

285

1.23

0.54

1.1

1.4

6.41

6.35

g/l

0.04

204

Maternal care for known or suspected malpresentation of fetus

632

0.87

0.54

1.4

6.12

6.44

g/l

0.43

454

Other blood glucose lowering drugs, excl. Insulins

543

1.16

0.53

1.2

1.4

6.36

6.94

g/l

0.68

375

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

204

0.73

0.53

1.3

1.4

6.10

6.60

g/l

—

149

Medical treatment for female infertility

106

946

1.12

0.52

1.3

1.4

6.72

6.43

g/l

0.43

662

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.62

0.52

1.3

1.4

5.05

5.88

g/l

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.61

0.52

1.3

1.4

5.05

5.96

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

245

1790

1.08

0.52

1.4

6.84

6.63

g/l

0.37

173

1284

Scissor bite

134

0.67

0.52

1.1

1.5

6.25

6.30

g/l

—

108

Benign neoplasm: Skin of other and unspecified parts of face

323

1.21

0.52

1.5

1.3

5.81

6.75

g/l

1.01

225

Polyhydramnios

170

1.30

0.51

1.4

6.81

6.05

g/l

0.60

116

Other disorders of amniotic fluid and membranes

613

0.86

0.51

1.8

1.4

7.16

6.37

g/l

0.68

436

Graves ophthalmopathy

1.47

0.51

1.3

1.4

5.89

7.10

g/l

0.82

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

324

1.21

0.50

1.4

6.53

6.23

g/l

0.26

226

Benign leiomyoma with endometriosis

565

1.15

0.50

1.2

1.4

6.10

6.62

g/l

0.86

380

Cholera

118

1.36

0.50

1.4

1.6

7.96

7.49

g/l

0.17

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

261

1.23

0.49

1.1

1.5

7.10

6.73

g/l

0.21

181

Foreign body or object entering through skin

216

1.25

0.49

1.4

1.3

5.99

6.33

g/l

0.36

153

Slow fetal growth and fetal malnutrition

1.56

0.49

2.1

1.3

5.72

6.25

g/l

—

Redundant prepuce, phimosis and paraphimosis

817

1.12

0.49

1.2

1.4

6.70

6.94

g/l

0.31

546

Coronary artery bypass grafting

602

1.13

0.49

1.5

1.4

7.32

7.06

g/l

0.23

405

Diabetic retinopathy, strict definition

588

1.14

0.49

1.4

6.79

6.70

g/l

0.07

391

Injury of muscle and tendon at lower leg level

558

1.15

0.48

2.0

1.3

6.93

6.82

g/l

0.08

382

Leiomyoma of uterus

316

1691

1.06

0.48

1.4

6.32

6.73

g/l

1.24

214

1215

Malignant neoplasm of head and neck

217

1.25

0.47

1.2

1.3

4.73

6.85

g/l

3.21

150

Postpartum care and examination

427

0.87

0.47

1.3

1.4

6.59

6.33

g/l

0.26

302

Generalized epilepsy

155

1.29

0.46

1.4

1.3

9.15

6.30

g/l

1.10

112

Complications following abortion and ectopic and molar pregnancy

111

1.36

0.46

1.1

1.6

5.71

7.25

g/l

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

299

1.20

0.46

1.5

1.4

6.97

7.05

g/l

0.05

216

Pre-eclampsia

872

1.11

0.46

1.5

1.4

6.53

6.66

g/l

0.16

605

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

291

1.21

0.46

1.1

1.4

6.41

6.33

g/l

0.05

204

Manic episode

1.43

0.45

1.4

1.3

5.17

6.90

g/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

684

1.13

0.45

1.3

1.4

6.78

6.70

g/l

0.05

484

Malignant neoplasm of kidney, except renal pelvis

228

1.23

0.45

1.0

1.3

6.77

6.95

g/l

0.09

162

Focal epilepsy

817

1.11

0.45

1.3

6.88

6.64

g/l

0.19

578

All dysplastic lesions of the cervix uteri

125

1140

1.10

0.44

1.3

1.4

7.07

6.56

g/l

0.63

811

Assault by bodily force

302

1.19

0.44

1.2

1.3

6.37

6.45

g/l

0.04

211

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

293

1.20

0.43

1.2

1.3

5.02

6.90

g/l

3.91

204

Non-small cell lung cancer, squamous

1.41

0.43

1.5

1.2

7.38

7.35

g/l

—

Non-small cell lung cancer, squamous, helper endpoint

1.41

0.43

1.5

1.2

7.38

7.35

g/l

—

Parodontitis, under 40 years

378

1.17

0.42

1.3

1.4

6.82

6.61

g/l

0.14

264

Parodontitis, under 40 years, or operation codes

378

1.17

0.42

1.3

1.4

6.82

6.61

g/l

0.14

264

Malignant melanoma

453

1.15

0.41

1.3

7.88

6.81

g/l

0.54

316

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

195

0.77

0.41

1.3

1.5

6.10

6.83

g/l

—

133

Frostbite

1.52

0.41

1.4

5.92

6.37

g/l

—

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.41

0.0

1.4

—

7.00

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

114

1.32

0.40

1.4

1.3

6.96

6.23

g/l

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.1

—

7.58

—

0.00

0.39

0.0

1.1

—

5.65

—

Acute and transient psychotic disorders

485

0.86

0.39

1.1

1.4

6.55

6.82

g/l

0.17

332

Noise effects on inner ear

124

1.29

0.38

1.2

1.3

5.41

7.01

g/l

—

Wide developmental disorders

142

1.27

0.38

1.3

4.82

6.15

g/l

1.85

108

Kela-code for severe mental illness

157

1685

0.93

0.38

1.2

1.4

6.57

6.75

g/l

0.23

105

1148

Colorectal cancer, excluding all cancers (controls excluding all cancers)

835

0.90

0.38

1.2

1.4

6.79

6.90

g/l

0.10

576

Postpartum haemorrhage due to anatomy

430

0.86

0.37

1.1

1.3

7.13

6.49

g/l

0.63

298

Multiple gestation

392

1.15

0.37

1.4

1.3

6.49

6.41

g/l

0.10

273

Other and unspecified injuries of head

170

1.24

0.37

1.2

1.3

5.58

6.75

g/l

1.17

116

Dental caries 3 and operation codes, only avohilmo

181

972

0.93

0.37

1.4

6.34

6.86

g/l

1.59

122

696

Open bite

216

1.21

0.37

1.2

1.4

7.02

6.24

g/l

1.00

154

Antenatal screening

105

645

0.92

0.36

1.2

1.4

6.51

6.46

g/l

0.07

462

Polycystic ovarian syndrome, broad definition

451

1.13

0.35

1.5

1.4

6.31

6.55

g/l

0.30

323

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.40

0.35

1.0

1.4

5.88

6.54

g/l

—

Malignant neoplasm of urinary organs

245

1.19

0.35

1.0

1.3

6.82

7.00

g/l

0.09

177

Unspecified lump in breast

584

1.11

0.35

1.6

1.4

5.86

6.61

g/l

1.33

405

Follow-up examination after treatment for malignant neoplasms

218

1.19

0.34

1.2

1.3

5.61

6.82

g/l

1.37

131

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.34

0.34

1.2

1.3

7.89

5.99

g/l

—

Type 1 diabetes, strict (exclude DM2)

461

1.13

0.33

1.2

1.4

6.27

6.58

g/l

0.27

335

Colorectal adenocarcinoma

573

0.89

0.33

1.3

6.40

6.99

g/l

0.54

400

Focal epilepsy, strict definition

739

1.10

0.33

1.3

6.40

6.65

g/l

0.22

525

Pedal cyclist injured in noncollision transport accidents

435

0.87

0.33

1.5

1.3

6.14

6.59

g/l

0.48

300

Obstructed labour due to malposition and malpresentation of fetus

981

0.92

0.32

1.3

1.4

7.08

6.49

g/l

0.70

700

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.28

0.32

1.0

1.3

5.88

6.35

g/l

—

Twin gestation

379

1.14

0.32

1.4

1.3

6.43

6.40

g/l

0.04

262

Pedestrian injured in collision with pedal cycle

1.33

0.32

1.2

1.3

7.07

6.68

g/l

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

1.33

0.32

1.5

1.2

7.38

7.39

g/l

—

Type 1 diabetes, definitions combined

463

1.12

0.32

1.2

1.3

6.27

6.59

g/l

0.28

338

Toxic effects of substances chiefly nonmedicinal as to source

427

1.13

0.31

1.3

6.31

6.57

g/l

0.27

304

Malignant neoplasm of skin

247

1770

1.05

0.31

1.5

1.4

6.38

7.01

g/l

1.64

174

1216

Labour and delivery complicated by fetal stress [distress]

123

764

1.07

0.31

1.2

1.4

6.88

6.32

g/l

1.11

545

Malignant melanoma, excluding all cancers (controls excluding all cancers)

551

1.11

0.31

1.3

1.4

7.46

6.76

g/l

0.38

384

Carcinoma in situ of cervix uteri

347

0.86

0.30

1.5

1.4

7.52

6.30

g/l

0.48

239

Maternal care related to the fetus and amniotic cavity and possible delivery problems

236

1321

1.05

0.30

1.4

6.56

6.59

g/l

0.05

177

950

Deep bite

424

1.12

0.30

1.3

1.4

6.36

6.62

g/l

0.28

312

Viral hepatitis

268

1.16

0.30

1.1

1.3

6.67

6.72

g/l

0.03

187

Transient global amnesia

260

0.85

0.29

2.5

1.4

5.55

7.23

g/l

2.21

176

Pre-eclampsia or eclampsia

102

948

1.08

0.29

1.5

1.4

6.55

6.69

g/l

0.19

658

Pedal cyclist injured in transport accident

929

0.93

0.28

1.5

1.3

6.78

6.71

g/l

0.07

652

Single delivery by forceps and vacuum extractor

459

0.91

0.28

1.2

1.4

7.63

6.37

g/l

1.24

346

Non-small cell lung cancer, adenocarcinoma

140

1.22

0.27

1.1

1.2

7.48

7.23

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

140

1.22

0.27

1.1

1.2

7.48

7.23

g/l

—

Burn and corrosion of head and neck

1.23

0.27

1.3

6.94

g/l

—

Ectopic pregnancy

749

1.08

0.27

1.4

6.20

6.97

g/l

1.56

524

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

113

1.24

0.26

1.0

1.3

6.93

6.95

g/l

—

Clear cell adenocarcinoma of kidney

113

1.24

0.26

1.0

1.3

6.93

7.01

g/l

—

Colorectal cancer

708

0.92

0.26

1.2

1.4

6.83

7.01

g/l

0.14

499

Nontraumatic intracranial haemmorrhage

596

1.09

0.26

1.3

1.4

7.30

6.81

g/l

0.54

413

Otosclerosis

244

1.15

0.25

1.0

1.5

8.35

7.06

g/l

0.90

170

Macular hole

127

0.79

0.25

1.1

1.5

6.22

7.41

g/l

—

Benign neoplasm of other and unspecified female genital organs

123

1.22

0.25

1.5

1.7

6.76

6.55

g/l

—

Other disorders of penis

339

1.12

0.25

1.6

1.3

6.59

6.86

g/l

0.22

243

Sulfonylureas

110

935

0.94

0.25

1.1

1.4

7.23

7.13

g/l

0.08

632

416

1.11

0.24

1.2

1.4

6.39

6.43

g/l

0.06

285

Burn and corrosion of trunk

1.27

0.24

1.3

5.84

6.85

g/l

—

Complications of labour and delivery

321

1727

1.04

0.24

1.3

1.4

6.66

6.61

g/l

0.08

225

1213

Benign neoplasm of breast

444

0.90

0.24

1.3

1.4

6.52

6.71

g/l

0.14

310

Carcinoma in situ of cervix uteri

339

0.88

0.24

1.5

1.4

7.52

6.42

g/l

0.42

235

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

254

0.87

0.23

1.4

1.3

6.04

7.13

g/l

0.79

178

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

504

1.09

0.23

1.2

1.3

6.06

6.89

g/l

1.52

355

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

504

1.09

0.23

1.2

1.3

6.06

6.71

g/l

1.11

358

Diabetes mellitus in pregnancy

163

1006

1.05

0.23

1.2

1.4

6.13

6.62

g/l

1.33

118

724

Supervision of high-risk pregnancy

107

608

1.06

0.23

1.4

6.50

6.49

g/l

0.02

438

Memory loss

237

1.14

0.23

1.2

1.4

6.93

7.05

g/l

0.03

164

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

264

0.87

0.23

1.3

1.4

5.96

6.92

g/l

0.71

188

Other specified disorders of external ear

1.24

0.23

1.8

1.3

4.94

7.73

g/l

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

463

0.91

0.22

1.4

7.35

6.74

g/l

0.24

327

Left ventricular outflow tract obstruction, narrow definition

181

1.16

0.22

1.5

1.3

7.27

6.57

g/l

0.23

128

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

556

0.92

0.22

1.3

1.4

6.40

6.86

g/l

0.40

387

Use of disulfiram, acamprosate or naltrexone

343

1.11

0.22

1.4

1.3

5.91

6.63

g/l

0.91

231

Other viral hepatitis

229

1.14

0.21

1.1

1.3

6.84

6.70

g/l

0.06

159

HSIL lesion of the vagina

1.19

0.21

1.4

9.80

7.16

g/l

—

Poor fetal growth

566

1.08

0.20

1.3

1.4

7.12

6.45

g/l

0.70

402

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

145

1.17

0.20

1.1

1.4

7.48

6.98

g/l

—

103

Dental caries 2 and operation codes, only avohilmo

411

2482

1.03

0.20

1.4

6.88

6.73

g/l

0.37

314

1692

Type 1 diabetes, strict definition, subgroup 1

344

1.10

0.20

1.3

6.06

6.53

g/l

0.36

262

Other and/or unspecified nontoxic goitre

261

0.88

0.20

3.3

1.3

5.82

6.97

g/l

1.29

179

Convergent concomitant strabismus

240

1.13

0.20

1.5

1.4

6.84

6.66

g/l

0.08

172

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.18

0.19

1.2

1.3

7.80

6.80

g/l

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

726

0.94

0.19

1.2

1.4

7.66

6.86

g/l

0.60

510

Malignant neoplasm of ovary

122

0.82

0.19

1.4

1.6

4.64

6.81

g/l

—

Malignant neoplasm of corpus uteri

213

1.13

0.18

1.1

1.4

7.57

6.99

g/l

0.26

147

Family history of malignant neoplasm

386

1.09

0.18

1.2

1.4

6.74

6.58

g/l

0.05

276

Alcohol withdrawal state with delirium

223

1.12

0.18

1.1

1.2

5.77

7.02

g/l

1.35

156

Postpartum hemorraghe, all women as controls

111

1159

0.95

0.18

1.2

1.4

6.87

6.59

g/l

0.49

824

Placenta praevia

185

1.14

0.18

1.3

1.4

6.66

6.37

g/l

0.10

126

malignant neoplasm of female genital organs

475

0.93

0.17

1.2

1.5

6.60

6.68

g/l

0.04

318

Renal cell carcinoma of kidney

0.72

0.17

1.0

1.2

7.29

7.64

g/l

—

Abnormal spermatozoa

359

1.09

0.16

1.2

1.3

6.74

7.07

g/l

0.17

256

Chronic viral hepatitis

194

0.88

0.16

1.1

1.3

7.36

6.63

g/l

0.24

135

Retinal detachment with retinal break

402

0.92

0.16

1.6

1.4

6.52

6.87

g/l

0.28

289

Myocardial infarction, unclassifiable

515

0.93

0.16

1.3

8.04

6.99

g/l

1.03

365

Postpartum haemorrhage

111

1010

0.96

0.16

1.2

1.4

6.87

6.51

g/l

0.68

721

Malignant neoplasm of rectum

246

0.89

0.16

1.4

1.3

5.87

7.12

g/l

0.80

172

Struck by thrown, projected or falling objec

158

1.14

0.16

1.3

7.08

6.39

g/l

—

110

Abnormalities of forces of labour

463

0.93

0.16

1.3

1.4

6.01

6.55

g/l

0.63

326

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.83

0.14

1.4

1.3

6.41

5.89

g/l

—

Lesion of plantar nerve

189

1.11

0.13

2.2

1.4

6.78

7.03

g/l

0.14

133

Adenocarcinoma and papilloma adenocarcinoma of rectum

242

0.91

0.13

1.4

1.3

6.04

7.13

g/l

0.79

171

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

252

0.91

0.12

1.3

1.4

5.96

6.91

g/l

0.69

178

Single delivery by caesarean section

100

557

1.04

0.11

1.4

6.51

6.53

g/l

0.02

424

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

143

1.12

0.11

1.4

1.3

6.15

6.93

g/l

—

104

Other obstructed labour

298

1.07

0.11

1.2

1.4

6.00

6.57

g/l

0.63

205

Pedal cyclist injured in collision with motor vehicle

1.16

0.11

2.0

1.3

5.82

6.84

g/l

—

Malignant melanoma of skin

321

0.93

0.10

1.4

8.03

6.87

g/l

0.37

229

Acute appendicitis, with complications

759

0.96

0.10

1.4

1.3

6.10

6.69

g/l

0.76

532

HSIL lesion of the vulva

1.14

0.10

1.2

1.3

7.70

7.23

g/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

232

1.08

0.09

2.0

1.4

6.89

6.56

g/l

0.23

167

Benign neoplasm of breast

422

0.95

0.09

1.3

1.5

6.52

6.68

g/l

0.11

295

Other complications of labour and delivery, not elsewhere classified

470

1.05

0.09

1.1

1.4

6.68

6.37

g/l

0.33

334

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

552

0.96

0.08

1.2

1.4

7.22

6.84

g/l

0.35

380

Congenital malformations of aortic and mitral valves

146

1.10

0.08

1.4

1.3

7.44

6.63

g/l

0.20

103

Spermatocele

224

1.07

0.08

1.5

1.3

5.88

7.11

g/l

1.16

153

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.77

0.08

1.0

1.2

7.29

7.25

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

156

1.09

0.08

1.1

1.3

6.36

6.30

g/l

—

111

Other disorders of prostate

1.05

0.08

1.6

1.2

5.96

7.62

g/l

—

Unspecified mental disorder

195

1915

1.02

0.08

1.2

1.4

6.53

6.81

g/l

0.46

135

1313

Gestational diabetes (for exclusion)

176

1269

0.98

0.07

1.2

1.4

6.27

6.63

g/l

0.85

129

910

Other obstetric trauma

215

1.07

0.07

1.1

1.3

6.49

6.18

g/l

0.25

152

Divergent concomitant strabismus

284

1.06

0.07

1.7

1.4

6.53

6.79

g/l

0.12

195

Burns and corrosions of external body surface, specified by site

422

1.04

0.07

1.6

1.3

5.95

6.58

g/l

0.79

297

Failed induction of labour

216

1.07

0.06

1.3

1.4

5.98

6.20

g/l

0.13

150

Benign neoplasm of other and unspecified female genital organs

138

1.09

0.06

1.5

1.6

6.76

6.78

g/l

—

Multiple delivery

364

1.04

0.06

1.4

1.3

6.21

6.53

g/l

0.40

278

Antepartum haemorrhage, not elsewhere classified

386

0.96

0.06

1.3

7.10

6.46

g/l

0.28

274

Pedal cyclist injured in other and unspecified transport accidents

404

1.04

0.06

1.3

7.19

6.62

g/l

0.47

279

Uterine polyps

335

0.95

0.06

1.4

5.41

6.65

g/l

2.39

235

Subarachnoid haemorrhage

294

0.95

0.06

1.4

7.34

6.76

g/l

0.34

205

Crowding of teeth, including avohilmo

334

0.96

0.05

1.3

1.4

6.32

g/l

0.00

239

Thyrotoxicosis with toxic multinodular goitre

151

0.93

0.05

2.0

1.5

5.81

7.20

g/l

—

107

Fall on and from ladder

228

1.05

0.05

1.4

1.2

8.04

6.95

g/l

0.52

162

severe traumatic brain injury, does not include concussion

703

1.02

0.05

1.5

1.3

7.43

6.88

g/l

0.42

491

Fracture of forearm

249

2356

0.99

0.05

1.3

1.4

6.65

6.69

g/l

0.07

177

1633

Traumatic amputation of wrist and hand

119

0.92

0.04

1.5

1.3

5.38

6.91

g/l

—

Abnormal findings on antenatal screening of mother

351

0.97

0.03

1.5

5.42

6.62

g/l

1.71

253

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

590

1.02

0.02

1.2

1.5

6.62

6.82

g/l

0.16

408

Colon adenocarcinoma

282

1.03

0.02

1.2

1.3

6.72

6.94

g/l

0.11

200

Contact with sharp glass

127

0.94

0.01

1.2

1.3

5.52

6.49

g/l

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

297

0.98

0.01

1.2

1.4

6.72

7.03

g/l

0.16

208

Orchitis and epididymitis

293

1.02

0.01

1.3

7.09

6.97

g/l

0.07

202

Type1 diabetes, definitions combined, early onset

322

1.02

0.01

1.3

6.31

6.52

g/l

0.12

234

Schizophrenia or delusion, excluding more controls

121

1193

1.01

0.01

1.2

1.4

6.89

6.81

g/l

0.07

794

Retained placenta and membranes, without haemorrhage

494

1.01

0.00

1.3

1.4

5.92

6.47

g/l

0.67

338

Maternal care for known or suspected abnormality of pelvic organs

116

796

1.01

0.00

1.3

1.4

6.15

6.56

g/l

0.67

572

Malignant neoplasm of colon

391

1.00

0.00

1.1

1.3

7.38

6.78

g/l

0.43

275

Postpartum hemorraghe, parous women as controls

111

968

1.00

0.00

1.2

1.3

6.87

6.58

g/l

0.52

680

Other sexually transmitted chlamydial diseases

251

1.00

0.00

1.3

1.4

6.90

6.58

g/l

0.19

166

Burns and corrosions

565

0.99

0.00

1.5

1.3

6.24

6.59

g/l

0.40

393

Combinations of oral blood glucose lowering drugs

103

1035

1.00

0.00

1.3

1.4

7.33

6.99

g/l

0.36

708

Respiratory and cardiovascular disorders specific to the perinatal period

141

1.01

0.00

1.8

1.3

5.61

6.11

g/l

0.42

122

Burn and corrosion of wrist and hand

108

1.02

0.00

2.1

1.3

5.28

6.47

g/l

0.80

Maternal care for cervical incompetence

119

1.01

0.00

1.3

1.5

6.53

6.63

g/l

—

Type 1 diabetes, strict definition

394

1.01

0.00

1.3

6.13

6.53

g/l

0.31

290

Respiratory distress of newborn

107

1.04

0.00

2.0

1.3

5.24

5.96

g/l

0.67

Rubella [German measles]

123

0.98

0.00

2.5

1.3

4.98

6.40

g/l

—

Liveborn infants according to place of birth

0.94

0.00

1.0

1.2

5.96

6.01

g/l

—

Staphylococcal scalded skin syndrome

0.00

0.0

1.2

—

7.20

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

1.4

—

7.27

—

Exposure to other and unspecified man-made environmental factors

1.02

0.00

1.0

1.3

6.22

6.77

g/l

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

0.97

0.00

1.2

5.83

6.98

g/l

—

Malignant neoplasm of testis

1.02

0.00

1.2

1.4

7.76

7.38

g/l

—

Burns and corrosions of multiple and unspecified body regions

0.99

0.00

1.0

1.3

7.17

7.13

g/l

—

Assault by hanging, strangulation and suffocation

0.00

0.0

1.0

—

5.42

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.0

1.0

—

5.76

—

Congenital malformation of optic disc

0.00

0.0

1.0

—

5.75

—

Other perinatal haematological disorders

0.00

0.0

1.1

—

5.81

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.3

—

6.83

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.0

1.4

—

5.17

—

Hirsprung

0.00

0.0

1.0

—

4.87

—

Birth injury to skeleton

0.00

0.0

1.5

—

6.99

—

Acne varioliformis

0.00

0.0

1.0

—

5.94

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.2

—

6.89

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 1 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS